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Abstract 
 
Podosomes are adhesion structures formed at the ventral side of cells whose 
physiological functions require an efficient cell migration across tissues. In 
addition to their adhesive properties, podosomes display a protrusive activity 
responsible for the local degradation of matrix components that helps cells to 
migrate across basement membranes. Because of their ability to degrade matrix 
components, podosome formation, activity and turnover need to be tightly 
regulated to avoid an uncontrolled protrusive activity that could damage tissues.   
The kinesin-3 KIF1C was shown to contribute to the regulation of podosome 
dynamics in macrophages and here, we used depletion-rescue and dominant 
negative approaches to show that KIF1C activity is required for podosome 
formation in A7r5 cells. Little is known about the mechanism regulating KIF1C 
activity. To better understand the molecular mechanism underlying the KIF1C-
control of podosome formation in A7r5 cells, we generated different truncations 
of the KIF1C tail, tested the ability of each construct to mediate podosome 
formation in these cells and identified a ~150 amino acid long region between 
KIF1C third and fourth coiled-coil domains that is required for podosome 
formation in A7r5 cells, suggesting that this ~150 amino acid long region of 
KIF1C tail participates in the regulation of KIF1C activity during the podosome 
formation process. This region of KIF1C tail is known to interact with two 
proteins that were both described for their involvement in the regulation of 
cellular adhesion: the non-muscle Myosin IIA and the Protein Tyrosine 
Phosphatase PTPD1.  
We addressed the involvement of the non-muscle Myosin IIA in podosome 
formation in A7r5 cells using two Myosin inhibitor: Blebbistatin and the Y27632 
ROCK inhibitor. The treatment of A7r5 cells with one or the other Myosin IIA 
inhibitor had no effect on the ability of these cells to form podosomes, 
suggesting that the non-muscle Myosin IIA is not required for the formation of 
podosomes in A7r5 cells. We therefore ruled out its involvement in the 
regulation of KIF1C activity during the podosome formation process to focus our 
work on PTPD1. 
PTPD1 is a scaffolding tyrosine phosphatase known to regulate focal adhesion 
and stress fibre stability. Using a depletion-rescue approach, we showed that 
PTPD1 expression is absolutely required for podosome formation in A7r5 cells. 
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As PTPD1 displays both a scaffolding and a phosphatase activity, we used the 
catalytic inactive mutant of the phosphatase PTPD1-C1108S to discriminate 
between these two activities and show that PTPD1 ability to mediate podosome 
formation in A7r5 cells does not require its catalytic activity.  
Because PTPD1 and KIF1C depletions performed independently of each other 
both led to a decrease of the ability of A7r5 cells to form podosomes and 
because these two proteins interact with each other, we tested the ability of 
PTPD1 and KIF1C to cooperate with each other to mediate podosome formation 
and showed that PTPD1-C1108S over-expression in KIF1C-depleted cells 
restored the ability of A7r5 cells to efficiently form podosomes. Taken together, 
results obtained suggested that the interaction of PTPD1 with KIF1C could 
stimulate the activity of the remaining pool of KIF1C motors.  
To test this hypothesis, we used a pre-established α5-integrin transport assay, 
as KIF1C is a known α5-integrin transporter and its motor activity can therefore 
be assessed by following its ability to transport GFP-tagged α5-integrin cargoes 
to the tail of migratory RPE-1 cells. Using this assay in KIF1C-depleted RPE-1 
cells stably expressing GFP-α5-integrin, we showed that PTPD1 over-
expression restores the transport of α5-integrin to the tail of RPE-1 cells, 
therefore stimulating the activity of the remaining pool of KIF1C motors. 
Results obtained in this study and in vitro data generated during the course of 
this work allowed us to establish the following model for KIF1C activation: in the 
absence of PTPD1, KIF1C is in its auto-inhibitory state and can't ensure its 
cellular function. In presence of PTPD1, the phosphatase binds to KIF1C tail, 
inducing the activation of the motor that can thus mediate podosome formation 
and transport α5-integrins to the tail of RPE-1 cells.   
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Chapter 1: Introduction 
 
 
1-1: Overview of the microtubule cytoskeleton and the kinesin 
family of molecular motors 
 
Cellular architecture and many cellular functions rely on the 
cytoskeleton, a dynamic structure made of four types of polymers: actin 
filaments, microtubules, intermediate filaments and septin filaments. Each type 
of cytoskeletal element displays a specific composition and ensures a specific 
range of function. Actin filaments mainly ensure cellular adhesion to the 
substratum and support cellular architecture (Revenu et al., 2004; Blanchoin et 
al., 2014) while microtubules are mainly used as tracks for the transport of 
cargoes to specific areas of the cell during interphase and form the mitotic 
spindle during cell division. Intermediate filaments mainly ensure the positioning 
of the nucleus in the cell and septin filaments act as scaffolding structures 
ensuring the interaction of proteins with each other (Mostowy & Cossart, 2012). 
Despite these features that are specific for each cytoskeletal element, the four 
types of filaments work together to ensure cellular functions.  
 
In this study, we are interested in microtubules (MTs), polar polymers of 
α and β-tubulin heterodimers that have a slow growing minus-end anchored in 
the Microtubule Organizing Centre (MTOC) they grow from and a fast growing 
plus-end. MTs are characterized by their ability to rapidly alternate between 
phases of growth and shrinkage, a phenomenon called dynamic instability 
(Mitchison & Kirschner, 1984). In many cells, the majority of MTs are anchored 
with their minus-end at the MTOC close the nucleus and with their plus-end 
extending towards the cell periphery. MTs are decorated by various 
microtubule-associated proteins (MAPs) that regulate their growth, stability, 3-
dimensional organisation or use them as tracks to ensure the trafficking of 
cargoes throughout the cell. Two classes of microtubule-based molecular 
motors ensure the transport of proteins or organelles throughout the cell: 
kinesins, most of them mediating plus end-directed transport and dyneins 
responsible for the minus end-directed traffic. These MT-based motors ensure 
the long-range cargo transport from one point of the cell to the other. 
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The first kinesin was identified in the middle of the 1980’s in the axon of 
the giant squid (Vale et al., 1985) and in sea urchin eggs (Scholey et al., 1985). 
The characterization of this first kinesin opened the way to the identification of a 
growing number of kinesins or kinesin-like proteins (KLPs) in the following 
years. Today, the human genome is known to contain at least 45 kinesin genes 
but alternative mRNA splicing might generate more than 45 distinct proteins 
(Miki et al., 2001). These have been classified in 14 subfamilies based on the 
position of their motor domain and the sequence homology of their tails 
(Lawrence et al., 2004) (Figure 1.1 A). 
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Figure 1.1: Kinesin families and structures. 
(A) Phylogenic tree of the 14 kinesin families. Blue: N-kinesins, Green: C-kinesins, 
Orange: M-kinesins. (B) N-kinesins move towards MT plus-end while C-kinesins move 
towards MT minus-end. M-kinesins induce the depolymerization of the MT they interact 
with. (C) Schematic representation of tetrameric, dimeric and monomeric kinesin 
structures.  
Based on Hirokawa et al., 2009. 
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1-2: Kinesin structure 
 
All kinesins share the same basic structure made of a conserved ~350 
amino acid long motor domain and a tail responsible for cargo binding, kinesin 
regulation and protein oligomerization. The position of the motor domain relative 
to the tail determines the directionality of the kinesin movement along MTs. 
Kinesins displaying an amino-terminal motor domain are MT plus-end-directed 
motors (N-kinesins; kinesin-1 to 12), while C-kinesins (kinesin-14), whose motor 
domain is positioned at their carboxy-terminal end move towards the minus-end 
of MTs. A third group of kinesins containing a central motor domain (M-kinesins; 
Kinesin-13) has been identified. On the contrary to N- and C-kinesins, M-
kinesins are not involved in cargo transport but are responsible for the 
destabilization and the depolymerization of MTs they interact with (Figure 1.1B; 
Hirokawa et al., 2009). 
The motor domain contains a MT-binding site (Woehlke et al., 1997) and a 
nucleotide-binding site (P-loop) while kinesin tail contains a various number of 
coiled-coil domains suspected to mediate kinesin oligomerization. The tail can 
also contain other structural domains specific of a kinesin subfamily (Hirokawa 
et al., 2009), such as light chain binding sites (Diefenbach et al., 1998), 
Forkhead homology-associated (FHA) domains (Miki et al., 2005) or additional 
MT-binding sites (Straube et al., 2006). 
 
Kinesin quaternary structure can vary from one kinesin subfamily to the 
other (Figure 1.1C). Some kinesins, as conventional kinesin-1 are tetramers 
made of two Kinesin Heavy Chains (KHCs) bearing the motor activity and two 
Kinesin Light Chains (KLCs) that mediate cargo binding and regulate KHC 
motor activity (Kuznetsov et al., 1988). Other kinesins, such as kinesin-2s, are 
heterotrimers made of two different but complementary motor chains (KIF3A 
and KIF3B) associated to a non-motor regulatory chain (KAP3) (Yamazaki et al., 
1996). Lastly, some kinesins are thought to be monomeric, as the kinesin-3 
KIF1A  (Okada et al., 1995) and KIF1B (Nangaku et al., 1994). Despite these 
structural differences, all kinesins use MTs as tracks to move within the cell, 
although the establishment of a canonical model to describe kinesin mechanical 
movement and its regulation is difficult because of this structural variability. 
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1-3: Kinesin function and regulation 
 
All kinesins use the chemical energy produced by ATP hydrolysis to 
move along MTs. The kinesin motor domain binds an ATP nucleotide in its P-
loop and hydrolyzes it to ADP-Pi. The chemical energy released by this ATPase 
activity is then converted into a mechanical force that promotes kinesin stepping 
on the MT track (Endow, 1999; Vale et al., 2000). Thus, kinesins oscillate 
between two states depending on the nucleotide bound in their motor domain. 
ATP binding in the P-loop makes the MT-binding domain of the kinesin 
accessible for tubulin interaction and hence, confers a high MT affinity to the 
motor domain. ATP hydrolysis induces a conformational change in the motor 
domain structure that impairs the kinesin interaction with tubulin (Naber et al., 
2003). Kinesin movement along MTs comes from the repetition of the cycling 
between the two states over time.   
 
Kinesin activity needs to be accurately regulated to ensure its efficiency 
and several levels of regulation have been described. The conventional kinesin-
1 has been extensively studied to understand the conformational change that 
occurs upon kinesin activation by cargo binding. Inactive kinesin-1 adopts a 
“closed” conformation, its tail interacting with the motor domain and covering its 
MT-binding domain, hence abolishing kinesin interaction with MTs and futile 
ATP hydrolysis. Upon cargo binding, the tail detaches from the motor domain 
that can then interact with and move along the MT (Coy et al., 1999).  
Kinesin activity can also be regulated by reversible post-translational 
modifications of specific residues of the motor domain or the kinesin tail.  The 
phosphorylation of specific serine residues of the kinesin motor domain was 
shown to stabilize kinesins “closed” conformation to negatively regulate kinesin 
motor activity (DeBerg et al., 2013; Morfini et al., 2009). The phosphorylation of 
tail residues can also modulate kinesin activity by promoting (Ichimura et al., 
2002) or inhibiting (Guillaud et al., 2008; Vagnoni et al., 2011) cargo binding. 
 
Kinesin regulation is complex due to the diversity of cargoes these 
motors transport within the cell. It is understood that cargo selection relies on 
adaptor proteins that link a cargo to the motor that transports it. Nonetheless, 
mechanisms governing the timing of cargo loading onto kinesins and controlling 
the delivery to specific cellular locations remain unclear. The timing of cargo 
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loading could be controlled by phosphorylation of the adaptor protein linking the 
cargo to its motor (Horiuchi et al., 2007). However, the control of cargo loading 
on a kinesin could be more complex as more than one adaptor protein may be 
required to ensure the cargo linkage to the kinesin that transports it (Blasius et 
al., 2007; Franker & Hoogenraad, 2013).  
As for the selection of cargo delivery site, it could rely on the MT track itself as 
tubulin can be post-translationally modified and these tubulin modifications were 
shown to have an influence on kinesin movement along MTs. For instance, 
KIF1C and KIF16B traffic to the cellular periphery is impaired upon MT 
acetylation (Bhuwania et al., 2014). Moreover, MTs are decorated with 
numerous MAPs that can modulate MT dynamics and kinesin affinity for the MT 
track (Trinczek et al., 1999; Sung et al., 2008; Lipka et al., 2016).  
 
1-4: The kinesin-3 family 
  
Kinesin-3s form a subfamily of N-kinesins whose founding member 
(Unc-104) was identified in the nematode Caenorhabditis elegans as an axonal 
synaptic vesicle transporter (Hall & Hedgecock, 1991; Otsuka et al., 1991). The 
first Unc-104 mammal ortholog was identified later as the murine KIF1A (Okada 
et al., 1995) and since then, the kinesin-3 family expended to also include 
KIF1B, KIF1C, KIF13A, KIF13B, KIF14, KIF16A and KIF16B (Lawrence et al., 
2004; Figure 1.1A). 
 
 Kinesin-3s share the overall N-kinesin structure made of a N-terminal 
motor domain followed by a cargo binding tail. In addition to this common basic 
structure, kinesin-3s display two more characteristics: a K-loop insertion in their 
motor domain (Marx et al., 2009) and the presence of a Forkhead homology-
associated (FHA) domain in their tail (Miki et al., 2005).  
K-loops are clusters of lysine residues in the MT-binding site of the kinesin-3 
motor domain (Marx et al., 2009). This positively charged motif is thought to 
interact with the negatively charged glutamate-rich tubulin C-terminal tail (E-
Hook) to facilitate kinesin interaction with MTs, retain the motor in close 
proximity to the MT track and avoid its release from the surface of the MT during 
the nucleotide exchange step of the ATP hydrolysis cycle (Soppina & Verhey, 
2014).  
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The second kinesin-3 specific feature is the presence of a structural FHA 
domain in the kinesin tail. This motif is found in a broad variety of proteins, such 
as transcription factors, phosphatases and kinesins (Hofmann & Bucher, 1995; 
Li et al., 2000). In addition to their structural properties, FHA domains 
specifically recognize and bind phosphoserine and phosphothreonine motive to 
mediate protein interactions (Li et al., 2000).  
 
 Kinesin-3 oligomeric status as well as its regulation have been the area 
of great debates and investigations. First studies conducted on KIF1A 
concluded on its monomeric status and its processive movement along MTs 
explained by the interaction of the kinesin K-loop with the tubulin E-hook during 
its MT low-affinity state (Okada & Hirokawa, 2000). However, several studies 
later on contradicted this unconventional monomeric status of kinesin-3s both in 
vitro and in vivo as kinesin-3 oligomeric status seems to be regulated by the 
local concentration of the motor (Al-Bassam et al., 2003; Lee et al., 2004; 
Hammond et al., 2009; Huckaba et al., 2011). At low local concentration, KIF1A 
adopts a closed conformation due to intra-molecular interactions (Al-Bassam et 
al., 2003; Lee et al., 2004) and is found as a monomer in cells. However, a local 
increase of the kinesin-3 concentration, at the membrane of cargoes for 
instance, destabilizes the intra-molecular interactions, enabling kinesin-3s to 
dimerize and move along MTs processively (Soppina et al., 2014; Huo et al., 
2012). 
 
Kinesin-3s were shown to transport various types of cargo, including 
synaptic vesicles (KIF1A and KIF1C; Hall & Hedgecock, 1991; Okada et al., 
1995), mitochondria (KIF1B; Nangaku et al., 1994) or proteins involved in the 
regulation of cellular adhesion (KIF1C; Theisen et al., 2012). Some kinesin-3s 
were also shown to participate to the regulation of the cell cycle. The drosophila 
kinesin-3 Khc73 (Siegrist & Doe, 2005) has been shown to participate to the 
polarization of Drosophila neuroblasts, a phenomenon that is essential for 
neuroblast assymetric division (Siegrist and Doe, 2005) and the kinesin-3 KIF14 
was shown to regulate chromosome congression, alignment and segregation 
during mitosis (Zhu et al., 2005; Carleton et al., 2006) 
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1-5: The kinesin-3 KIF1C 
  
The kinesin-3 KIF1C has been identified in a yeast two-hybrid screen for 
its interaction with the FERM (4.1 Ezrin Radixin Moesin) domain of the Tyrosine 
phosphatase PTPD1 (Protein Tyrosine Phosphatase D1) and named after 
KIF1A and KIF1B because of the high degree of sequence homology in their 
motor domain (Dorner et al., 1998). KIF1C is a 1.103 amino acid long fast non-
processive molecular motor (Rogers et al., 2001) sharing the two kinesin-3 
specific features: it contains a K-loop in its motor domain (Rogers et al., 2001) 
and a FHA domain (amino acids 523 to 590) in its tail. KIF1C FHA domain is 
flanked by four coiled-coil domains and a proline-rich domain at the very 
carboxy-terminal end (Figure 1.2). 
 
 
Figure 1.2: KIF1C domain structure and identified binding sites of its known interactors. 
 
 
KIF1C is ubiquitously expressed and preferentially accumulates in the 
pericentrosomal region of the cell, in close proximity to the Golgi apparatus 
(Dorner et al., 1998; Nakajima et al., 2002; Kopp et al., 2006; Efimova et al., 
2014), a localization that is in agreement with its cargo transport activity. Indeed, 
the Golgi apparatus acts as a hub for protein maturation, loading of molecular 
motors and distribution to the cellular periphery. Some proteins need to be re-
routed from the Golgi apparatus to the Endoplasmic Reticulum (ER) because 
they are ER-residing proteins or because they are misfolded. Cell treatment with 
the Golgi disrupting agent Brefeldin-A (BFA) highlighted the involvement of 
KIF1C in the retrograde transport of Golgi vesicles to the ER (Figure 1.3; Dorner 
et al., 1998). Nonetheless, KIF1C might not be the only molecular motor 
involved in this retrograde transport as its knockout has no significant effect on 
this Golgi to ER retrograde transport (Nakajima et al., 2002).  
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In addition to a potential role in Golgi to ER retrograde transport activity, 
KIF1C is also required for the maintenance of the Golgi structure, a function that 
seems to be independent of its motor activity (Simpson et al., 2012; Lee et al., 
2015). A first clue to explain the involvement of KIF1C in the maintenance of the 
Golgi apparatus structure was provided recently when Rab6 was identified as 
new interactor for KIF1C (Lee et al., 2015). Rab6 is a cargo adaptor protein that 
mainly localizes to the trans-Golgi network (Antony et al, 1992) where it controls 
the trafficking of proteins to and from it (Storrie et al, 2012). Both KIF1C and 
Rab6 depletions performed independently from each other lead to the same 
phenotype of Golgi fragmentation, suggesting that they cooperate to ensure the 
maintenance of the Golgi structure (Storrie et al., 2012; Lee et al., 2015).  
 
To a lesser extent, KIF1C also localizes at the cell periphery where it 
participates to the regulation of cellular adhesion. In macrophages, KIF1C has 
been shown to accumulate at the plus-end of a subset of MTs responsible for 
the targeting of peripheral podosomes (Figure 1.3; Chapter 1-9). The repeated 
targeting of these peripheral podosomes by KIF1C-decorated MTs induces their 
fission or their dissolution (Kopp et al., 2006). KIF1C seems to participate in the 
control of podosome targeting by MTs. Indeed, it decorates the plus-end of a 
subset of MTs and only these KIF1C-decorated MTs seem to be able to contact 
peripheral podosomes to induce their fission or dissolution whereas non-
decorated MTs do not target peripheral podosomes (Kopp et al., 2006). 
Moreover, as mentioned above, only peripheral podosomes are targeted by 
KIF1C-decorated MTs, suggesting an unknown guidance mechanism. It has 
been suggested that KIF1C’s interaction with the non-muscle Myosin IIA could 
guide targeting MTs to podosome sites as Myosin IIA is known to localize to 
podosomes (Kopp et al., 2006; Bhuwania et al., 2012; van den Dries et al., 
2013) and Myosin IIA has been co-precipitated with KIF1C from cell extracts, 
suggesting a physical interaction (Kopp et al., 2006). 
 
 
 10 
 
Figure 1.3: Schematic representation of motor-based KIF1C functions in cells.  
KIF1C mainly localizes at the perinuclear region to ensure the retrograde transport of 
vesicles from the Golgi to the Endoplasmic Reticulum. At the cell periphery, KIF1C 
accumulates at the plus-end of a subset of MTs that target peripheral podosomes, 
inducing their fission or their dissolution. KIF1C also mediates the transport of α5- 
integrin to the tail formed at the rear of migratory cells to ensure the maturation of rear 
adhesions and facilitate directional persistence of cell migration.  
Based on Kopp et al., 2006; Theisen et al., 2012; Dorner et al., 1998; Nakajima et al., 
2002.  
 
 
 
The involvement of KIF1C in the regulation of cellular adhesion has 
clearly been demonstrated in migratory RPE-1 cells. Indeed, KIF1C has been 
shown to transport the α5-integrin fibronectin receptor to the tail formed at the 
rear of migratory RPE-1 cells (Figure 1.3; Theisen et al., 2012). This KIF1C-
mediated α5-integrin transport activity is required for the maturation of rear 
adhesions and the stability of the tail. Impairing KIF1C-mediated α5-integrin 
trafficking to the cell rear weakens the tail stability and impairs the directionality 
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of the cell migration (Theisen et al., 2012), reinforcing the importance of KIF1C 
for the regulation of cellular adhesion. 
 
 The molecular mechanisms controlling KIF1C movement along MTs 
have not been unraveled yet but KIF1C interacts with various proteins that could 
regulate its activity. KIF1C was first described to interact with 14-3-3 proteins 
through its C-terminal proline-rich domain in a phosphoserine-dependent 
manner (Figure 1.2; Dorner et al., 1999).  
14-3-3 proteins are a family of highly conserved small acidic proteins named 
after their characteristic migration pattern on scratch gel electrophoresis (Moore 
& McGregor, 1965). The 14-3-3 protein family contains at least seven isoforms 
that are ubiquitously expressed and that are able to form homo- or hetero-
dimers interacting with a broad range of proteins (Liu et al., 1995; Xiao et al., 
1995) in a phosphoserine or phosphothreonine dependent manner (Muslin et 
al., 1996). Because 14-3-3 proteins are able to dimerize, each dimer can 
interact with two proteins in the same time to regulate their activity. Indeed, 14-
3-3 protein interaction with their binding partners can either bring these 
interactors in close proximity to one another to stabilize their interaction and 
favor their activation; 14-3-3 protein dimers can also inhibit the activity of bound 
proteins by sequestering them or by competing for the binding of an activator of 
these interactors (Mrowiec & Schwappach, 2006).  Because of their ability to 
interact with numerous proteins, 14-3-3 proteins participate in the regulation of a 
broad spectrum of cellular functions such as cellular adhesion, cell signaling, 
cell metabolism, protein biogenesis or mitosis (Mhawech, 2005).  
 
 14-3-3 proteins are known to participate in the regulation of kinesin-
mediated cargo transport (Geiger et al., 2014; Ichimura et al., 2002). Indeed, in 
addition to their ability to directly bind kinesin tails (Dorner et al., 1999; Ichimura 
et al., 2002), 14-3-3 proteins can interact with cargo adaptors to regulate cargo 
loading onto kinesin tails. For instance, 14-3-3 proteins can interact with the 
cargo adaptor GRIP1 (Glutamate Receptor Interacting Protein 1) in a phospho-
dependent manner to impair its interaction with the conventional kinesin KIF5 
and therefore inhibit the transport of GRIP1-associated vesicles to the cell 
periphery (Geiger et al., 2014).  
14-3-3 proteins are also known to regulate kinesin clustering. Indeed, 14-3-3 
proteins were shown to interact with MKLP1 (KIF23) in a phosphodependent 
manner to regulate its MT bundling activity (Douglas et al., 2010). 
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The relevance of 14-3-3 protein interaction with KIF1C tail has not been 
addressed yet but it could either regulate the binding of KIF1C cargo to the 
kinesin tail or regulate KIF1C folding or dimerization.  
 
KIF1C is known to interact with the dynein adaptor and Rab6 interactor 
Bicaudal D-related protein 1 (BICDR-1) (Schlager et al., 2010) and during the 
course of this work, KIF1C has been shown to directly interact with Rab6 (Lee et 
al., 2015). Rab6 is a cargo adaptor that interacts in a very unusual manner with 
KIF1C as it can interact with both the KIF1C motor domain and a 40 amino acid 
long sequence in the kinesin tail (Figure 1.2). Rab6 interaction with KIF1C tail is 
thought to mediate cargo binding whereas Rab6 interaction with KIF1C motor 
domain inhibits the interaction of the kinesin with MTs and impairs its movement 
along them (Lee et al., 2015).  
 
BICDR-1 interacts with KIF1C, Rab6 and the dynein/dynactin complex 
and is suspected to bring together these proteins to form a molecular complex 
that regulates the bidirectional trafficking of Rab6-associated vesicles during 
neuronal development (Schlager et al., 2010).  Indeed, during early neuronal 
development, BICDR-1 is highly expressed and retains Rab6-associated 
vesicles in the pericentrosomal region due to its ability to bind and activate the 
MT minus end-directed motor dynein. Later, when the neuronal system matures, 
BICDR-1 expression decreases, and the reduction of its expression correlates 
with the gradual scattering of Rab6-associated vesicles towards the cell 
periphery (Figure 1.4; Schlager et al., 2010).  
Hence, a high expression level of BICDR-1 seems to favor the dynein-mediated 
retrograde transport of Rab6-associated vesicles to the detriment of KIF1C 
transport activity. The gradual decrease of BICDR-1 expression with neuronal 
development is suspected to destabilize the balance between dynein and KIF1C 
activities in favor of KIF1C, leading to the transport of Rab6-associated vesicles 
to the cell periphery. Hence, BICDR-1 could act as a molecular switch 
controlling the balance between anterograde and retrograde transport during 
neuronal development (Figure 1.4).  
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Figure 1.4: Model of BICDR-1 control of dynein and KIF1C activities during neuronal 
development. 
BICDR-1, dynein, KIF1C and Rab6 form a complex at the surface of neuronal secretory 
vesicles. At early stages of neuronal development, the high expression of BICDR-1 
favors the Dynein motor activity to the detriment of the KIF1C one leading to the 
retention of Rab6-associated vesicles at the pericentrosomal region. During neuronal 
development, BICDR-1 expression level gradually decreases, destabilizing the balance 
between dynein and KIF1C activities in favor of KIF1C. KIF1C then mediates Rab6-
associated vesicle transport toward the plus-end of MTs.  
Based on Schlager et al., 2010; Lee et al., 2015. 
 
 
The regulation of this balance between plus end-directed and minus 
end-directed transports could be of major importance for neuronal development 
and function as the impairment of KIF1C activity leads to serious neuronal 
defects. Indeed, a point mutation introducing a premature STOP codon in the 
exon 22 of KIF1C gene has been shown to be responsible for the development 
of cerebellar dysfunction and spastic paraparesis in patients carrying this 
mutation, a syndrome caused by nerve dysfunction or defects (Dor et al., 2014; 
Caballero Oteyza et al., 2014).  
 
 
 14 
1-6: Overview of the cellular adhesion system 
 
 Cell matrix adhesions are actin-based structures that were first 
described in 1964 in embryonic chick fibroblasts using Interference Reflection 
Microscopy (Curtis, 1964) and since then, the study of the structure, the 
composition and the dynamics of cell matrix adhesions is the area of active 
investigations. Despite the great progresses that have been made in the field, 
the study of cellular adhesions remain challenging as more than 150 proteins 
have been identified as being involved in the formation and the regulation of 
cellular adhesion (Zaidel-Bar et al., 2007; Byron et al., 2011). Cell matrix 
adhesions are usually classified in four main subfamilies and the current view is 
that each adhesion subtype derives from the maturation of another one: nascent 
adhesions maturate in focal complexes than can evolve in focal adhesions and 
later on, in fibrillar adhesions (Hanein & Horwitz, 2012).  
 
 Nascent adhesions are small (<0.25µm) short-lived adhesions (~1 
minute) formed in the lamellipodium of migratory cells. At the very leading edge 
of migratory cells, signaling events induced by the interaction of 
transmembranous integrin receptors and matrix components induce the local 
polymerization of actin filaments and the recruitment of talin at these sites 
(Izzard, 1988; Parsons et al., 2010). These initial contacts can rapidly (60 to 90 
seconds) maturate into small (<1µm2) dot-like adhesions called focal complexes 
that last for at least several minutes and characterized by their enrichment in the 
tension-sensitive protein vinculin that brings the ventral cell side in close 
proximity to the underlying matrix to locally secure cellular adhesion 
(DePasquale & Izzard, 1987; Izzard, 1988). Whilst nascent adhesions formation 
and maturation is Myosin II-independent, the maturation of focal complexes 
depends on traction forces exerted by the contractile activity of the non-muscle 
Myosin II on these adhesion structures (Parsons et al., 2010; Galbraith et al., 
2002).  
 
 Focal adhesions are stable and elongated adhesions (up to several 
microns) evolving from focal complexes (Zamir et al., 2000; Parsons et al., 
2010) and bridging membrane-substratum adhesion sites to actin stress fibers. 
Focal adhesions are characterized by their enrichment in zyxin (Hanein & 
Horwitz, 2012), a phospho-protein localizing at both focal adhesions and stress 
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fibers to enhance actin polymerization at these sites (Hirata et al., 2008). 
Because of their size (3-10µm long) and their stability, focal adhesions provide 
strong attachment sites for the cell to the substratum (Block et al., 2008; 
Dumbauld et al., 2013). Focal adhesions usually last for 10 to 20 minutes and 
can evolve in fibrillar adhesions when cells are plated on fibronectin and when 
focal adhesions are enriched in the fibronectin α5β1-integrin receptor (Zamir et 
al., 2000; Pankov et al, 2000). Fibrillar adhesions are more elongated and more 
stable than focal adhesions and they are usually associated with larger actin 
bundles and are involved in the assembly and the reorganization of fibronectin 
matrix (Parsons et al., 2010) 
 
 These cell matrix adhesion described above have been extensively 
studied during cell spreading and migration on a 2-Dimensional substratum and 
for a long time, they were thought to form only when cells were plated on a 2-
Dimensional surface as they could not be distinguished in 3D migration assays. 
However, recent progress in microscopy resolution allowed the visualization of 
focal-like adhesions in invasive cells (Kubow & Horwitz, 2011; Kubow et al., 
2013), suggesting that these adhesions structures are not artifact of 2-
Dimensional cell culture but may actually be formed in vivo.    
 
 A fifth type of cell matrix adhesions called invadosomes has been 
described in invasive cells. The term invadosomes designate dot-like adhesion 
structures called podosomes when formed by normal cells and invadopodia 
when formed by cancer cells. Invadosomes differ from cell matrix adhesions 
described above though their columnar-like organization and their ability to 
protrude into the underlying matrix to degrade it and facilitate cell migration 
across basement membranes (Burgstaller & Gimona, 2005; Linder, 2007). 
 
1-7: Podosomes 
 
Podosomes are adhesion structures that were first described in cultured 
osteoclasts (Marchisio et al., 1984) and in Rous Sarcoma Virus-transformed 
fibroblasts, where they were defined as “short protrusions of the ventral cell 
surface that contact the substratum at their apical portion […] which may 
represent cellular feet” (Tarone et al., 1985). Podosomes were then described in 
various cell types such as macrophages (Linder et al., 1999), dendritic cells 
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(Burns et al., 2001), endothelial cells (Moreau et al., 2003) and Vascular 
Smooth Muscle Cells (VSMCs) (Hai et al., 2002) where they appear as light-
dense structures in phase contrast microscopy (Hai et al., 2002; Kaverina et al., 
2003).  
Hence, podosomes are not specific adhesion features of one cell type but rather 
an adhesion structure commonly formed by different cell types whose functions 
require an efficient 3-Dimensional migration (Schachtner et al., 2013). Cell 
migration is also commonly observed during cancer progression and podosome 
pathological counterparts, called invadopodia (Chen, 1989) are often observed 
in and used by transformed cells to exit from the primary tumor and spread 
throughout the organism (Seano & Primo, 2015).  
 
If podosomes and invadopodia are often indifferently called 
invadosomes, slight differences between podosomes and invadopodia should 
be noted. First, normal cells usually tend to form numerous podosomes (>100) 
whereas cancer cells form only a few invadopodia (Linder, 2007). To 
compensate for the low number of protrusive structures they form compared to 
normal cells, transformed cells form invadopodia that are much bigger in size 
than podosomes (Buccione et al., 2004). While podosome diameters typically 
range from 0.3 to 0.4µm and their height from 0.5 to 0.6µm (Marchisio et al., 
1988; Gavazzi et al., 1989; Destaing et al., 2003; Gawden-Bone et al., 2010), 
invadopodia diameters can reach 8µm and their depth several micrometers 
(Buccione et al., 2004), giving individual invadopodia a stronger capacity to 
penetrate the matrix to degrade it compared to single podosomes.  
 
One of the main functions of invadosomes is to locally degrade matrix 
components to facilitate cell migration across basement membranes (Linder, 
2007; Schachtner et al., 2013) and the second notable difference between 
podosomes and invadopodia relates to their matrix-degrading capacity and how 
it affects their structural organization. Invadopodia were shown to be protrusive 
structures by nature whereas the protrusive activity of podosomes seems to 
require its activation. At a structural level, this difference in the regulation of 
podosomes and invadopodia protrusive activity results in the presence of an 
adhesive ring in podosomes (Linder & Aepfelbacher, 2003; Murphy and 
Courtneidge, 2011; van den Dries et al., 2013b) mainly made of 
transmembranous adhesion receptors (Gaidano et al., 1990; Linder & 
Aepfelbacher, 2003) and surrounding the actin-rich core that is absent in 
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invadopodia (Linder et al., 2011). The adhesive ring of podosomes physically 
connect the podosome structure to the plasma membrane and the underlying 
matrix, sense the matrix properties and transduce signals modulating podosome 
protrusive activity depending on the molecular properties and the stiffness of the 
substratum (Collin et al., 2008; Labernadie et al., 2014). The adhesive ring 
could be dispensable for invadopodia protruding activity as they extend for 
several micrometers into the matrix to mediate their protruding activity (Gimona 
et al., 2008; Artym et al., 2011; Buccione et al., 2004; Linder, 2007; Linder et al., 
2011). 
 
At a molecular level, invadosomes share most of their components with 
focal adhesions but the relative amount and the organization of each component 
differ between the different types of adhesions (Block et al., 2008). The core of 
invadosomes is made of densely packed branched-actin filaments associated 
with actin nucleation promoting factors such as the Arp2/3 complex, cortactin or 
the Wiskott-Aldrich syndrome protein WASP (Figure 1.5; Kaverina et al, 2003; 
Burgstaller and Gimona, 2004; Linder et al., 1999; Garcia et al., 2012). These 
proteins mainly localize at the base of the actin column, in close proximity to the 
plasma membrane where actin polymerization takes place (Pfaff & Jurdic, 
2001). Electron microscopy studies conducted in VSMC podosomes also 
highlighted the presence of short loosely arranged actin filaments with no 
apparent organization in the podosome core (Gimona et al., 2003) whose role 
remains unknown. Two types of adhesion proteins were identified to localize at 
the podosome core: the integrin β1 (Marchisio et al., 1988) and the hyaluronan 
receptor CD44 (Chabadel et al., 2007).  These adhesion proteins are most likely 
involved in the anchoring of the podosome core structure to the underlying 
matrix (Figure 1.5). So far, reports showing a clear accumulation of adhesive 
proteins at the actin-rich core of invadopodia are scarce (Deryugina et al., 2001; 
Mueller et al., 1991; Linder et al., 2011), suggesting that invadopodia adhesive 
properties may only be limited (Linder et al., 2011). 
 
A protein cap made of the formin FMNL-1 (Mersich et al., 2010) and 
Supervillin, a member of the villin and gelsolin family (Bhuwania et al., 2012) sits 
on top of the core (Figure 1.5). The role of this cap remains elusive but it is 
suspected to serve as a hub for vesicle trafficking and to be involved in the 
regulation of the size and the growth of the core (Linder & Wiesner, 2015).  
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The core of podosomes is surrounded by an adhesive ring mainly made 
of transmembranous integrin receptors anchoring the adhesive ring to the 
underlying matrix (Pfaff & Jurdic, 2001; Chabadel et al., 2007) and associated 
with plaque proteins such as vinculin, paxillin and talin (Figure 1.5; Pfaff & 
Jurdic, 2001; Zambonin-Zallone et al., 1989). Recent ultrastructural studies 
revealed that the apparent ring homogeneity that was described initially was 
actually an artifact caused by the diffraction limit of light microscopy. Proteins of 
the ring form clusters sitting next to each other rather than forming a 
homogenous continuum of adhesion proteins, suggesting these islets could 
work as local sensors of the cell-matrix interface  (van den Dries et al., 2013b; 
Walde et al., 2014). 
 
These recent structural studies also highlighted the presence of actin 
filaments radiating from the core toward the ring that physically link core and 
ring together (Figure 1.5; Gawden-Bone et al., 2010; van den Dries et al., 
2013b). This network of radiating actin filaments is of major importance for the 
maintenance of the adhesive ring composition. For instance, vinculin is not 
evenly distributed in the adhesive ring but peaks in close proximity to the actin 
core and its intensity decreases with distance to it. The disruption of its binding 
to the radiating actin network results in its dispersion in the adhesive ring (van 
den Dries et al., 2013b). 
The non-muscle Myosin IIA, known to localize to the adhesive ring while being 
strictly excluded from the core (Burgstaller & Gimona, 2004; Gawden-Bone et 
al., 2010) associates with these radiating actin filaments. Hence, the Myosin IIA 
is not part of the adhesive ring but rather sits on top of it (Figure 1.5) to pull on 
radiating actin filaments and ensure the maintenance of the podosomal 
structural integrity as well as generating forces for its protruding activity  
(Gawden-Bone et al., 2010; van den Dries et al., 2013). 
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Figure 1.5: Schematic representation of the structure of an individual podosome. 
Podosomes are bipartite structures made of a central actin-rich core surrounded by an 
adhesive ring. The core is made of densely packed branched actin filaments associated 
with actin nucleation promoting factors such as cortactin and ARP2/3 complex. The core 
is anchored in the matrix by CD44 and β1-integrin receptors and a cap of supervillin and 
formin sits on top of it. The adhesive ring is made of β2- and β3-integrins associated 
with plaque proteins (Vinculin, Talin). Radiating actin filaments associated with the non-
muscle Myosin IIA connect the structure of the core to the adhesive ring. 
Based on Gawden-Bone et al., 2010; Marchisio et al., 1988; Kaverina et al., 2003; Pfaff 
& Jurdic, 2001, Mersich et al., 2010; Bhuwania et al., 2012. 
 
 
In contrast to focal adhesions, which are found as single entities 
dispersed throughout the cell, podosomes can either be found as single 
scattered adhesion structures or re-arranged as clusters and rings, allowing 
them to cooperate and coordinate their activity (Figure 1.6). To do so, 
podosomes are physically connected to each other through a heterogeneous 
actin filament network extending from each podosome core toward neighbouring 
ones, meaning that virtually, all the podosomes of a cluster are connected to 
each other (Destaing et al., 2003; Saltel et al., 2008). Concomitantly, the 
adhesive ring surrounding each core fuses with the ring of neighbouring 
podosomes, creating a carpet of adhesion proteins rather than individual well-
defined rings sitting next to each other to secure the adhesion of the cluster to 
the substrate (van den Dries et al., 2013b) (Figure 1.6). This higher organization 
of podosomes is particularly important in mature osteoclasts. Indeed, mature 
osteoclasts display a podosome belt that surrounds their cytoplasm and allow 
them to tightly adhere to the bone matrix (Saltel et al., 2008). This podosome 
belt, called the sealing zone, is the site of local degradation of bone matrix and 
impairing its formation impairs osteoclast’s ability to degrade the bone matrix 
(Destaing et al., 2005).   
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Figure 1.6: Schematic representation of the different types of podosome organization. 
Podosomes can be found scattered throughout the cell, form clusters or rings. Mature 
osteoclasts display a very peculiar organization of podosomes in a belt that surround the 
cell periphery. 
 
 
1-8: Mechanism of podosome formation and dynamics 
 
The molecular mechanism regulating podosome formation and turnover 
has to be tightly regulated to avoid an inappropriate podosome protrusive 
activity that could damage tissues (Rudijanto, 2007; Georgess et al., 2014). 
Cells forming podosomes can be divided in two subfamilies: cells forming 
podosomes without the requirement of any additional signals than those 
provided by their adhesion to the substratum (cells deriving from the monocytic 
lineage mainly e.g. macrophages, dendritic cells, osteoclasts; Marchisio et al., 
1984; Marchisio et al., 1988; Kopp et al., 2006) and cells requiring external 
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signals in addition to those provided by the substratum they adhere on to trigger 
podosome formation (VSMCs, endothelial cells; Hai et al., 2002; Brandt et al., 
2002; Moreau et al., 2003). Additional signals can either be growth factors 
(Quintavalle et al., 2010), the expression of the constitutively active v-Src kinase 
(Tarone et al., 1985) or chemical compounds such as phorbol esters (Hai et al., 
2002; Brandt et al., 2002). It is therefore difficult to establish a canonical 
signaling pathway triggering the induction of podosome formation as different 
kind of signals can induce their formation. Moreover, it is unclear how the site of 
emergence of a podosome is chosen in most podosome-forming cell types 
(Gimona et al., 2008).  
 
However, several studies point at the same general molecular 
mechanism for podosome formation in all podosome-forming cell types. This 
mechanism can be divided in 3 main phases that occur in a very short period of 
time as podosome lifespan ranges from 2 to 10 minutes (Kaverina et al., 2003; 
Destaing et al., 2003; Gimona et al., 2008): 
1) polymerization of the actin core, 
2) recruitment of adhesion and plaque proteins at the ring, 
3) local accumulation and release of proteases responsible for the degradation 
of the matrix at podosome sites. 
 
 The recruitment of the actin polymerizing machinery at the future site of 
podosome emergence is likely to start before the induction of podosome 
formation. Indeed, studies conducted in VSMCs highlighted the local 
accumulation of the two actin nucleation promoting factors Arp2/3 complex 
(Kaverina et al., 2003) and cortactin (Burgstaller & Gimona, 2004) at the 
interface between focal adhesions and stress fibers in resting conditions (Figure 
1.7). The induction of podosome formation by phorbol esters induces some of 
these accumulation foci to grow in size and to be used as platforms for the 
assembly of the podosome structure (Kaverina et al., 2003). Within minutes, 
other actin regulatory proteins and scaffolding proteins, such as α-actinin 
(Luxenburg et al., 2012) or Tks5 (Crimaldi et al., 2009) are recruited to the core 
of the newly forming podosome to facilitate its assembly (Figure 1.7). 
Likewise, studies conducted in cells of the monocytic lineage highlighted the 
requirement of the Wiskott-Aldrich syndrome protein WASP, a well-known 
Arp2/3 activator, for podosome formation in macrophages (Linder et al., 1999) 
and dendritic cells (Burns et al., 2001), suggesting that the polymerization of 
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branched-actin at the core is a fundamental step for podosome formation in all 
podosome-forming cell types.  
 
Once a basic core is assembled, adhesion and adaptor proteins such as 
integrins and talin are recruited to the podosome formation site to form the ring 
(Figure 1.7; Luxenburg et al., 2012; van den Dries et al., 2013). Some adhesion 
plaque proteins, paxillin for instance, are recruited to the ring during early stages 
of core assembly, most likely to stabilize its polymerization and facilitate the 
recruitment of other podosome components recruited at later stages of 
podosome formation (Luxenburg et al., 2012). 
 
 Mature podosomes are sites of local accumulation and exocytosis of 
matrix metalloproteases as MMP2, MMP9 and the transmembranous MT-MMP1 
(Tatin et al., 2006; Gawden-Bone et al., 2010; Xiao et al., 2010). These MMPs 
locally degrade matrix components and mediate, at least partially, podosome 
protrusive activity (Tatin et al., 2006; Wiesner et al., 2010; Gawden-Bone et al., 
2010; Xiao et al., 2010). Interestingly, matrix-degrading enzymes also 
participate in the endocytosis of the matrix components they degrade (Gawden-
Bone et al., 2010) as well as in the regulation of podosome turnover (West et 
al., 2008; Goto et al., 2002). Thus, the recruitment of matrix-degrading enzymes 
to podosomes is of major importance for podosome homeostasis and function. 
The involvement of these proteases in these processes could be explained by 
their ability to modify the matrix podosomes are in contact with. As 
mechanosensors, podosomes are able to detect modifications in the 
organization, stiffness or molecular composition of the matrix, leading in turn to 
modifications of their size, stiffness or turnover rate (Collin et al., 2008; 
Labernadie et al., 2010; Labernadie et al., 2014). 
 
Finally, individual podosomes can organized in higher structures to 
potentiate their activity. The best example of podosome reorganization is 
probably provided by the dynamic rearrangement of podosomes in maturing 
osteoclasts. Immature osteoclasts form single podosomes that rearrange into 
clusters and rings while the cell matures. Podosome rings gradually expand and 
fuse with each other to finally form the bone matrix-resorbing podosome belt 
characteristic of mature osteoclasts (Destaing et al., 2003). The same kind of 
dynamic podosome reorganization has been described in Rous-Sarcoma Virus 
transformed Baby Hamster Kidney cells (RSV-BHK cells; Badowski et al., 
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2008), suggesting that molecular mechanisms regulating podosome 
reorganization may be shared by various cell types. 
 
 
Figure 1.7: General mechanism of podosome formation. 
In resting conditions, the interface between a focal adhesion and a stress fiber is the site 
of local accumulation of actin nucleation promoting factors. Upon podosome induction, 
the podosome core polymerizes thanks to the local recycling of components released by 
disassembling focal adhesions and stress fibers. Once a basic core is polymerized, the 
adhesive ring forms around the core. Mature podosomes are sites of local release of 
matrix degrading enzymes. 
Based on Kaverina et al., 2003; Luxenburg et al., 2012; van den Dries, 2013. 
 
 
 The regulation of podosome formation is tightly linked to the internal 
podosome dynamics that has been reported in numerous studies to occur over 
time. Podosomes undergo small and rapid oscillations generated by actin 
turnover in the podosome core (Labernadie et al., 2010). Indeed, actin filaments 
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forming the core are constantly polymerizing and depolymerizing and FRAP 
experiments conducted in osteoclasts showed that during the 2 to 3 minutes 
average lifespan of a podosome, the amount of actin a core contains is renewed 
about 2.5 times (Destaing et al., 2003). In the core, actin polymerization occurs 
at the base of the structure, in close proximity to the plasma membrane where 
actin filament barbed-ends localize and where actin nucleation promoting 
factors accumulate (Pfaff & Jurdic, 2001). The addition of actin monomers at the 
base of pre-existing actin filaments pushes the plasma membrane towards the 
underlying substrate, while monomers are removed at the top of the actin core 
(van den Dries et al., 2013). 
 
 In addition to these small oscillations of the core, podosomes are 
submitted to larger oscillations of their whole structure (Labernadie et al., 2010). 
This second type of oscillations seems to be mediated by the Myosin IIA 
contractile activity as cell treatment with the Blebbistatin Myosin IIA inhibitor 
abolishes them in dendritic cells (Labernadie et al., 2010; van den Dries et al., 
2013). The Myosin IIA localizes at radiating actin filaments linking the core and 
the adhesive ring together (Gawden-Bone et al, 2010). Its contractile activity 
pulls onto these radiating actin filaments, bringing the whole podosome 
structure in closer proximity to the underlying matrix and hence, creating large 
vertical oscillations of the entire podosome structure (Labernadie et al., 2010). 
These two types of oscillations are thought to mediate, in association with the 
local release and activation of matrix proteases, the protrusive activity of 
podosomes (Labernadie et al., 2010). 
 
 
1-9: Podosome regulation by MTs and MAPs 
 
 The existence of an interplay between MTs and the adhesion system 
was first suggested in the end of the 1980’s when the growing end of some MTs 
were found to enter the lamellipodium formed at the leading edge of migratory 
fibroblasts to co-localize with focal contact sites (Rinnerthaler et al., 1988). Later 
on, several studies highlighted the influence of MTs on the adhesion system and 
vice versa, showing that the interaction of adhesions and MTs is not fortuitous 
as it modulates the dynamics of both structures. 
 25 
 Indeed, MT disruption was shown to stimulate the formation of stress 
fibers and focal adhesions (Bershadsky et al., 1996; Enomoto, 1996; 
Krylyshkina et al., 2002), most likely because it induces an increase of Rho 
activation and actomyosin contractility (Danowski, 1989; Enomoto, 1996; 
Pletjushkina et al., 1998; Liu et al., 1998). Contemporary, MTs were shown to 
target focal adhesions, sometimes repeatedly (Kaverina et al., 1998), inducing 
the turnover of the targeted adhesions (Kaverina et al., 1999). This 
phenomenon is most likely due to the cargo transport activity of kinesins that 
use MTs as tracks to deliver cargoes at precise cellular locations. Indeed, 
inhibition of the activity of the kinesin-1 MT-based motor has been shown to 
induce an increase in focal adhesion size but no modification of the average 
number of contact sites formed in cell could be detected, suggesting that 
kinesin-1 motor activity is required for focal adhesion turnover (Kaverina et al., 
1997; Krylyshkina et al., 2002).  
 
 The long-term hypothesis for the regulation this phenomenon relies on 
the ability of kinesin-1 to transport relaxing factors to focal adhesions. Little is 
known about these factors kinesin-1 could transport to regulate focal adhesion 
turnover but a recent study suggested a possible involvement of IQGAP1 in this 
mechanism. Indeed, kinesin-1 was suggested to transport IQGAP1 at the 
leading edge of migratory cells (Schiefermeier et al., 2014), where it interacts 
with Rac1 and Cdc42 to stimulate the dynamic actin polymerization required for 
cell migration (Noritake et al., 2005). The impairment of kinesin-1-mediated 
IQGAP1 transport in migratory cells leads to its accumulation at focal adhesions 
rather than at the leading edge of the cell and this accumulation of IQGAP1 
correlates with a twofold increase in focal adhesion size (Schiefermeier et al., 
2014). In addition to its ability to activate Rac1 and Cdc42, IQGAP1 is also 
known to enhance RhoA activity (Goode & Eck, 2007) through its interaction 
with the RhoA effector Dia1 (Brandt & Grosse, 2007). The local accumulation of 
IQGAP1 at focal adhesions upon kinesin-1 impairment could increase RhoA 
activity and therefore stabilize focal adhesions. This result is in agreement with 
previous reports showing an increase in RhoA activity upon MT 
depolymerization (Ren et al., 1999; Ory et al., 2002). 
 
 Another explanation for MT-induced focal adhesion turnover relies on 
the ability of MTs to stimulate the dynamin- and clathrin-mediated endocytosis 
of adhesion components (Ezratty et al., 2009; Ezratty et al., 2005). Given that 
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MTs repeatedly target focal adhesions (Kaverina et al., 1998; Kaverina et al., 
1999), one may think that each targeting stimulates the endocytosis of focal 
adhesion components such as integrins (Ezratty et al., 2009; Ezratty et al., 
2005), destabilizing the structure of the targeted adhesion and inducing its 
disassembly over time.  
 
 The crosstalk between MTs and cellular adhesions is reciprocal and also 
involves a modulation of MT dynamics by the adhesion system. Adhesion sites 
targeted by MTs were first shown to capture and transiently stabilize targeting 
MTs against the MT depolymerizing agent nocodazole (Kaverina et al., 1998), 
suggesting that focal adhesions may have a stabilizing effect on MTs. This 
hypothesis was reinforced by the ability of focal adhesions to nucleate MTs 
during the recovery phase after nocodazole treatment and the observation that 
MTs are more stable in cells displaying a high number of focal adhesions than in 
cells forming only few adhesions (Kaverina et al., 1998; Small et al., 2002 Nat 
Rev Mol Cell Biol). The ability of focal adhesions to stabilize MTs seems to be 
the result of the accumulation of many cycles of shrinkage and rescue of the MT 
plus-end, as MTs were shown to be more dynamic in close proximity to focal 
adhesions than in cell regions devoid of adhesion sites (Efimov et al., 2008). 
The overall stabilizing effect of adhesions on MTs is thought to rely on the 
interaction of tubulin with paxillin (Herreros et al., 2000) in close proximity to 
adhesion sites that has been shown to stabilize the MT plus-end by inhibiting 
catastrophe events (Efimov et al., 2008). 
 
 Similarly to regulating focal adhesions, MTs and MAPs decorating them 
were shown to regulate podosome formation and dynamics. Cell treatment with 
the MT depolymerizing agent Nocodazole highlighted the requirement of an 
intact microtubular system for proper podosome formation (Linder et al., 2000; 
Efimova et al., 2014) and patterning (Babb et al., 1997; Destaing et al., 2003; 
Zhu et al., 2016). MTs were shown to target podosomes, sometimes repeatedly 
to induce their fission or dissolution (Kopp et al., 2006; Cornfine et al., 2011). 
Indeed, podosomes formed in cells can be divided in two distinct populations: 
dynamic podosomes undergoing frequent fission or fusion events at the 
periphery and static podosomes in the inner region of the cell. Podosomes of 
the two populations can be targeted by MTs (Kopp et al., 2006; Cornfine et al., 
2011; Bhuwania et al., 2012), however, the plus-ends of MTs targeting each 
podosome population were shown to be differently decorated with MAPs. MTs 
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targeting the peripheral population of podosomes are characterized by the 
accumulation of KIF1C motors at their plus-end (Kopp et al., 2006) whereas the 
growing-end of MTs targeting central static podosomes is decorated by KIF9 
kinesins (Cornfine et al., 2011). In both cases, MT-targeting induces the fission 
or the dissolution of the contacted podosomes but this molecular bias suggests 
that these motors function in the selection of the podosome to target.  
 
The molecular mechanism controlling the fission or the dissolution of the 
targeted podosome has not been addressed yet but given the nature of 
identified MAPs accumulating at the plus-end of targeting MTs, MT contact with 
podosomes could induce the uptake of podosome components by the 
accumulated kinesins, inducing the destabilization of the podosome structure. 
This hypothesis is reinforced by data showing that some MT-associated 
molecular motors transport podosomes components (Weisner et al., 2010). 
Hence, the dynein minus end-directed motor as well as KIF3A/KIF3B and KIF5B 
plus end-directed kinesins were shown to coordinate the delivery and surface 
exposure of MT-MMP1 at podosomes, a cargo trafficking activity that is crucial 
for podosomes to be able to degrade the matrix they protrude into (Wiesner et 
al., 2010).  
 
Some MAPs were shown to interact with podosome components, 
providing a physical link between podosomes and MTs targeting them. For 
instance, KIF1C motors decorating the plus-end of podosome targeting MTs 
interact with the non-muscle Myosin IIA, an interaction proposed to coordinate 
the delivery of KIF1C motors to podosomes (Kopp et al., 2006). Another 
example is the Cdc42-interacting protein 4 CIP4 that interacts with the actin 
nucleation-promoting factor WASP and this interaction seems to be required for 
podosome formation in macrophages  (Linder et al, 2000). A third example is 
the MT end-binding protein EB1 that is known to interact with two podosome 
components: cortactin and vinculin (Biosse-Duplan et al., 2014). EB1 interaction 
with cortactin is thought to guide MT plus-ends to podosomes in osteoclasts 
(Biosse-Duplan et al., 2014). EB1 is known to modulate MT dynamic instability 
(Manna et al., 2008) to control cortactin interaction with and phosphorylation by 
the Src kinase, a phenomenon known to regulate cortactin activity, including its 
ability to nucleate actin filaments (Tehrani et al., 2007) and to regulate the 
formation of the podosome belt in osteoclasts (Luxenburg et al., 2006).  
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 Finally, MT stability was shown to participate in the regulation of 
podosome organization in cells. Podosome patterning in maturing osteoclasts 
relies on an intact microtubular system as osteoclast treatment with the MT-
depolymerizing agent nocodazole impairs their ability to reorganize and 
maintain their podosomes into a belt surrounding the cell (Destaing et al., 2003; 
Destaing et al., 2005). The stability of MTs relies on post-translational 
modifications of tubulin (Garnham & Roll-Mecak, 2012) and MT acetylation has 
been shown to be involved in the regulation of podosome patterning in 
osteoclasts. Indeed, MT acetylation increases during osteoclast maturation 
(Destaing et al., 2005; Jurdic et al., 2006; Akisaka et al., 2011) and the 
impairment of MT acetylation results in the collapse of the podosome belt in 
mature osteoclasts (Destaing et al., 2005; Gil-Henn et al., 2007), suggesting 
that MT acetylation stabilizes podosome belts in osteoclasts (Akisaka et al., 
2011). However, the molecular mechanism regulating the stability of the 
podosome belt by acetylated MTs remains unknown, as no physical interaction 
between MTs and podosomes of the belt has ever been proven.  
 
1-10: VSMCs and podosomes  
 
Vascular Smooth Muscle Cells are contractile cells surrounding blood 
vessels and acting to regulate blood pressure (Davis-Dusenbery et al., 2011). 
After an injury, cytokines and growth factors secreted during the inflammatory 
response induce VSMCs to switch from the contractile to a synthetic phenotype 
characterized by cell proliferation, migration and matrix remodeling due to their 
ability to form podosomes and secrete matrix components (Rudijanto, 2007). 
VSMCs were shown to form podosomes in vivo (Quintavalle et al., 2010) and 
the molecular mechanism triggering podosome formation has been extensively 
studied in vitro. In resting conditions, VSMCs display a very well developed actin 
stress fiber network (Fultz et al., 2000). VSMC treatment with Phorbol 12,13-
dibutyrate (PDBu) activates the PKC pathway and induces the reorganization of 
the actin cytoskeleton characterized by the gradual depolymerization of the pre-
existing system of stress fibers and focal adhesions and the formation of 
podosomes (Hai et al., 2002).  
 
In VSMCs, podosomes form at the interface between stress fibers and 
focal adhesions, a region that is enriched in actin nucleation promoting factors, 
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such as the Arp2/3 complex (Kaverina et al., 2003) and cortactin (Burgstaller & 
Gimona, 2004). Podosomes formed in VSMCs display the same characteristics 
as podosomes formed in other cell types, with a central actin-rich core 
surrounded by an adhesive ring, a 3 to 10 minutes average lifespan and a fully 
functional matrix protruding activity (Hai et al., 2002; Kaverina et al., 2003; 
Burgstaller & Gimona, 2005).  
 
Podosome formation in VSMCs needs to be tightly regulated in vivo as a 
non-regulated podosomal activity can lead to pathological lesions of artery walls 
(Rudijanto, 2007; Lacolley et al., 2012). Indeed, after an injury and once the 
artery wall remodeling mediated by activated VSMCs is completed, synthetic 
VSMCs need to reacquire their contractile phenotype to avoid their podosomal 
protruding activity damaging blood vessel walls. If cells fail to switch back to this 
inactive state, the accumulation of active VSMCs, the local secretion of ECM 
proteins by these cells and the extensive ECM remodeling activity they mediate 
can lead to the gradual thickening of the artery wall and the development of 
hypertension and atherosclerosis (Rudijanto, 2007). Hence, control of 
podosome formation and turnover is of major importance to maintain the arterial 
system integrity.  
  
 
1-11: Outline of this work 
 
 Prior to this work, KIF1C was suggested to be involved in the formation 
and the regulation of podosome dynamics in macrophages (Kopp et al., 2006). 
Here we confirm a role for KIF1C in podosome formation in VSMCs (Chapter 3-
1). We then use structure-function analysis to identify the domains of KIF1C 
required for this process (Chapter 3-2). Finally, we identify PTPD1 as a KIF1C 
activator that is essential for podosome formation (Chapter 3-2) and we show 
that catalytically inactive PTPD1 stimulates KIF1C trafficking in human cells 
(Chapter 3-3). 
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Chapter 2: Materials and Methods 
 
2-1: Cell Biology 
 
 2-1-1: Cell maintenance 
 
 A7r5 rat Vascular Smooth Muscle Cells were a kind gift from Dr. Irina 
Kaverina (Vanderbilt University, Nashville, USA). A7r5 cells were grown in 
VSMC growth medium (low glucose Dulbecco’s modified Eagle’s Medium 
(DMEM, Sigma) supplemented with 10% Fetal Bovine Serum (FBS; Sigma), 
2mM L-Glutamine (Sigma), 100 U/ml Penicillin (Sigma) and 100µg/ml 
Streptomycin (Sigma)) in a humidified incubator at 37°C and 5% CO2. For 
maintenance, A7r5 cells were grown to 90% confluency, washed with PBS and 
incubated with 0.05% Trypsin and 0.02% EDTA (w/v) solution (Sigma). Cell 
detachment was assessed using an inverted microscope and split 1 in 5 in fresh 
pre-warmed VSMC growth medium.  
 
 The GFP-α5-integrin RPE-1 stable cell line was established by Dr Anne 
Straube as followed: hTERT RPE-1 cells (Clonetech) were transfected with 
GFP-α5-integrin (kind gift from Benjamin Geiger) followed by selection with 
500µg/ml Geneticin (Gibco). GFP-α5-integrin RPE-1 stable cell line was grown 
in RPE-1 growth medium (DMEM/Nutrient F-12 Ham (Sigma) supplemented 
with 10% FBS (Sigma), 2mM L-Glutamine (Sigma), 100 U/ml Penicillin (Sigma), 
100µg/ml Streptomycin (Sigma) and 2.3g/l Sodium Bicarbonate (Sigma)) 
supplemented with 500µg/ml Geneticin (Gibco). For maintenance, GFP-α5-
integrin RPE-1 cells were grown to 70% confluency, washed with PBS and 
incubated with 0.05% Trypsin and 0.02% EDTA (w/v) solution (Sigma). Cell 
detachment was assessed using an inverted microscope and split 1 in 10 in 
fresh pre-warmed RPE-1 growth medium supplemented with 500µg/ml 
Geneticin.  
 
 Normal Rat Kidney epithelial cells (NRK) were a kind gift from Dr. Steven 
Royle (Centre for Mechanochemical Cell Biology, University of Warwick) and 
were grown in Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma) 
supplemented with 10% Fetal Bovine Serum (FBS; Sigma), 2mM L-Glutamine 
(Sigma), 100 U/ml Penicillin (Sigma) and 100µg/ml Streptomycin (Sigma)) in a 
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humidified incubator at 37°C and 5% CO2. For maintenance, NRK cells were 
grown to 90% confluency, washed with PBS and incubated with 0.05% Trypsin 
and 0.02% EDTA (w/v) solution (Sigma). Cell detachment was assessed using 
an inverted microscope and split 1 in 5 in fresh pre-warmed growth medium.  
 
 2-1-2: siRNA-mediated protein depletion and rescue experiments 
 Protein expression depletion was carried out using small interfering RNA 
(siRNA) as indicated in Table 1. siRNA oligonucleotides were delivered into 
A7r5 cells using HiPerfect transfection reagent (Qiagen) as followed: 4.5µl of 
the 20µM siRNA oligonucleotide stock solution (see Table 2 for siRNA 
sequence) were resuspended in 150µl Opti-MEM (Gibco) before the addition of 
12µl of HiPerfect Transfection reagent (Qiagen). The transfection solution was 
vigorously mixed and incubated for 15 minutes at room temperature. In the 
mean time, 100 000 A7r5 cells were seeded in individual wells of a 6-well plate 
(6x3.5mm) in 1.5ml of VSMC growth medium. The transfection mix was then 
added to freshly seeded A7r5 cells. For efficient protein depletion, experiments 
were conducted 72 hours after siRNA transfection. 
When a rescue experiment was required, plasmid transfection occurred 24 to 36 
hours before the experiment was conducted as indicated in section 2-1-3.  
 
Oligofectamine (Invitrogen) was used for the delivery of siRNA into GFP-
α5-integrin RPE-1 cells. GFP-α5-integrin RPE-1 cells were seeded 24 hours 
prior siRNA transfection in individual wells of a 6-well plate (6x3.5mm) and RPE-
1 growth medium was replaced by 1.5ml of fresh pre-warmed RPE-1 growth 
medium before transfection. siRNA transfection solutions were prepared as 
indicated in Table 1: 4.5µl of the 20µM stock solution of siRNA oligonucleotide 
were resuspended in 150µl of Opti-MEM in a first 1.5ml Eppendorf tube. In a 
second tube, 9µl of the Oligofectamine transfection reagent were resuspended 
in 36µl Opti-MEM. Tubes were incubated 8 minutes at room temperature and 
mixed together. The transfection mix was incubated for an additional 25 minutes 
at room temperature before addition to cells. RPE-1 growth medium was 
replaced 24 hours after siRNA transfection by 2ml of fresh pre-warmed RPE-1 
growth medium. 
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Transfection using HiPerfect Transfection Reagent 
Opti-MEM (Gibco) 150µl 
siRNA Oligo (20µM stock) 4.5µl 
HiPerfect Transfection Reagent 12µl 
Incubation Time 15 minutes 
Transfection using Oligofectamine 
 
Tube 1 Tube 2 
Opti-MEM 150µl Opti-MEM 36 
 
siRNA Oligo 
(20µM stock) 
4.5µl Oligofectamine 9µl 
Incubation time prior Tube 1 and Tube 
2 mixing 
8 minutes 
Incubation time prior addition to cells 25 minutes 
Table 1: siRNA component volumes mixed per individual well of a 6-well plate. 
 
 
 
 
siRNA 
name 
siRNA sequence Target 
mRNA 
Source 
siControl GGACCUGGAGGUCUGCUGU-[dT]-[dT] 
ACAGCAGACCUCCAGGUCC-[dT]-[dT] 
None Sigma 
siKIF1C GUGAGCUAUAUGGAGAUCU-[dA]-[dT] 
AGAUCUCCAUAUAGCUCAC-[dA]-[dT] 
KIF1C Sigma 
siPTPD1 UUCAGCCUCUGGUACUACA-[dT]-[dT] 
UGUAGUACCAGAGGCUGAA-[dT]-[dT] 
PTPD1 Sigma 
Table 2: Sequences of siRNA oligonucleotides used in this study. 
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 2-1-3: DNA transfection 
 Fugene6 (Promega) was used for plasmid transfection as described in 
Table 3. Cells were seeded 24 hours before DNA transfection and medium was 
replaced with fresh pre-warmed growth medium prior DNA transfection. DNA 
was resuspended in Opti-MEM (Gibco) before Fugene6 addition. The DNA 
transfection mix was vigorously shaken and incubated 15 minutes at room 
temperature before addition to cells.  
 
Vessel size Individual wells of 6-well 
plate (6x3.5mm) 
Individual well of 4 
quadrant fluorodish 
Opti-MEM 150µl 37.5µl 
DNA 1.5µg 0.375µg 
Fugene6 4.5µl 1.125µl 
Table 3: Volumes of components used for DNA transfection. 
 
 
 2-1-4: Drug treatments 
 All the drugs used in this study were resuspended in fresh pre-warm 
growth medium. Growth medium cells were grown in was then replaced by 
growth medium supplemented with the drug of interest. Podosome formation 
was induced in A7r5 cells using 5µM PDBu (Phorbol 12,13-dibutyrate; Sigma). 
Myosin IIA contractile activity inhibition was performed using different working 
concentration of the Y27632 Rock inhibitor (5, 10 and 15µM; Sigma) or 
Blebbistatin (10, 20 and 30µM; Sigma). To do so, Myosin IIA inhibitors were 
diluted in the pre-warmed VSMC growth medium supplemented with 5µM PDBu 
before its addition to cells. The myosin IIA inhibition was hence carried out 
during the whole time course of podosome induction. When required, DMSO 
(Sigma) was used a negative control. 
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2-2: Podosome formation assay 
24 hours before experiment, ~ 5000 A7r5 cells were seeded on 16mm 
glass coverslips coated for 24 hours with 10µg/ml Fibronectin. Podosome 
formation was induced replacing growth medium with fresh pre-warmed medium 
supplemented with 5µM PDBu (Phorbol 12,13-dibutyrate; Sigma). The duration 
of podosome induction is indicated for each experiment in the result section. 
Cells were then fixed for 15 minutes with 4% Paraformaldehyde (Electron 
Microscopy Sciences) diluted in Cytoskeleton Buffer (10mM MES pH6.1, 
138mM KCl, 3mM MgCl2, 2mM EGTA, 0.32M Sucrose). Fixed cells were 
incubated for 2 minutes with 0.1% TritonX100 (Fisher Scientific) diluted in PBS. 
Coverslips were then washed for at least an hour with PBS and incubated for 30 
minutes with 0.5% Bovine Serum Albumin (BSA; Sigma) diluted in PBS-
0.1%Tween (PBST). Cells were then stained for an hour at room temperature or 
overnight at 4°C with primary antibodies (see Table 4) diluted in 0.5% BSA-
PBST solution. Coverslips were washed 10 minutes with PBS and three time 10 
minutes with PBST and incubated for 45 minutes at room temperature with 
secondary antibodies and Phalloidin or Acti-stain diluted in 0.5% BSA-PBST 
solution. Nuclei were stained with DAPI for 1 minute and coverslips washed for 
10 minutes with PBS and three times 10 minutes with PBST prior mounting on 
glass slides with Vectashield (Vector Laboratories).  
 
Cells were imaged using a Deltavision Elite Wide-field microscope and 
Z-stack of individual cells were acquired using a 40x objective and a Z-spacing 
of 0.2µm. To determine the number of podosome formed in each cell, Z-stack 
images of the cortactin channel were first transformed in a Z-projection. 
Cortactin Z-projection images were then analyzed using the ImageProAnalyzer 
7 software as indicated in Figure 2.1: images were thresholded and every object 
with a size larger than 16 pixels (0.259µm2, corresponding to the minimal size of 
the core, Chapter 1-7) was automatically identified. Individual objects identified 
in cortactin Z-projection images were then visually compared to the actin 
channel to confirm they are podosomes, removed if the cortactin staining didn’t 
coincide with the actin one and podosome clusters were split into individual 
podosomes. 	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Antibody 
Name 
Manufacturer Specie Primary / 
secondary 
antibody 
Dilution Usage 
Cortactin  Millipore Mouse Primary 1/100 IF 
Phalloidin Sigma - - 1/1000 IF 
Acti-stain 555 Cytoskeleton - - 1/1000 IF 
Anti-mouse 
IgG 647 
conjugate 
Molecular 
Probes 
Donkey Secondary 1/300 IF 
KIF1C Abcam Rabbit Primary 1/2000 WB 
Tubulin DM1A Sigma Mouse Primary 1/10 000 WB 
Anti-mouse 
IgG HRP 
conjugate 
Promega Goat Secondary 1/4000 WB 
Anti-rabbit IgG 
HRP 
conjugate 
Promega Goat Secondary 1/4000 WB 
IF: Immunofluorescence; WB; Western Blot 
Table 4: List of antibodies used in this study.  
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Figure 2.1: Podosome counting method. 
Z-stack (spacing=0.2µm) of the actin and cortactin channels were acquired and images 
from the cortactin channel were transformed in Z-projection (Maximum Z projection) in 
ImageJ. Z-projections were loaded in Image-Pro Analyzer 7 and podosomes counted as 
following. Z-projections were thresholded and every object larger than 16 pixels were 
automatically detected. Podosome clusters were split in individual podosomes. The 
image was then compared with the actin channel and the colocalization of automatically 
detected podosomes in Image-Pro Analyzer 7 with the actin channel was visually 
addressed. Objects counted as podosomes in the cortactin channel that do not 
colocalize with spots detected in the actin channel were manually removed using the 
toggle function of the software (arrows). Results were then exported and compiled in an 
excel file.  
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2-3: α5-integrin transport assay 
 GFP-α5-integrin RPE-1 cells were split 24 hours before imaging in a 4 
quadrants fluorodish coated for 24 hours with 10µg/ml Fibronectin. 
Photobleaching and imaging were conducted on a Deltavision Elite Wide-field 
microscope. Cell tail was imaged once prior photobleaching with a 488nm laser 
and every 0.5second for 2 minutes after photobleaching to detect GFP-α5-
integrin trafficking in the photobleached area.  
 
  GFP-α5-integrin trafficking was analyzed using ImageJ image analysis 
software. 21 pixels width kymographs were drawn in the photobleached area 
and the movement of each vesicle detected in each kymograph was tracked. 
Vesicles movement was then classified as previously reported (Theisen et al., 
2012) in stationary vesicle if the total displacement of the vesicle does not 
exceed 1µm and in moving vesicle if the total displacement of the vesicle 
exceeds 1µm. As PTPD1 overexpression could have an effect on the directional 
persistence of KIF1C-mediated GFP-α5-integrin transport, moving vesicles were 
then classified in 3 subcategories: jiggling vesicles if vesicles show a repeated 
forward and backward movement and if the distance between directional 
changes does not exceed 3µm; uni-directional movement if the vesicle moves 
towards one direction and if its total displacement is larger than 1µm; bi-
directional movement was defined as vesicles moving in both directions with a 
distance range larger than 3µm between each directional change. A cutoff of 
3µm to distinguish jiggling vesicles from bi-directionally moving vesicles was 
chosen based on personal observations as the distance between directional 
changes usually did not exceed 3µm for the majority of jiggling vesicles. 	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2-4: Molecular Biology 
	  
 2-4-1: RT-PCR 
 Cells were harvested, washed in PBS and kept at -80°C in 1.5ml 
Eppendorf tubes until mRNA extraction. Cells harvested from an individual well 
of a 6-well plate (6x3.5mm) at 75% confluency were resuspended in 400µl 
Trizol (Ambion Life Technologies) and incubated 5 minutes at room temperature 
before the addition of 300µl Chloroform. Tube content was vigorously shaken 
for 15 seconds and incubated 5 minutes at room temperature prior 
centrifugation for 10 minutes at maximum speed. The upper layer was 
transferred into a new 1.5ml Eppendorf tube before the addition of 350µl 
Isopropanol. After gentle mixing, tubes were incubated 10 minutes at room 
temperature and centrifuged for 10 minutes at maximum speed. The 
supernatant was removed and pelleted mRNA resuspended in 70% Ethanol 
prior centrifugation for 5 minutes at maximum speed. Supernatant was removed 
and pelleted mRNA allowed to dry before resuspension in 20µl ddH2O. mRNA 
concentration was measured using a NanoDrop 2000. 
 
 For RT-PCR, 2µg total mRNA were mixed with 0.2µg random hexamers 
and the volume adjusted to 12.5µl with ddH20. The mix was incubated 5 minutes 
at 70°C and chilled on ice before addition of 4µl 5X Reaction buffer, 0.8µl 25mM 
dNTP mix (NEB) and 0.5µl RNase inhibitor (NEB). After 5 minutes incubation at 
25°C, 1µl of H-minus Reverse Transcriptase (NEB) was added and the mix was 
incubated 10 minutes at 25°C and 60 minutes at 42°C. The reaction was 
stopped by heating the mix 10 minutes at 70°C and the cDNA obtained stored at 
-20°C.  	  
 2-4-2: PCR 
PCR mixes were prepared in PCR tubes in a total volume of 50µl and 
reactions performed as indicated in Table 5. PCR product amplification was 
confirmed running 5µl of PCR reaction mixed with 1µl 6X Orange G loading 
buffer on agarose gel.  PCR product size was compared to the GeneRuler 1kb 
ladder (Fermentas). When needed, PCR products were purified using PureLink 
Quick PCR Purification Kit as per manufacturers guidelines (Invitrogen) and 
resuspended in 50µl ddH2O. Primers used for PCR are listed in Table 6. 
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To confirm PTPD1 depletion, primers AS380 and AS416 were used to amplify a 
350bp fragment of PTPD1 cDNA and AS453 and AS454 to amplify a 500bp 
fragment of GAPDH cDNA. 	  
PCR Mix PCR Reaction 
10ng/µl DNA 1µl Step Temp. Time 
100µM Forward Primer 1µl 1 98° 2 min. 
100µM Reverse Primer 1µl 2 60° 30 sec. 
25mM dNTP mix 0.4µl 3 72° 30 sec./kb 
25mM MgCl2 2µl     4 98°C 10 sec. 
10X Reaction Buffer 5µl Step 2 to 4 repeated 34 times 
Taq Polymerase (5U/µL; 
Sigma) 
1µl 5 72° 10 min. 
ddH2O 38.6 µl 6 4°C ∞ 
Table 5: PCR mix and reaction. 
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Name Direction 5’ to 3’ sequence Target 
AS83 Reverse GCCGTTTACGTCGCCGTC GFP 
AS264 Forward CGCAAATGGGCGGTAGGCGTG CMV 
AS362 Forward CTGTGGAGGTGtctTAcATGGAaATCTACT
GTGAGCG 
Human 
KIF1C 
AS358 Reverse GAAGGGATCCACAGTTCCCCCATCCTC Human 
KIF1C 
AS359 Reverse GGGGATCCCCTCGTTCCCGTTCC Human 
KIF1C 
AS360 Reverse GCTGGATCCTCACTGCCACCACCAC Human 
KIF1C 
AS370 Forward CGGGGTCGACTCTGACAAGCGCTCTTG Human 
KIF1C 
AS371 Forward GGAGGTCGACCGAGGGGCGGAGGTGG Human 
KIF1C 
AS379 Reverse GTTGTAGTACCAtAatgaaAAGTAAGTGACC Rat PTPD1 
AS380 Reverse GAGCCCTCTGTATTTCTGATG Rat PTPD1 
AS416 Forward TTGGAGTGGTGTTTTATGTGC Rat PTPD1 
AS453 Forward CTGAGAATGGGAAGCTGGTCA Rat GAPDH 
AS454 Reverse GCCAGTGAGCTTCCCGTTC Rat GAPDH 
AS495 Reverse TGCGGATCCTGCAGCCGTAGCTGCTC Human 
KIF1C 
AS588 Forward GAAGTGCAGTCCAAGATTGAG Rat 
Transgelin 
AS589 Reverse GGTCGCCCATAGCCTGTC Rat 
Transgelin 
UT01 Forward GGAATTCTGGAGCTATGGCTGGTG Human 
KIF1C 
UT05 Forward CAACACGGAGTCCCAGATTG Human 
KIF1C 
UT170 Reverse ACTGACCTTCTCCGAGTCC Human 
KIF1C 
Table 6: Primers used in this study.  
AS362 and AS379 were used to generate RNAi-protected KIF1C and PTPD1 
respectively. Lower cases indicate silent point mutations. 	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 2-4-3: Mutagenesis PCR 
Mutagenesis PCR was used to generate RNAi-protected plasmids using 
the High-fidelity Phusion Polymerase (NEB). The PCR mix was set up mixing in 
a PCR tube 10ng of template DNA with 1µl of 10µM upstream primer, 1µl of 
10µM mutagenesis primer (AS362 to generate KIF1C-RIP; AS379 to generate 
PTPD1-RIP), 10µl of 5X High-Fidelity PhusionBuffer, 1µl of Physion polymerase 
and 0.4µl of 25mM dNTP mix. The final volume was adjusted to 50µl using 
ddH2O. The PCR was then carried out as indicated in Table 7. PCR product 
amplification was confirmed loading 5µl of the PCR product diluted in 6X 
Orange G loading buffer on an agarose gel. PCR product was purified using 
PureLink Quick PCR Purification Kit as per manufacturers guidelines 
(Invitrogen) and resuspended in 50µl ddH2O.  	  	  
Mutagenesis PCR program 
Step Temperature Duration 
1 98°C 2 min. 
2 98°C 10 sec. 
3 60°C 30 sec. 
4 72°C 10 sec. 
Step 2 to 4 repeated 9 times  
5 72°C Pause 
Addition of 0.5µl of 100µM downstream primer 
6 98°C 10 sec. 
7 60°C 30 sec. 
8 72°C 20 sec. 
Step 6 to 8 repeated 9 times 
9 72°C Pause 
Addition of 0.5µl of 100µM upstream primer 
10 98°C 10 sec. 
11 60°C 30 sec. 
12 72°C 20 sec. 
Step 10 to 12 repeated 9 times 
13 72°C 10 min. 
14 4°C ∞ 
Table 7: PCR Mutagenesis steps 
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 2-4-4: Cloning 
 Restriction enzymes used to digest plasmids and PCR products were 
purchased from New England Biolab and used as per manufacturers 
instructions. Digested plasmids were loaded on agarose gel, DNA band of 
interest cut out from the gel and purified using PureLink Quick Gel Extraction Kit 
as per manufacturer instructions (Invitrogen) while digested PCR products were 
purified using PureLink Quick PCR Purification kit as per manufacturers 
instructions (Invitrogen). Ligation was carried out for an hour at room 
temperature in a total volume of 10µl mixing 6µl insert with 1µl plasmid, 2µl 5X 
Fast Ligation Buffer (Fermentas) and 1µl T4 DNA ligase (Thermo Scientific).  
Ligation mix was incubated for 30 minutes with TOP10 competent cells on ice. 
Transformation was carried out incubating TOP10 competent cells mixed with 
the ligation product for 45 seconds at 42°C. Transformed cells were chilled on 
ice for 2 minutes and resuspended in 700µl SOC. Cells were allowed to recover 
at 37°C with shacking for at least 30 minutes prior seeding on LB plates 
containing the required selection antibiotic and plates were incubated at 37°C 
overnight.  
Colonies that grew on the plate were picked in 3ml DYT containing the correct 
selection antibiotic and kept in culture overnight at 37°C with shaking. Plasmids 
were purified using UltraClean 6 minutes Mini Plasmid Prep Kit (Cambio) and 
resuspended in 50µl ddH2O. Purified plasmids were subjected to test digestion 
and/or sent for sequencing (ATCC). Plasmids expressed in mammal cells were 
purified from 50ml culture using the PureLink HiPure Plasmid Midiprep Kit 
(Invitrogen) as per manufacturer instructions and resuspended in 200µl TE. 
Details of primers, enzymes and plasmids used for cloning are indicated in 
Table 8.  	  
pKIF1C-RIP-GFP was cloned by PCR mutagenesis using pKan-CMV-hsKIF1C-
GFP (cloned by Ulrike Theisen) as a template, UT01 as the upstream primer, 
AS362 as the mutagenesis primer and UT170 as the downstream primer. The 
PCR product and the template plasmid were both digested with EcoRI and 
BsiWI and the digested PCR product was cloned into to the digested pKan-
CMV-hsKIF1C-GFP.  	  
pKIF1C-RIP-1_490-GFP was cloned by amplification of KIF1C region of interest 
using pKIF1C-RIP-GFP as a template, UT01 as the forward primer and AS358 
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as the reverse primer. The PCR product and the template were digested with 
BsiWI and BamHI and the digested PCR product ligated in the digested 
pKIF1C-RIP-GFP. 	  
pKIF1C-RIP-1_610-GFP was cloned by amplification of KIF1C region of interest 
using pKIF1C-RIP-GFP as a template, UT05 as the forward primer and AS359 
as the reverse primer. The PCR product and the template were digested with 
BspEI and BamHI and the digested PCR product ligated in the digested 
pKIF1C-RIP-GFP. 	  
pKIF1C-RIP-1_822-GFP was cloned by amplification of KIF1C region of interest 
using pKIF1C-RIP-GFP as a template, UT05 as the forward primer and AS360 
as the reverse primer. The PCR product and the template were digested with 
BspEI and BamHI and the digested PCR product ligated in the digested 
pKIF1C-RIP-GFP. 	  
pKIF1C-RIP-1_950-GFP was cloned by Nida Siddiqui by amplification of KIF1C 
region of interest using pKIF1C-RIP-GFP as a template, UT05 as the forward 
primer and AS459 as the reverse primer. The PCR product and the template 
were digested with BspEI and BamHI and the digested PCR product ligated in 
the digested pKIF1C-RIP-GFP. 
 
pKIF1C-RIP-Δ623_679-GFP was cloned by Nida Siddiqui by amplification of 
KIF1C C-terminal region using pKIF1C-RIP-GFP as a template, AS370 as the 
forward primer and AS83 as the reverse primer. The PCR product and the 
template were digested with SalI and BamHI and the PCR product was ligated 
into the digested vector.  	  
pKIF1C-RIP-Δ623_825-GFP was cloned by amplification of KIF1C C-terminal 
region using pKIF1C-RIP-GFP as a template, AS371 as the forward primer and 
AS83 as the reverse primer. The PCR product and the template were digested 
with SalI and BamHI and the PCR product was ligated into the digested vector.  	  
pKIF1C-RIP-CHK2-GFP was cloned digesting both pKIF1C-RIP-GFP and pKan-
CMV-KIF1C-rescue(1-500)-CHK2(501-623)-KIF1C-rescue(624-end)-2XFlag 
(cloned by Ulrike Theisen) plasmids with BsiWI and BamHI. The DNA fragment 
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excised from pKan-CMV-KIF1C-rescue(1-500)-CHK2(501-623)-KIF1C-
rescue(624-end)-2XFlag and corresponding to the CHK2 FHA domain was then 
transferred in the digested pKIF1C-RIP-GFP. 	  
pHA-PTPD1-RIP-WT was cloned by Daniel Roth by mutagenesis PCR using 
pHA-PTPD1-WT as a template (kind gift from A. Feliciello; Cardone et al., 
2004), AS380 as the upstream primer, AS379 as the mutagenesis primer and 
AS264 as the downstream primer. The PCR product and pHA-PTPD1-WT were 
both digested with NheI and the digested PCR product ligated in the digested 
plasmid. 	  
pHA-PTPD1-RIP-C1108S was cloned digesting pHA-PTPD1-RIP-WT and pHA-
PTPD1-C1108S (kind gift from A. Feliciello; Cardone et al., 2004) with BsgI. The 
fragment excised from pHA-PTPD1-C1108S was then cloned into the digested 
pHA-PTPD1-RIP-WT.  	  	  
 2-4-5: Western Blotting 
 Samples were prepared harvesting and resuspending cells in 50µl PBS 
before addition of 10µl 6X Laemmeli containing β-Mercaptoethanol. Samples 
were boiled for 10 minutes at 95°C and stored at -20°C. For protein size 
reference, 5 µl of the Color Plus Pre-stained Protein Ladder Broad range (10-
230kDa) (NEB) was loaded on the first well of each gel. After protein transfer on 
nitrocellulose membrane (GE healthcare), membranes were incubated for 30 
minutes in 5% Milk (Sigma) diluted in PBS and probed with primary antibodies 
overnight at 4°C or an hour at room temperature. After extensive washes with 
PBS and TBS-0.1%Tween (TBST), membranes were incubated with HRP-
coupled secondary antibodies for 45 minutes at room temperature (see Table 4 
for the list of antibodies and dilutions used in this study). After extensive 
washes, revelation was carried out with SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Scientific). 	  	  	  	  	  
 45 
Plasmid 
name 
Backbone Primers Restriction 
enzymes 
Comments 
pKIF1C-RIP-
GFP 
pKan-CMV-
hsKIF1C-
GFP 
UT01 (forward)  
AS362 
(mutagenesis) 
UT170 (reverse) 
EcoRI, 
BsiWI 
 
pKIF1C-RIP-
1_490 
pKIF1C-
RIP-GFP 
UT01 (forward) 
AS358 (reverse) 
BsiWI, 
BamHI 
 
pKIF1C-RIP-
1_610 
pKIF1C-
RIP-GFP 
UT05 (forward) 
AS359 (reverse) 
BspEI, 
BamHI 
 
pKIF1C-RIP-
1_822 
pKIF1C-
RIP-GFP 
UT05 (forward) 
AS360 (reverse) 
BspEI, 
BamHI 
 
pKIF1C-RIP-
1_950 
pKIF1C-
RIP-GFP 
UT05 (forward) 
AS459 (reverse) 
BspEI, 
BamHI 
Cloned by Nida 
Siddiqui 
pKIF1C-RIP-
Δ623_679-
GFP 
pKIF1C-
RIP-GFP 
AS370 (forward) 
AS83 (reverse) 
SalI, BamHI Cloned by Nida 
Siddiqui 
pKIF1C-RIP-
Δ623_825-
GFP 
pKIF1C-
RIP-GFP 
AS371 (forward) 
AS83 (reverse) 
SalI, BamHI  
pKIF1C-RIP-
CHK2-GFP 
pKIF1C-
RIP-GFP 
 BsiWI, 
BamHI 
FHA domain 
from 8728 
cloned by Ulrike 
Theisen 
pKIF1C-
Headless 
pKan-CMV   Cloned by Ulrike 
Theisen  
Efimova et al., 
2014 
pKIF1C-
G102E 
pKan-CMV   Cloned by Ulrike 
Theisen 
Efimova et al., 
2014 
pHA-PTPD1-
WT 
pcDNA3.1   Gift from A. 
Feliciello 
Cardone et al., 
2004  
pHA-PTPD1-
C1108S 
pcDNA3.1   Gift from A. 
Feliciello 
Cardone et al., 
2004  
pHA-PTPD1-
RIP-WT 
pHA-
PTPD1-WT 
AS264 (forward) 
AS379 
(mutagenesis) 
AS380 (reverse) 
NheI Cloned by 
Daniel Roth 
pHA-PTPD1-
RIP-C1108S 
pHA-
PTPD1-WT 
 BsgI Cloned by 
Daniel Roth 
pFlag pKan-CMV   Cloned by Ulrike 
Theisen 
pTks5-GFP    Gift from T. 
Oikawa 
Oikawa et al., 
2008  
pGFP-Vinculin    Gift from B. 
Geiger 
pEGFP-N1 pKan-CMV   Clonetech 
8728: pKan-CMV-KIF1C-rescue(1-500)-CHK2(501-623)-KIF1C-rescue(624-end)-2XFlag 
Table 8: List of plasmids used in this study.  
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2-5: Statistical analysis and figure preparation 
The significance of the results was tested using a Mann-Whitney U-test using 
Origin Pro 8 software. Results were considered significant for p<0.05. 
Graphs were made using Origin Pro 8 software. Box plots show 10-90 range 
Whisker. 
Figures were made using Adobe Illustrator.  
Cortactin and actin stainings inserted in figures show inverted images of Z 
stack. 
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Chapter 3: Results 
 
3-1: Podosome formation in VSMCs requires a functional 
KIF1C 
 
 3-1-1: PDBu induction of podosome formation in VSMCs 
  
In physiological conditions, Vascular Smooth Muscle Cells (VSMCs) 
surround blood vessel to regulate blood flow pressure through their contractile 
activity (Davis-Dusenbery et al., 2011). The inflammatory response caused by 
an injury or some specific pathological conditions (such as atherosclerosis) 
causes the release of pro-inflammatory factors (cytokines, chemokines, growth 
factors) in the circulation that activates the de-differentiation of VSMCs from a 
static contractile to an active synthetic phenotype characterized by cell 
proliferation, cell migration and podosome formation (Rudijanto, 2007; 
Chistiakov et al., 2015). 
 
In vitro, VSMCs sporadically form very few podosomes. VSMC 
podosome formation can be induced by the overexpression of the constitutively 
active form of Src (v-Src) (Zhu et al., 2016) or the incubation of cells with growth 
factors (Quintavalle et al., 2010) or specific chemical compounds (Hai et al., 
2002; Brandt et al., 2002). One of the most widely used chemical agent to 
induce podosome formation in VSMCs is the Phorbol-12,13-dibutyrate ester 
(PDBu). PDBu activates the PKCα signaling pathway to induce a global 
remodeling of the actin cytoskeleton and podosome formation (Hai et al., 2002).  
 
To confirm that the rat Vascular Smooth Muscle Cell line used in this 
study behaves as previously described (Hai et al., 2002), A7r5 cell phenotype 
was characterized before and after podosome induction with 5µM PDBu. We 
first confirmed that the A7r5 cell line used in this study retained its smooth 
muscle characteristics even after growing it for several years in culture. To test 
this, we confirmed by RT-PCR the expression of the smooth muscle myosin 
heavy chain or transgelin by A7r5 cells, a specific marker for smooth muscle 
cells (Figure 3.1; Miano et al., 1994). We compared the level of expression of 
transgelin in A7r5 cells used in podosome formation assays (A7r5 synthetic) to 
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the expression level of transgelin in A7r5 cells freshly isolated from the aorta of 
embryonic rat and obtained from ATCC (A7r5 contractile). No significant 
difference in the expression level of transgelin could be detected between the 
two A7r5 cell lines tested (Figure 3.1), confirming that the A7r5 cells used during 
the course of this work actually were VSMCs. To confirm the specificity of the 
transgelin primers we designed, we tested their ability to amplify cDNA obtained 
from the retro-transcription of total mRNA purified from NRK cells. NRK cells are 
epithelial-like cells; they therefore do not express smooth muscle myosin heavy 
chain (Figure 3.1), providing a good negative control for transgelin expression in 
rat cells. A fragment of the GAPDH (Glyceraldheyde 3-phosphate 
dehydrogenase) cDNA of similar size (~500bp) was amplified in parallel and 
used as a loading control (Figure 3.1). 
 
 
Figure 3.1: A7r5 cells used in this study express the transgelin smooth muscle cell 
specific marker. 
Total mRNA of fresh A7r5 cells (Contractile A7r5 cells), A7r5 cells kept in culture for 
several years (Synthetic A7r5 cells) or epithelial like cells (NRK cells) were extracted 
and reverse transcribe using random hexamers primers. Transgelin and GAPDH cDNA 
were amplified with specific primers 
 
A7r5 cells were then tested for their ability to form podosomes in 
response to treatment with the phorbol ester PDBu. Podosomes were immuno-
stained using cortactin as a marker for the podosome core (Figure 3.2). Actin 
was also stained and observed in parallel to the cortactin staining to confirm its 
podosomal specificity. 
In unstimulated cells, the actin cytoskeleton was well developed with stress 
fibers forming a strong well-organized network throughout the cytoplasm and 
the cortactin showed a diffuse distribution in the cytoplasm and accumulating at 
the cell cortex (Figure 3.2). As early as 10 minutes after PDBu addition, 
modifications of the actin cytoskeleton and podosome formation could be 
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detected. The actin network density was reduced in the cell body and an 
increase of the peripheral membrane ruffling activity was observed. Newly 
forming podosomes appeared as cortactin- and actin-enriched punctae at the 
very periphery of the cell (Figure 3.2). 
After 30 minutes of PDBu treatment, the number of podosomes detected in cells 
was greatly increased and a modification in the general distribution of 
podosomes was observed. Cortactin-enriched punctae were not confined to the 
cell periphery as observed after only 10 minutes of PDBu treatment but 
podosomes covered a cellular area extending towards the cell centre. This 
phenomenon is most likely due to the centripetal relocation of material from old 
depolymerizing podosomes into more central newly forming ones (Zhu et al., 
2016). 	  
	  
Figure 3.2: Phenotypical characterization of unstimulated and PDBu-treated A7r5 cells.  
A7r5 cells were stained for cortactin and actin in resting condition (left panel), after 10 
minutes (middle panel) or 30 minutes (right panel) of stimulation with 5µM PDBu. 
Unstimulated cells show a well-developed actin stress fiber network (arrowheads) and 
the cortactin staining is dispersed throughout the cytoplasm. After 10 minutes of 
stimulation with 5µM PDBu, podosomes (arrows) are visualized as cortactin-dense 
spots formed at the very periphery of the cell. After 30 minutes of PDBu treatment, cells 
display an increased number of podosomes (arrow) scattered throughout the cytoplasm. 	  	  
To confirm the podosomal specificity of the cortactin immuno-staining 
used, another specific marker of podosome core was used: the adaptor protein	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Tks5. Tks5 has been shown to localize at the podosome core in Src-
transformed fibroblasts (Abram et al., 2003) where it participates in the 
regulation of podosome formation and function (Seals et al., 2005) through its 
scaffolding activity, and is responsible for the recruitment of podosome 
components such as cortactin (Crimaldi et al., 2009). A GFP-fusion of Tks5 was 
expressed in A7r5 cells and its localization determined after podosome 
induction by PDBu treatment. Endogenous actin and cortactin were 
concomitantly stained and signals detected for each of these channels 
compared to Tks5-GFP localization (Figure 3.3). 
Tks5-GFP was enriched at membrane ruffles and at podosome cores. 
Comparison of the GFP signal to cortactin and actin channels showed a very 
high degree of co-localization of cortactin and actin signals with GFP 
accumulations at podosome cores, proving the reliability of the cortactin staining 
as a podosome core specific marker for future experiments. 	  
 
Figure 3.3: Cortactin, Actin and Tks5 colocalize at podosomes in VSMCs. 
A7r5 cells expressing Tks5-GFP were treated for 30 minutes with 5µM PDBu prior 
fixation. Cortactin and actin stainings show a very high degree of colocalization with 
Tks5-GFP at the podosome core. 	  	  
 The cortactin staining used to detect podosomes in stimulated A7r5 cells 
only stains the podosome core. However, podosomes are considered as 
functional structures if they are able to assemble the adhesive ring around the 
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actin-rich core (Linder et al., 2011). To make sure podosomes formed in our 
A7r5 cell line were mature adhesion structures, GFP-vinculin was expressed in 
A7r5 cells and podosome formation induced for 30 minutes with 5µM PDBu. 
Podosome cores were stained with cortactin and the localization of vinculin-GFP 
at podosomes was determined (Figure 3.4).  
Vinculin-GFP was enriched at elongated structures scattered throughout the cell 
and looking like focal adhesions. Podosome cores visualized by cortactin 
accumulations were often localized in close proximity to focal adhesions and 
vinculin-GFP formed a ring around the podosome core (Figure 3.4), confirming 
that A7r5 cells are able to form mature podosomes. 
 
 
Figure 3.4: Vinculin-GFP forms a ring around the podosome core in A7r5 cells. 
A7r5 cells expressing vinculin-GFP were treated for 30 minutes with 5µM PDBu prior 
fixation. Vinculin-GFP stains elongated structures scattered throughout the cells and 
resembling focal adhesions and forms a ring around the core of podosomes visualized 
with the cortactin staining. 
  	  
3-1-2: Functional KIF1C is required for podosome formation in VSMCs 
 
Prior to this work, KIF1C had been shown to participate in podosome 
dynamics in macrophages (Kopp et al., 2006). The macrophagic model differs 
from the VSMC one because it does not require extra-cellular signaling to 
trigger podosome formation as signals provided by their adhesion on a surface 
are sufficient to induce podosome formation. In VSMCs, podosome formation 
can be triggered subsequently to adhesion and these cells are thus a good 
model to study podosome formation mechanisms.  
 
To test the requirement of KIF1C for podosome formation in VSMCs, a 
depletion-rescue approach was used. The expression of endogenous KIF1C 
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was reduced using a small-interfering RNA (siRNA) designed to specifically 
target KIF1C transcripts (Figure 3.5A) and the protein expression was restored 
using a RNAi-protected (RIP) version of KIF1C. To generate the RNAi-protected 
version of KIF1C, silent point mutations were introduced in the sequence of 
KIF1C cDNA to generate a transcript that cannot be recognized by the siRNA 
targeting KIF1C, and thus restores KIF1C protein expression in cells depleted 
for the endogenous protein without changing its amino acid sequence (Figure 
3.5A). 
The depletion of endogenous KIF1C and its re-expression with KIF1C-RIP were 
confirmed by Western-blot of cellular lysates. An antibody specifically 
recognizing KIF1C (region between amino acids 850 and 900) was used to 
detect KIF1C protein level in each condition and tubulin was used as a loading 
control. Two bands were detected for KIF1C: one around 130kDa and another 
one around 170kDa. The 130kDa band corresponds to the endogenous protein 
and the higher one to KIF1C-GFP. The shift observed between the two KIF1C 
forms comes from the GFP tag (Figure 3.5B). 
Western-blot showed that the expression level of the endogenous KIF1C was 
strongly reduced after 72 hours of KIF1C siRNA treatment compared to control 
cells, confirming the efficiency of the siRNA used to target KIF1C transcript. It 
also showed that KIF1C was efficiently re-expressed with the RNAi-protected 
version of it (Figure 3.5B). The GFP-tagged protein is expressed at similar level 
as the endogenous protein and at the same level in control and KIF1C-depletion 
conditions, allowing the podosome formation assay to be performed.  
 
For each condition, cells were seeded on fibronectin-coated glass 
coverslips 24 hours prior to the induction of podosome formation with 5µM 
PDBu to give cells enough time to adhere and spread on the substratum. After 
podosome induction for 30 minutes, cells were fixed, the endogenous cortactin 
was immuno-stained and the average number of podosomes formed in each 
condition was determined and compared to the average number of podosomes 
formed in control cells. To confirm the podosomal specificity of cortactin punctae 
observed, actin was stained and the colocalization of actin and cortactin 
stainings at podosome core was checked for each podosome detected in the 
cortactin channel (Figure 2.1).  
A significant decrease of the average number of podosomes formed in KIF1C-
depleted cells compared to the control condition was observed (p=0.02 using a 
Mann-Whitney U-test). KIF1C-depleted cells formed 33±3 podosomes on 
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average when control cells formed 47±5 podosomes (results indicate mean ± 
SEM; Figure 3.6), indicating that podosome formation is impaired in KIF1C-
depleted cells and that KIF1C is required for podosome formation in VSMCs. 
KIF1C-depleted cells expressing KIF1C-RIP formed an average number of 
podosomes that was very close to that formed in control cells (48±5 against 
47±5 in control cells; Figure 3.6) and significantly different from KIF1C-depleted 
cells (33±3 podosomes formed per cell on average; p = 0.02 using a Mann-
Whitney U-test). This result indicates that KIF1C re-expression after its 
depletion restores podosome formation in A7r5 cells and proves that the KIF1C 
depletion phenotype previously observed was specific to KIF1C depletion and 
not the result of the unspecific targeting of another transcript by the siRNA the 
cells were treated with. 
 
 We took advantage of the GFP tag fused to KIF1C-RIP to determine the 
localization of KIF1C at podosome in fixed cells. The GFP signal formed a ring 
around the cortactin core and seemed to be excluded from it (Figure 3.7), 
indicating that KIF1C most likely localizes at the podosome adhesive ring. 
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Figure 3.5: KIF1C depletion is efficient in A7r5 cells. 
A: Principle of KIF1C depletion. A siRNA oligonucleotide (KIF1C siRNA sequence) was 
designed to target a sequence of the KIF1C transcript (mRNA sequence; red 
nucleotides) to induce its degradation. Silent point mutations (green nucleotides) were 
introduced in KIF1C cDNA sequence (RIP DNA sequence) to generate a transcript 
(siRNA resistant mRNA sequence) that cannot hybridize to the siRNA and thus, 
resistant to its degrading effect. B: Western-Blot showing the efficient KIF1C depletion 
after 72 hours of cell treatment with siKIF1C and the re-expression of a RNAi-protected 
version of the protein.  
 
 
 55 
 
Figure 3.6: PDBu-induced podosome formation relies on KIF1C in VSMCs. 
A7r5 cells depleted for KIF1C expression for 72 hours and transfected with a control 
(pEGFP) or the RNAi-protected version of KIF1C (pKIF1C-RIP-GFP) were treated with 
5µM PDBu for 30 minutes prior fixation and cortactin immunostaining (A). Podosome 
number formed per cell was counted for each condition and compared to the control 
condition (B). n=60 cells pooled from 3 independent experiments; * p<0.05 using a 
Mann-Whitney U-test. 
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Figure 3.7: KIF1C forms a ring around the podosome core. 
GFP-fusion of KIF1C was over-expressed in A7r5 cells. Cells were treated with 5µm 
PDBu for 30 minutes prior fixation. Podosome core was stained with cortactin. KIF1C-
GFP forms a ring around the core of podosomes and seems to be excluded from it. 
 
 
Results obtained so far suggested that KIF1C is required for the 
formation of a normal podosome number in VSMCs.  As a member of the 
kinesin superfamily, KIF1C displays a motor activity to move along MTs and 
transport cargoes within the cell. To test if KIF1C involvement in podosome 
formation in VSMCs was motor-dependent, KIF1C motor activity was impaired 
using two different dominant negative forms of the kinesin: a KIF1C Headless 
mutant and a KIF1C rigor mutant (KIF1C-G102E). The Headless mutant 
contains only KIF1C tail and lacks its MT-interacting motor domain. The 
truncated protein can then bind its cargoes but it cannot interact with MTs 
anymore to ensure its cargo transport activity.  
A rigor mutant is a catalytically inactive version of the kinesin (Nakata & 
Hirokawa, 1995). Point mutations inserted in the motor domain P-loop generate 
a kinesin that retains its ability to bind ATP but that had lost its ability to 
hydrolyze it, making it unable to generate the force required for its movement 
along MTs. However, kinesin rigor mutant capacity to bind microtubules stays 
intact as well as its cargo binding ability. 
 
KIF1C dominant negative constructs were expressed in A7r5 cells and 
the ability of cells to form podosomes after 30 minutes of 5µM PDBu treatment 
was determined and compared to a control expressing pFlag. In both cases, a 
significant decrease in podosome formation was observed compared to control 
cells (Figure 3.8A). While control cells formed an average of 38±3 podosomes, 
cells transfected with the Headless construct formed 27±4 podosomes on 
average and cells expressing the rigor mutant only 21±3 podosomes (Figure 
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3.8A). It is noteworthy that the decrease of podosome formation after the over-
expression of dominant negative mutants is stronger than the phenotype 
observed after KIF1C knockdown (Figure 3.6). As the endogenous KIF1C has 
not been depleted before the over-expression of the dominant negative 
constructs, it is suspected that these KIF1C mutants impair the activity of the 
endogenous motor, most likely through their ability to dimerize with the 
endogenous KIF1C.  
 
Looking more closely at the cortactin staining of control cells and cells 
expressing KIF1C dominant negative constructs, an intriguing difference in 
podosome localization and distribution was observed. Podosomes formed in 
control cells were scattered throughout the cell cytoplasm with the exception of 
the perinuclear region whereas podosomes seemed to be preferentially 
localized to the cell periphery in cells expressing KIF1C dominant negative 
constructs (Figure 3.8B).  
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Figure 3.8: KIF1C motor activity is required for podosome formation in VSMCs. 
A7r5 cells expressing a control plasmid (pFlag), a KIF1C mutant lacking its motor 
domain (pKIF1C-Headless) or a KIF1C rigor mutant (pKIF1C-G102E) were treated with 
5µM PDBu for 30 minutes prior fixation and cortactin staining (B). Podosome number 
formed in each condition was determined and compared to the control condition (pFlag) 
to test the requirement of KIF1C motor activity for podosome formation (A). 
n=60 cells pooled from 3 independent experiments, **p<0.005; ***p<0.0005 using a 
Mann-Whitney U-test.  
 
 
 3-1-3: KIF1C-dependent timing of podosome formation in VSMCs 
 
Podosome formation capacity of rat VSMCs was determined after 30 
minutes of PDBu treatment in the first set of experiments of this work. However, 
podosome patterns observed at 10 and 30 minutes of podosome induction as 
well as in KIF1C dominant negative expressing cells suggested that KIF1C 
might be required for the relocation of podosomes from the cell periphery to the 
cell centre. The formation of the first batch of podosomes occurs at the cell 
periphery in VSMCs, at the interface between focal adhesions and stress fibers 
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to be more precise (Kaverina et al., 2003; Burgstaller & Gimona, 2004). 
Centrally located podosomes appear later on following the transfer of proteins 
from peripheral depolymerizing podosomes to newly forming ones at the cell 
centre. KIF1C involvement in this phenomenon as well as its requirement for 
podosome formation throughout time was thus tested. Podosome formation was 
induced with 5µM PDBu for 10, 20, 30, 40, 50, 60, 75 and 90 minutes in control 
and KIF1C-depleted A7r5 cells in parallel and the average number of 
podosomes formed in KIF1C-depleted cells was compared to the control 
condition for each time point (Figure 3.9A).  
 
The results of this time course experiment suggested that podosome 
formation in control and KIF1C-depleted cells could be divided into 2 phases. 
During the early phase of podosome formation (first 20 to 30 minutes of 
podosome formation), the average podosome number formed in control and 
KIF1C-depleted cells increased at the same rate (Figure 3.9A). However, from 
40 minutes after podosome induction, the average number of podosomes 
formed in KIF1C-depleted cells stagnated at ~ 30 podosomes per cell while the 
average number of podosomes formed in control cells continued to gradually 
increase and stabilized around 40 podosomes per cell after 60 minutes of PDBu 
treatment. At 90 minutes of PDBu treatment, a decrease in the number of 
podosomes formed per cells was detected in both conditions that may be due to 
the degradation of the phorbol ester and a decrease of the signals it mediates. 
 
 Taken together, results obtained so far highlight the importance of KIF1C 
for podosome formation in VSMCs. We showed here that KIF1C involvement in 
podosome formation is not cell-type specific as the same kind of results were 
previously obtained in macrophages (Kopp et al., 2006). KIF1C ability to form 
podosomes relies on its motor activity, as the over-expression of catalytically 
inactive forms of KIF1C impairs podosome formation (Figure 3.8). The main 
function of kinesin motor activity is to mediate cargo transport throughout the 
cell. The observation of cortactin stainings and podosome patterning at different 
time points of podosome induction revealed that impairing KIF1C motor activity 
results in the retention of podosomes at the cell periphery, most likely because 
of KIF1C inability to transport podosome components in a centripetal way. 
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Figure 3.9: Kinetic of podosome formation in control and KIF1C-depleted VSMCs. 
A7r5 cells treated for 72 hours with a control (siControl) or a KIF1C-targeting siRNA 
(siKIF1C) were treated with 5µM PDBu for various periods of time prior to fixation and 
cortactin staining. The number of podosomes formed was then determined for each time 
point (A). Data show mean ± SEM. n=90 cells pooled form 3 independent experiments. 
(B) Examples of cortactin staining of cells treated for 10, 30 or 60 minutes with 5µM 
PDBu.  
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3-2: KIF1C and PTPD1 cooperate to form podosomes in 
VSMCs 
 
 3-2-1: The Myosin IIA / PTPD1-binding domain of KIF1C is required for 
podosome formation in VSMCs. 
 
Results produced in the first part of this study highlighted the 
requirement of a functional KIF1C motor activity for podosome formation in 
VSMCs. Apart from the recent discovery of Rab6-mediated control of KIF1C 
activity during synaptic vesicle transport (Lee et al., 2015), little is known about 
mechanism(s) controlling KIF1C transport activity. As I described in the 
introduction (Chapter 1-1), kinesin tails are known to participate in the regulation 
of kinesin motor activity. Depending on its cargo binding status, the tail can 
interact with or release the motor domain, leading to kinesin inactivation or 
activation respectively. Moreover, kinesin tails can mediate the oligomerization 
of the motor, allowing it to move along microtubules. 
 
The KIF1C tail contains various structural domains separated from each 
other by regions without apparent structural characteristics. It is known to 
interact with a number of proteins whose functional role remains poorly 
understood but which could influence KIF1C transport activity. In order to 
identify regions in the KIF1C tail that are important for podosome formation in 
VSMCs and hereby the activation of its motor activity, KIF1C truncation 
constructs were tested for their ability to mediate podosome formation. To do 
so, the RNAi-protected KIF1C construct (pKIF1C-RIP-GFP) previously 
generated to restore KIF1C expression after its depletion was used as a 
template for the design of various KIF1C mutants lacking a specific region or 
domain of its tail (Figure 3.10). Truncation sites were chosen in unstructured 
regions of the protein to preserve the structural integrity of any folded domains 
as much as possible. Known binding domains for KIF1C interactors were also 
preserved as protein interactions may regulate KIF1C activity during the 
podosome formation process. Each construct was then expressed in KIF1C-
depleted A7r5 cells and the ability of these cells to efficiently form podosomes in 
the absence of the endogenous protein was tested. Cells were treated with 5µM 
PDBu for an hour and not 30 minutes as previously as the time course 
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experiments conducted in the first part of this study (Figure 3.9) suggested that 
a stronger phenotype could be observed after an hour of podosome induction. 
 
Four C-terminal truncations were initially generated to determine the 
minimal length of KIF1C tail required to mediate podosome formation in VSMCs. 
To do so, the motor domain and the two first coiled-coil domains were preserved 
to form a minimal construct (pKIF1C-RIP-1_490). The tail length was then 
gradually increased to include the FHA domain (pKIF1C-RIP-1_610), the FHA 
domain plus the third coiled-coil domain (pKIF1C-RIP-1_822) and finally the 
fourth coiled-coil domain (pKIF1C-RIP-1_950). The full length KIF1C-RIP 
construct (pKIF1C-RIP) was used as a control to compare podosome formation 
in each condition with and determine the ability of each truncation to mediate 
podosome formation in the absence of the endogenous motor (Figure 3.10).  
 
 
Figure 3.10: Schematic representation of KIF1C mutants used to identify the region of 
the kinesin that is important for podosome formation in VSMCs. 
 
 
KIF1C-depleted cells (siKIF1C pEGFP) formed 43±3 podosomes on 
average (Figure 3.11), a result that is significantly different from the 84±5 
podosomes formed in control cell (siControl pEGFP) (p<0.00001 using Mann-
Whitney U-test). In these experiments, cells formed a higher number of 
podosomes than those used in the previous experiments (Chapter 3.1). This 
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difference can be explained by the gradual decrease of VSMC contractility with 
time when cells are kept in culture that favors podosome formation. To confirm 
the ability of the RNAi-protected version of KIF1C full-length to restore 
podosome formation after 60 minutes of podosome induction, KIF1C-depleted 
cells were transfected with pKIF1C-RIP-GFP (siKIF1C KIF1C-FL condition) and 
their ability to form podosomes was tested after 60 minutes of PDBu treatment. 
These cells formed 75±4 podosomes on average. This result is significantly 
different from that obtained in the KIF1C depletion condition (siKIF1C pEGFP 
cells; p<0.00001 using Mann-Whitney U-test) and not significantly different from 
the control condition (siControl pEGFP cells; p=0.31 using a Mann-Whitney U-
test). Hence, podosome formation can be restored after 60 minutes of PDBu 
treatment in KIF1C-depleted cells using the RNAi-protected version of KIF1C 
and these results provided baselines to compare podosome formation with in 
the different conditions tested below. 
 
The first truncation that has been tested for its ability to mediate 
podosome formation in KIF1C-depleted cells was the KIF1C minimal construct 
described above. After an hour of PDBu treatment, KIF1C-depleted cells 
expressing the KIF1C-RIP-1_490 truncation (siKIF1C KIF1C1_490 condition) 
formed only 40±4 podosomes on average, a number that is significantly different 
from the 75±4 podosomes formed in the rescue condition (siKIF1C KIF1C-FL 
condition; p=0.0015 using Mann-Whitney U-test). However, this result is not 
different from the KIF1C depletion condition (siKIF1C pEGFP; p=0.85 using 
Mann-Whitney U-test), showing that this KIF1C minimal truncation is not able to 
mediate podosome formation in VSMCs. 
 
KIF1C tail was then extended to include the FHA domain (pKIF1C-RIP-
1_610), a specific feature of kinesin-3s. Again, KIF1C-depleted cells expressing 
this construct were not able to restore podosome formation as cells of the 
siKIF1C KIF1C-1_610 condition formed an average number of only 48±5 
podosomes (Figure 3.11), a number that is significantly different from the 75±4 
podosomes formed with the full length construct (p=0.02 using Mann-Whitney 
U-test).  
 
The longer truncation containing the third coiled-coil domain and 
truncated just before the fourth coiled-coil domain was then tested for its ability 
to restore podosome formation in the absence of the endogenous KIF1C motor. 
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KIF1C-depleted cells expressing this construct (siKIF1C KIF1C-1_822 
condition) formed a number of podosomes that is not significantly different from 
the full-length rescue condition (63±4 compared to 75±4; p=0.25 using Mann-
Whitney U-test), meaning that this truncation is able to support KIF1C 
podosome-forming activity (Figure 3.11).  
 
Likewise, the longest truncation lacking only the carboxy-terminal 
Proline-rich domain formed a normal number of 85±7 podosomes on average 
(Figure 3.11).  
 
Results obtained using these KIF1C truncations suggest that KIF1C full 
length is not absolutely required for podosome formation in VSMCs as the 
KIF1C-1_822 truncation can efficiently mediate podosome formation in the 
absence of the endogenous kinesin. The shortest truncation (KIF1C-1_610) is 
unable to efficiently mediate podosome formation, suggesting that the KIF1C-
610_822 region is required for podosome formation in VSMCs.  
 
FHA domains are structural domains that were first identified in 
transcription factors and kinases (Hofmann & Bucher, 1995) and that have since 
been identified in many other types of proteins such as phosphatases, 
glycoproteins and kinesins (Li et al., 2000). In addition to their structural 
properties, FHA domains also recognize and interact with phospho-serine and 
phospho-threonine epitopes exposed at the protein surface (Li et al., 2000).   
FHA domains were shown to regulate kinesin-3 activity through their ability to 
interact with kinesin coiled-coil domains. Indeed, KIF1A FHA domain can 
interact with the coiled-coil domain that immediately follows it in the protein 
sequence to negatively regulate KIF1A motor activity (Lee et al., 2004). The 
same FHA domain can also work in tandem with KIF1A first coiled-coil domain 
to mediate kinesin dimerization and thus facilitate KIF1A motor activity (Huo et 
al., 2012). Therefore, the FHA domain appears to be crucial for the regulation of 
KIF1A activity and as a specific feature of the kinesin-3 family, it might regulate 
the activity of the other members of the family.  
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Figure 3.11: KIF1C truncations revealed the crucial importance of a ~ 150 amino acid 
long domain to mediate its podosome forming activity. 
A7r5 cells depleted for the endogenous KIF1C were transfected with tail truncations as 
indicated and their ability to form podosomes determined after 60 minutes of treatment 
with 5µM PDBu. Each condition tested was compared to a control condition (siControl 
pEGFP) and to the rescue condition (siKIF1C KIF1C-FL). Results colored in green are 
not significantly different from the rescue condition; results colored in red are 
significantly different from the rescue condition. The table indicates U-test p values. 
n=90 pooled form 3 different experiments.  
 
 
To determine the requirement of the FHA domain for KIF1C function and 
without interfering with the structural role of the FHA domain, KIF1C FHA 
domain was replaced by an FHA domain from an unrelated protein, the CHK2 
kinase (pKIF1C-RIP-CHK2). This KIF1C mutant was able to restore podosome 
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formation in cells depleted for the endogenous protein (siKIF1C KIF1C-CHK2 
FHA domain condition). Indeed, these cells formed 86±5 podosomes on 
average, which is not significantly different from the 75±4 podosomes formed in 
cells expressing KIF1C full-length (Figure 3.11; p=0.84 using Mann-Whitney U-
test). This result suggests that if KIF1C FHA domain is important for KIF1C 
podosome-forming activity, it’s most likely due to its structural function rather 
than to its phospho-specific interactions with proteins. 
 
As mentioned above, the KIF1A FHA domain can modulate the kinesin 
folding and hence its activity through its interaction with the coiled-coil domain 
that immediately follows it (Lee et al., 2004). To test if the coiled-coil domain that 
follows KIF1C FHA domain is involved in the regulation of KIF1C activity, a 
deletion mutant lacking KIF1C third coiled-coil domain (pKIF1C-RIP-Δ623-679) 
was generated and its ability to restore podosome formation tested in KIF1C-
depleted cells. These cells formed an average number of podosomes of 62±4 
after 60 minutes of PDBu treatment, a number that is not significantly different 
from the rescue with the full length construct (Figure 3.11; p=0.44 using Mann-
Whitney U-test), thus indicating that the third coiled-coil domain of KIF1C is not 
absolutely required to mediate its podosome-forming activity.  
 
The region of interest identified with the four initial KIF1C truncations 
highlighted the importance of the region between amino acids 610 and 822 for 
podosome formation in VSMCs. As deleting the third coiled-coil domain that falls 
within that region had no effect on KIF1C ability to mediate podosome 
formation, an additional deletion mutant lacking the third coiled-coil and the 
following unstructured domains was generated (pKIF1C-RIP-Δ623-825) and its 
ability to mediate podosome formation tested. KIF1C-depleted cells expressing 
this construct (siKIF1C KIF1C-Δ623-825 cells) formed a strikingly low number of 
podosomes compared to all of the other conditions tested. Indeed, these cells 
formed only 26±3 podosomes on average, a number that is even lower than the 
one formed in KIF1C-depleted cells only (Figure 3.11). This result suggests that 
this region comprised between the third and fourth coiled-coil domain is of major 
importance to mediate KIF1C podosome-forming activity.  
 
Rescue experiments using these seven KIF1C mutants allowed the 
identification of a region of about 150 amino acids in the tail of KIF1C that 
seems to be crucial to mediate its podosome forming activity. This region 
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between the third and fourth coiled-coil domain is known to interact with the 
non-muscle Myosin IIA (Kopp et al., 2006) and the tyrosine phosphatase PTPD1 
(Dorner et al., 1998). Interestingly, these two proteins were shown to participate 
to the regulation of the cellular adhesion (Conti et al., 2004; Carlucci et al., 
2008) and are thus good candidate to investigate to understand the mechanism 
ruling KIF1C-mediated podosome formation in VSMCs. 
 
 
 3-2-2: The non-muscle Myosin IIA is not required for podosome 
formation in VSMCs. 
 
The non-muscle Myosin IIA is a well-known podosome component that 
localizes on top of the adhesive ring where it crosslinks radial actin filaments to 
maintain podosome structural integrity and mediate podosome oscillations 
(Gawden-Bone et al., 2010; van den Dries et al., 2013). Myosin IIA interaction 
with KIF1C has previously been suggested to be important for podosome 
formation in macrophages (Kopp et al., 2006). Indeed, the microinjection of a 
truncated version of KIF1C containing only KIF1C Myosin IIA/PTPD1 binding 
domain impairs podosomes reformation in macrophages after their disruption 
with the PP2 Src inhibitor (Kopp et al, 2006). A similar GFP-tagged construct 
was tested (pKIF1C-708_822-GFP) and appeared to localize to the nucleus in 
A7r5 cells (Figure 3.12) and the published effect on podosome formation could 
not be confirmed. To address the requirement of the Myosin IIA contractile 
activity for podosome formation in VSMCs, an inhibitory approach was chosen.  
 
Figure 3.12: KIF1C-708_822 localizes to the nucleus of A7r5 cells. 
A7r5 cells were transfected with the pKIF1C-708_822-GFP construct, fixed and stained 
with DAPI and Acti-staining. The GFP signal colocalizes with the DAPI staining, proving 
the nuclear localization of the KIF1C-708_822 construct. 
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Cells were first treated with Blebbistatin, a Myosin II inhibitor that binds 
to the Myosin-ADP-Pi complex with high affinity and impairs the release of the 
hydrolyzed nucleotide. Hence, Blebbistatin-bound Myosin IIA is blocked in its 
low actin affinity state and cannot bind actin filaments after the first cycle of ATP 
hydrolysis (Kovács et al, 2004). Podosome formation was induced for 60 
minutes with 5µM PDBu and in the same moment, Myosin IIA contractile activity 
was inhibited using different concentration of Blebbistatin (0, 10, 20 and 30µM). 
The efficiency of the Blebbistatin inhibitor was confirmed comparing the actin 
stress fiber network in control cells (0µM Blebbistatin) and cells treated with the 
Myosin IIA inhibitor. Indeed, the loss of the actin stress fiber network has 
previously been associated with an efficient Blebbistatin-mediated decrease of 
Myosin IIA contractile activity (Even-Ram et al., 2007). While DMSO-treated 
cells (0µM Blebbistatin) retain a well-developed actin stress fiber network at the 
cell center, Blebbistatin treated cells lost most, if not completely, their actin 
stress fibers (Figure 3.13B), proving the efficiency of the Blebbistatin inhibitor.  
 
The number of podosomes formed in each condition was then 
determined and compared to the number of podosomes formed in DMSO-
treated cells (0µM Blebbistatin; Figure 3.13A). For every inhibitor concentration 
tested, no significant difference between DMSO-treated cells and Blebbistatin-
treated cells could be detected (Figure 3.13A), suggesting that inhibiting Myosin 
IIA contractile activity has no effect on podosome formation in VSMCs.  
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Figure 3.13: Myosin IIA inhibition with Blebbistatin has no effect on podosome formation 
in VSMCs.  
A7r5 cells treated for 60 minutes with 5µM PDBu were concomitantly treated with 
different concentrations (0, 10, 30 or 30µM) of the Myosin IIA inhibitor Blebbistatin. Cells 
were fixed and stained with actin and cortactin (B). The number of podosomes formed in 
each condition was determined and compared to the DMSO-treated control condition 
(0µM Blebbistatin) using Mann-Whitney U-test (A). No significant difference could be 
observed between control cells (0µM Blebbistatin) and cells treated with the inhibitor. 
n=90 pooled from 3 independent experiments. 
 
 
To confirm this result, we used an alternative method to reduce Myosin 
IIA activity: the Y27632 Rho-associated Coiled-coil containing protein Kinase 
(ROCK) inhibitor. This chemical compound competes with ATP for the binding 
of the ROCK catalytic site and impairs the activation of its downstream effectors, 
including the non-muscle Myosin IIA-regulating kinase MLCK (Myosin Light 
Chain Kinase). Hence, treatment with Y27632 impairs Myosin IIA contractile 
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activity but in contrast to Blebbistatin, it doesn’t compromise its ability to bind 
and crosslink actin filaments. 
Three different concentrations of the ROCK inhibitor were tested (5µM, 10µM 
and 15µM) while podosome formation was induced with PDBu and the average 
number of podosomes formed in cells treated with Y27632 was determined and 
compared to a DMSO-treated control condition (0µM Y27632). Y27632 
efficiency was confirmed using the actin staining. While control cells (0µM 
Y27632) displayed a well-developed actin stress fiber network throughout their 
cytoplasm, the actin network was weakened in Y27632-treated cells (Figure 
3.14B), proving the efficiency of the Myosin IIA contractile activity inhibition. No 
significant difference in the average number of podosomes formed per cell was 
detectable when the Myosin IIA contractile activity was inhibited with 5 and 
10µM of the ROCK inhibitor (Figure 3.14A). Cells treated with 15µM displayed a 
significant increase of the average number of podosomes they formed (130±7 
on average) compared to control cells (109±6 podosomes formed on average; 
p=0.009 using a Mann-Whitney U-test; Figure 3.14A). 
 
These results suggest that the inhibition of the Myosin IIA contractile 
activity using two different methods has no dramatic effect on the ability of cells 
to form podosomes. Moreover, in contrast to the Y27632 ROCK inhibitor, the 
Blebbistatin inhibitor not only impairs Myosin IIA contractile activity but also 
abolishes its ability to bind and crosslink actin filaments. Thus, Myosin IIA 
appears to be dispensable for podosome formation in VSMCs and in light of 
these results, it was ruled out as the relevant KIF1C interactor to explain KIF1C-
mediating podosome formation in VSMCs. 
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Figure 3.14: Myosin IIA inhibition with the Y27632 ROCK inhibitor has no dramatic effect 
on podosome formation in VSMCs.  
A7r5 cells treated for 60 minutes with 5µM PDBu were concomitantly treated with 
different concentrations (5, 10 and 15µM) of the ROCK inhibitor Y27632. Cells were 
fixed, stained with actin and cortactin (B) and the average number of podosomes formed 
in each condition determined (A). No significant difference could be observed between 
DMSO-treated control cells (0µM Y27632) and cells treated with 5 and 10µM of the 
inhibitor. n=90 pooled from 3 independent experiments.  	  	  
 3-2-3: PTPD1 is necessary for podosome formation in VSMCs. 	  
The important region of KIF1C tail for podosome formation in VSMCs is 
known to interact with two proteins: the non-muscle Myosin IIA (Kopp et al., 
2006) and the non-receptor Protein Tyrosine Phosphatase PTPD1 (Dorner et 
al., 1998). The involvement of the Myosin IIA for KIF1C-mediated podosome 
formation had been ruled out using Myosin II inhibitors, leaving PTPD1 as a 
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potential candidate to explain KIF1C involvement in podosome formation in 
VSMCs. 
 
PTPD1 is known to participate in the regulation of focal adhesion and 
stress fiber formation and stability (Carlucci et al., 2008) but its possible 
involvement in the regulation of podosome formation has not been addressed 
yet. To test it, PTPD1 expression was depleted in A7r5 cells using a siRNA 
oligonucleotide that specifically targets PTPD1 transcript (Figure 3.17). As we 
were unable to detect PTPD1 with commercial antibodies, depletion efficiency 
was assessed by RT-PCR. Total cellular RNAs was extracted and random 
primed cDNA synthesized. Then, a 300bp fragment of PTPD1 cDNA was 
amplified using specific primers to address the relative amount of mRNA still 
present after 72 hours of siRNA treatment compared to control cells. A fragment 
of the GAPDH (Glyceraldehyde 3-phosphate dehydrogenase) cDNA of similar 
size (500bp) was amplified in parallel and used as a loading control. PTPD1 
mRNA reduction was very efficient after 72 hours of siRNA treatment, proving 
the efficiency of the siRNA designed to depleted PTPD1 expression in rat 
VSMCs (Figure 3.15). 	  
	  
Figure 3.15: PTPD1 siRNA efficiently reduces PTPD1 expression in VSMCs. 
Total RNA of A7r5 cells treated for 72 hours with a control or a PTPD1-targeting siRNA 
were extracted and reverse transcribe using random hexamer primers. PTPD1 and 
GAPDH cDNA were amplified with specific primers. 	  	  
Next, PTPD1-depleted cells were tested for their ability to form 
podosomes. Control and PTPD1-depleted cells seeded on fibronectin-coated 
glass coverslips were treated with 5µM PDBu for 60 minutes prior fixation and 
cortactin immuno-staining. While control cells (siControl pFlag condition) formed 
46±3 podosomes on average, barely any podosomes were detected in PTPD1-
depleted cells (average podosome number formed per cell in the siPTPD1 
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pFlag condition: 6±1; p<0.00001 using a Mann-Whitney U-test; Figure 3.16), 
suggesting that the presence of PTPD1 is absolutely required for podosome 
formation in VSMCs.  	  
	  
Figure 3.16: PTPD1 is required for podosome formation in VSMCs.  
Control or PTPD1-depleted A7r5 cells transfected with a control plasmid (pFlag) or a 
RNAi-protected version of PTPD1 (pHA-PTPD1-RIP) were treated for 60 minutes with 
5µM PDBu prior fixation and cortactin immunostaining (B). The number of podosomes 
formed in cells was quantified for each condition (A) and compared to that formed in 
control cells (siControl pFlag). n=90 pooled from 3 independent experiments; NS=non 
significant; * p<0.05; *** p<0.0005 using a Mann-Whitney U-test. 	  	  
To prove the specificity of the PTPD1 depletion phenotype observed, 
silent point mutations were introduced in the PTPD1 cDNA sequence to 
generate a RNAi-protected (RIP) version of PTPD1 without changing its amino 
acid sequence (pHA-PTPD1-RIP; Figure 3.17). PTPD1 was then re-expressed 
in PTPD1-depleted cells and cellular ability to form podosomes was tested. 
PTPD1-depleted cells expressing the RNAi-protected version of the 
phosphatase (siPTPD1 pHA-PTPD1-RIP-WT) formed 38±3 podosomes on 
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average after 60 minutes of PDBu treatment (Figure 3.16), a number that is not 
significantly different from the 46±3 podosomes formed in control cells (p=0.07 
using a Mann-Whitney U-test). This result confirms the specificity of the 
phenotype observed after cell treatment with the siRNA targeting PTPD1.  	  
	  
Figure 3.17: Principle of PTPD1 depletion and re-expression. 
A double stranded siRNA oligonucleotide was designed to specifically target a sequence 
of PTPD1 transcript (mRNA sequence, red nucleotides) to induce its degradation. Silent 
point mutations (green nucleotides) were introduced in PTPD1 cDNA sequence (RIP 
DNA sequence) to generate a RNAi-resistant PTPD1 transcript (siRNA resistant mRNA 
sequence) that can’t be recognized by the siRNA and, thus that can’t be degraded.  	  	  
 In addition to its phosphatase activity, PTPD1 is known to act as a 
scaffold protein that brings two proteins together to potentiate their activities (Jui 
et al., 2000; Carlucci et al., 2008). Results previously obtained highlighted the 
absolute requirement of PTPD1 for podosome formation in VSMCs (Figure 
3.16). We took advantage of our ability to restore PTPD1 expression after its 
depletion with a RNAi-protected version of the phosphatase to test the 
requirement of its catalytic activity for podosome formation. To do so, a RNAi-
protected version of a catalytically inactive mutant of PTPD1 was re-expressed 
in PTPD1-depleted cells (siPTPD1 pHA-PTPD1-RIP-C1108S) and their ability to 
form podosomes was tested and compared to the ability of cells re-expressing 
the active phosphatase to form podosomes. Cells re-expressing the catalytically 
inactive form of PTPD1 formed 38±4 podosomes on average, a number that is 
significantly different from the 6±1 podosomes formed in PTPD1 depleted cells 
(siPTPD1 pFlag; p<0.00001 using a Mann-Whitney U-test) but not from the 
38±3 podosomes formed by cells rescued with the active form of the 
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phosphatase (siPTPD1 pHA-PTPD1-RIP-C1008S; p=0.39 using a Mann-
Whitney U-test) (Figure 3.16).  
Taken together, these results suggest that PTPD1 is absolutely required for 
podosome formation in VSMCs and that its catalytic activity is dispensable to 
mediate podosome formation in these cells. 
 
 
 3-2-4: KIF1C and PTPD1 cooperate to form podosomes in VSMCs 	  
Results obtained so far highlighted some important information to 
understand podosome formation in VSMCs. First, efficient podosome formation 
relies on the kinesin-3 KIF1C as its knockdown impairs it. Moreover, KIF1C 
podosome forming activity is most likely due to its cargo carrier function as 
impairing its motor activity impairs podosome formation in a similar way than 
reducing its expression level. 
Then, rescue experiments with truncations of the KIF1C tail highlighted the 
importance of a ~150 amino acid long domain between its third and fourth 
coiled-coil domain, a region that interacts with two proteins involved in the 
regulation of cellular adhesion: the non-muscle Myosin IIA and the Tyrosine 
phosphatase PTPD1. However, the inhibition of the Myosin IIA contractile 
activity with Blebbistatin or the Y27632 ROCK inhibitor ruled out its involvement 
in podosome formation in A7r5 cells, as it has no apparent effect on this 
phenomenon.  
Finally, PTPD1 deletion highlighted its absolute requirement for podosome 
formation in A7r5 cells. Given that PTPD1 depletion generated a more severe 
phenotype than impairing KIF1C, one hypothesis is that KIF1C transports 
PTPD1 to reach podosomes more efficiently.  
 
To test this hypothesis, PTPD1 was over-expressed in KIF1C-depleted 
cells and the ability of these cells to form podosomes was determined after 60 
minutes of PDBu treatment. KIF1C depletion efficiency was first addressed 
comparing the number of podosomes formed in control cells (siControl pFlag) to 
that formed in KIF1C-depleted cells (siKIF1C pFlag). KIF1C-depleted cells 
formed 50±4 podosomes on average, a number that is significantly different 
from the 86±5 podosomes formed in control cells (p<0.00001 using a Mann-
Whitney U-test; Figure 3.18). PTPD1 was then over-expressed in control and 
KIF1C-depleted cells to test its ability to stimulate podosome formation. The 
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over-expression of the active phosphatase in KIF1C-depleted cells (siKIF1C 
pHA-PTPD1-WT) couldn’t restore the ability of these cells to form podosomes 
as they formed only 57±5 podosomes on average, a number that is not 
significantly different from the KIF1C depletion condition (p=0.25 using a Mann-
Whitney U-test; Figure 3.18). Interestingly, the over-expression of the 
catalytically active PTPD1 significantly reduced the ability of VSMCs to form 
podosomes. Indeed, cells over-expressing the active form of PTPD1 (siControl 
pHA-PTPD1-WT) formed 65±4 podosomes on average, which is significantly 
different to the 86±5 podosomes formed in the control condition (p=0.006 using 
a Mann-Whitney U-test; Figure 3.18).  	  
Given this dominant negative effect of the over-expression of the active 
form of PTPD1 on podosome formation, we couldn’t conclude with certainty on 
the inability of the phosphatase to restore podosome formation in KIF1C-
depleted VSMCs. However, results previously obtained showed that the 
catalytically inactive form of PTPD1 was able to restore podosome formation in 
cells depleted for the endogenous phosphatase (Figure 3.16). The ability of the 
inactive phosphatase to restore podosome formation in KIF1C-depleted cells 
was thus tested. We first over-expressed PTPD1-C1108S in control cells to 
address its effect on podosome formation. Inactive PTPD1 overexpression in 
control cells has no effect on podosome formation as these cells (siControl pHA-
PTPD1-C1108S) formed a normal number of 86±5 podosomes on average 
(Figure 3.18). This result suggests that the dominant negative effect on 
podosome formation observed when the active PTPD1 was over-expressed in 
control cells is due to its catalytic activity.  
KIF1C-depleted cells over-expressing the inactive form of PTPD1 were then 
tested for their ability to form podosomes. These cells efficiently formed 70±4 
podosomes on average after 60 minutes of PDBu treatment, a number that is 
not significantly different from the 86±5 podosomes formed in control cells 
(p=0.56 using a Mann-Whitney U-test; Figure 3.18). This result suggests that 
PTPD1 scaffolding activity is sufficient to restore podosome formation in VSMCs 
depleted for KIF1C expression. 	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Figure 3.18: Catalytically inactive PTPD1 restores podosome formation in KIF1C-
depleted VSMCs. 
A7r5 cells treated for 72 hours with siControl or siKIF1C and expressing a control 
plasmid (pFlag), the active PTPD1 (pHA-PTPD1-WT) or the catalytically inactive PTPD1 
(pHA-PTPD1-C1108S) were treated 60 minutes with 5µM PDBu prior to fixation and 
cortactin staining (A). The number of podosomes formed in each condition was 
determined (B) and compared to the control condition (siControl pFlag). NS: non 
significant; ** p<0.005; *** p<0.0005; n=90 pooled from 3 independent experiments. 	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3-3: PTPD1 activates KIF1C transport activity 
 
 Results obtained using the podosome-forming assay highlighted the 
absolute requirement of the Tyrosine Phosphatase PTPD1 for podosome 
formation in VSMCs. Interestingly, its catalytic activity is dispensable for 
podosome formation as re-expressing the catalytically inactive form of PTPD1 
(PTPD1-C1108S) in cells depleted for the endogenous protein restores 
podosome formation in A7r5 cells. In addition to its phosphatase activity, PTPD1 
displays a scaffolding activity that brings two proteins together to potentiate their 
activities (Jui et al., 2000; Carlucci et al., 2008) and this additional function is 
suspected to mediate podosome formation in VSMCs. More importantly, 
experiments performed using the podosome-forming assay pointed at 
cooperation between PTPD1 and the kinesin-3 KIF1C to mediate podosome 
formation in VSMCs.  
 
 As PTPD1 restores podosome formation in KIF1C-depleted A7r5 cells 
and is known to directly interact with KIF1C (Dorner et al., 1998), we 
hypothesized that PTPD1 could activate KIF1C transport activity. Indeed, the 
knockdown of a protein doesn’t induce its complete depletion (Figure 3.5B) and 
we thought that the over-expression of PTPD1 could activate the remaining pool 
of KIF1C motors, facilitate its cargo transport activity and hence, help KIF1C-
mediated podosome formation in VSMCs.  
 
 Previous work conducted in the lab identified α5-integrin as one of 
KIF1C cargoes and we have at our disposal a α5-integrin transport assay to test 
the ability of KIF1C motors to transport a GFP-fusion of α5-integrin in RPE-1 
cells (Theisen et al., 2012). Indeed, migratory RPE-1 cells form a tail at their 
rear, whose stability relies on the formation of stable focal adhesions and that is 
required for the directional persistence of the migration (Theisen et al., 2012). 
One of the major components of focal adhesions is the α5β1 integrin 
heterodimer and KIF1C has been shown to be of crucial importance for α5-
integrin transport to the tail of migratory RPE-1 cells (Theisen et al., 2012). 
Hence, the trafficking of GFP-fusion α5-integrins in the tail of RPE-1 cells 
depends on KIF1C and the α5-integrin transport assay can be used to address 
the activation of KIF1C transport activity.  
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The trafficking of GFP-α5-integrin receptors in the tail of RPE-1 cells can 
easily be detected using a FRAP (Fluorescence Recovery After Photobleaching) 
approach. To do so, a selected area of the tail is photobleached using a 488nm 
laser and the trafficking of GFP vesicles within the photobleached area is 
tracked over a 2 minutes period of time (Figure 3.19).  
 
 
Figure 3.19: α5-integrin transport assay principle. 
An area of the cell tail is selected (1) and photobleached using a 488nm laser (2). The 
trafficking of GFP-α5-integrin in the photobleached area is then recorded for 2 minutes 
(3). Kymographs are drawn to cover the photobleached area (4) and the movement of 
vesicles is tracked over time (5). Vesicle movement is then classified (6). Stationary 
vesicles don’t show a displacement bigger than1µm. Jiggling vesicles show frequent 
directional changes and their movement doesn’t exceed 3µm between starting and 
ending points. Bi-directional vesicles show long runs with at least one directional 
change. Uni-directional vesicles move in one direction and their total displacement is 
bigger than 1µm. 
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 Using this approach, we were able to identify two main populations of 
vesicles: stationary vesicles, whose displacement doesn’t exceed 1µm in any 
direction and motile vesicles, whose movement is larger than 1µm. Three 
categories of motile vesicles could be distinguished: jiggling vesicles, vesicles 
moving in one direction and vesicles moving in two directions. Jiggling vesicles 
display repeated forward and backward movements within a 3µm distance 
range whereas bi-directional vesicles display longer runs (>3µm) intersperse 
with at least one direction change. Uni-directional vesicles show persistent 
movement in one direction and their total displacement is larger than 1µm.  
 
23.4±2.5% of vesicles were stationary in control cells (siControl pFlag; 
n=623 pooled from 105 cells of 7 independent experiments), a fraction that 
increases to 44.6±4.1% in KIF1C-depleted cells (siKIF1C pFlag; n=346 pooled 
from 45 cells of 5 independent experiments) (Figure 3.20A,D). It is noteworthy 
that we deliberately performed a partial knockdown of KIF1C expression in 
GFP-α5-integrin RPE-1 cells as a too efficient KIF1C depletion impaired the 
ability of cells to form tails. Despite this partial KIF1C depletion, results we 
obtained were in agreement with results previously described (Theisen et al., 
2012), proving the reliability of the assay. The ability of PTPD1 to activate 
KIF1C transport activity was then addressed. To do so, control and KIF1C-
depleted cells were transfected with PTPD1-WT and PTPD1-C1108S to over-
express both the active and inactive phosphatase respectively and the ability of 
GFP-α5-integrin vesicles to be transported within the cell tail in each condition 
was tested.  
 
 The effect of PTPD1 over-expression on GFP-α5-integrin vesicle 
transport was first addressed in control cells. Control cells expressing the active 
phosphatase (siControl pPTPD1-WT) displayed 26.1±6.1% stationary vesicles 
(n=328 pooled from 68 cells of 4 independent experiments; Figure 3.20B), 
which is not significantly different from the 23.4±2.5% stationary vesicles 
measured in control cells (siControl pFlag). The over-expression of the inactive 
phosphatase (siControl pPTPD1-C1108S) resulted in 25.6±3.8% GFP-α5-
integrin vesicles (n=197 pooled from 63 cells of 3 independent experiments; 
Figure 3.20C) were stationary, which is also very similar to results obtained in 
control cells. No significant differences in the occurrence of the three different 
types of motile vesicles could be observed between these three conditions 
(siControl pFlag; siControl pPTPD1-WT; siControl pPTPD1-C1108S; Figure 
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3.20A-C). These results suggest that the over-expression of the active or 
inactive form of PTPD1 does not impair KIF1C transport activity of GFP-α5-
integrin vesicles within the tail of RPE-1 cells, but also does not significantly 
increase it. 
 
 The ability of PTPD1 to restore KIF1C-mediated GFP-α5-integrin 
transport in RPE-1 tail was then tested. RPE-1 cells stably expressing GFP- α5-
integrin and depleted for KIF1C expression were transfected with the active 
(siKIF1C pHA-PTPD1-WT) or inactive phosphatase (siKIF1C pHA-PTPD1-
C1108S) and submitted to the α5-integrin transport assay. 
 
 Whereas KIF1C-depleted cells displayed 44.6±4.1% stationary vesicles, 
this number was decreased to that observed in control cells in KIF1C-depleted 
cells over-expressing either form of PTPD1 (Figure 3.20E,F). Indeed, KIF1C-
depleted cells over-expressing the active phosphatase (siKIF1C pHA-PTPD1-
WT) displayed 20.5±0.5% stationary vesicles (n=87 pooled from 18 cells of 3 
independent experiments) and KIF1C-depleted cells over-expressing the 
inactive form of PTPD1 (siKIF1C pPTPD1-C1108S) showed 26±2.2% stationary 
vesicles (n=449 pooled from 126 cells of 3 independent experiments).  
 
Taken together, results obtained using the α5-integrin transport assay 
suggest that PTPD1 activates KIF1C transport activity. Indeed, the significant 
increase of stationary vesicles observed in KIF1C-depleted cells is brought back 
to its basal level (23.4±2.5% in siControl pFlag cells) when PTPD1 is over-
expressed in KIF1C-depleted cells. More importantly, it appears that PTPD1 
catalytic activity is dispensable to stimulate KIF1C motor activity. Indeed, the 
inactive phosphatase is able to activate remaining KIF1C motors after their 
depletion to the same extent the active phosphatase does, possibly due to its 
scaffolding activity. 
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Figure 3.20: PTPD1 activates KIF1C transport of α5-integrins in the tail of RPE-1 cells.  
RPE-1 cells stably expressing GFP-α5-integrin treated with a control siRNA (siControl) 
or a siRNA targeting KIF1C (siKIF1C) were transfected with a control plasmid (pFlag) or 
a plasmid coding for the active (pHA-PTPD1-WT) or inactive PTPD1 (pHA-PTPD1-
C1108S). A selected area of the cell tail was photobleached using a 488nm laser and 
the trafficking of α5-integrins within the photobleached area was recorded for 2 minutes. 
Vesicle movement was tracked and classified for each condition. Two representative 
kymograph examples are shown for each condition. A: n=623 pooled from 105 cells of 7 
independent experiments. B: n=328 pooled from 68 cells of 4 independent experiments. 
C: n=197 pooled from 63 cells of 3 independent experiments. D: n=346 pooled from 45 
cells of 5 independent experiments. E: n=87 pooled from 18 cells of 3 independent 
experiments. F: n=449 pooled from 126 cells of 7 independent experiments. 
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4: Discussion 
  
4-1: KIF1C and the transport of podosome components in 
VSMCs 
 
 Prior to this work, the kinesin-3 KIF1C had been shown to be involved in 
the regulation of podosome formation and dynamics in macrophages (Kopp et 
al., 2006). Here we showed that KIF1C contributes to podosome formation in 
VSMCs (Figures 3.6, 3.8, 3.9). 
 
 VSMC are characterized by a very well developed actin cytoskeleton 
(Fultz et al., 2000) and their treatment with PDBu induces a general remodeling 
of this actin cytoskeleton that is characterized by the gradual disassembly of 
pre-existing focal adhesions and stress fibers and the rapid formation of 
podosomes (Hai et al., 2002). Podosome formation in VSMCs has been divided 
in two phases: a first phase starting within 2 minutes following the addition of 
PDBu to cells and characterized by the polymerization of unstable podosomes 
at the interface between focal adhesions and stress fibers and a later phase 
occurring after 30 to 70 minutes of PDBu treatment characterized by the 
weakening or the complete disappearance of focal adhesions and stress fibers 
and the formation of more stable podosomes (Kaverina et al., 2003). 
In this study, we addressed the possible involvement of the kinesin-3 KIF1C for 
podosome formation in A7r5 cells and results obtained highlighted its 
requirement for the proper formation of these structures in VSMCs. At the 
beginning of this study, experiments were conducted after 30 minutes of PDBu 
treatment and although results were significant, the phenotype observed in 
KIF1C-impaired cells was only mild (Figure 3.6; Figure 3.8). Time course 
experiments (Figure 3.9) revealed that a stronger KIF1C depletion phenotype 
could be observed after 40-60 minutes of podosome induction, suggesting that 
the requirement of KIF1C activity could be more crucial during the late phase of 
podosome formation in VSMCs.  
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Figure 4.1: Model for KIF1C-mediated centripetal relocation of podosomes in VSMCs. 
Unstimulated VSMCs (-PDBu) display a well-developed actin stress fiber network with 
actin stress fiber bundles anchored on focal adhesions. Upon PDBu treatment, focal 
adhesions and stress fibers depolymerize and their components are recycled at the 
podosome formation site located at the interface between the two depolymerizing 
structures. Later, podosomes are relocated to the cell centre, most likely thanks to 
KIF1C motor activity.  
Adapted from Kaverina et al., 2003. 
 
 
 Upon PDBu addition, VSMCs rapidly form podosomes at the cell 
periphery and at the interface between focal adhesions and stress fibers to be 
more precise (Kaverina et al., 2003; Burgstaller & Gimona, 2004). In 
unstimulated cells, these micro-domains are enriched in actin nucleation 
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promoting factors such as cortactin and Arp2/3 complex (Burgstaller & Gimona, 
2004; Kaverina et al., 2003) and they were shown to be the initial site of 
podosome formation in VSMCs (Kaverina et al., 2003; Burgstaller & Gimona, 
2004). Upon PDBu treatment, these micro-domains grow in size due to the 
Arp2/3-mediated actin de novo polymerization to form unstable podosomes that 
are rapidly replaced by new ones formed in their immediate vicinity but slightly 
proximally to the stress fiber (Kaverina et al., 2003). During the late phase of 
podosome formation, these unstable podosomes are replaced by more stable 
ones enriched in plaque proteins as vinculin and zyxin most likely recycled from 
depolymerizing focal adhesions located in close proximity (Kaverina et al., 
2003). As podosomes are mainly made of actin and share most of their 
components with focal adhesions, one might assume that proteins released by 
focal adhesions and stress fibers during their disassembly are incorporated in 
nascent podosomes polymerizing at the interface between the two 
disassembling structures (Kaverina et al., 2003; Dorfleutner et al., 2008). Thus, 
the formation of the first batches of podosomes might not require the transport 
of podosomes components to the future site of podosome formation as the 
components are released there upon induction of podosome formation, 
explaining the mild phenotype observed after 30 minutes of podosome induction 
in KIF1C-impaired A7r5 cells.  
 
 Podosome lifespan ranges from 3 to 10 minutes in VSMCs (Kaverina et 
al., 2003), and the successive cycles of podosome assembly and disassembly 
that occur over time were shown to result in the relocation of podosomes formed 
at the cell periphery towards the cell centre (Kaverina et al., 2003; Zhu et al., 
2016). Podosome centripetal relocation requires the translocation of podosome 
components from a peripheral depolymerizing podosome to a more centrally 
located newly forming one and the hypothesis of the involvement of KIF1C in 
this phenomenon is reinforced by several clues. First, podosome relocation 
relies on MTs as VSMC treatment with the MT-depolymerizing agent 
Nocodazole impairs this phenomenon and leads to the reformation of 
podosomes at the exact same place than depolymerizing podosomes were 
located (Zhu et al., 2016). This observation strongly suggests that podosome 
relocation could be mediated by MT-based transport and given its requirement 
for podosome formation (Figure 3.6 and 3.8; Efimova et al., 2014) and its 
affiliation to the MT-based molecular motor, KIF1C is a good candidate to 
mediate the centripetal relocation of podosome components. 
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Cortactin stainings provided in the 3-1 section of this thesis reinforce this 
hypothesis. Indeed, cells that efficiently form podosomes often display a 
podosome distribution extending toward the cell centre (Figure 3.8B pFlag 
cortactin staining example; Figure 3.9B siControl cortactin staining examples) 
on the contrary to cells impaired for KIF1C motor activity, which often display 
peripheral podosomes and a cell centre almost devoid of any podosomes 
(Figure 3.8B pKIF1C-Headless and pKIF1C-G102E cortactin staining examples; 
Figure 3.9B siKIF1C cortactin staining examples).  
 
 The assumption of a KIF1C involvement in podosome centripetal 
relocation was indirectly reinforced by recent observations incriminating the 
requirement of the MT plus end-associated proteins CLASPs (Akhmanova et al., 
2001) for podosome centripetal relocation in A7r5 cells (Zhu et al., 2016). Upon 
PDBu treatment, a fraction of the pool of KIF1C motors that are initially located 
in the pericentrosomal region of unstimulated cells translocates to the cell 
periphery in a CLASP-dependent manner (Efimova et al., 2014). Indeed, PDBu 
treatment induces the recruitment of KIF1C motors at MTs by CLASPs that are 
then able to move along CLASP-associated MTs (Efimova et al., 2014). CLASP 
depletion has been shown to impair podosome formation (Efimova et al., 2014) 
as well as their centripetal relocation in A7r5 cells (Zhu et al., 2016), reinforcing 
the hypothesis of an involvement of KIF1C in podosome translocation toward 
the cell centre.   
 
 Finally, podosome centripetal relocation has recently been shown to 
correlate with KIF1C movement within cells (Zhu et al., 2016). As previously 
mentioned, upon PDBu treatment, KIF1C motors translocate from the 
pericentrosomal region to the cell periphery where they locally accumulate 
(Efimova et al., 2014; Zhu et al., 2016) and the appearance of these KIF1C-rich 
punctae often precedes the local appearance of podosomes (Zhu et al., 2016). 
Once podosomes are formed at KIF1C accumulation sites, KIF1C rearranges to 
form a ring around the cortactin core (Figure 3.7; Efimova et al., 2014; Zhu et 
al., 2016). Upon removal from the ring, KIF1C often moves towards the cell 
centre to form another accumulation point whose location correlates with the 
appearance of a new podosome (Zhu et al., 2016). Taken together, all these 
results strongly reinforce the assumption of an active involvement of KIF1C in 
podosome translocation from the cell periphery to the cell centre. 
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 KIF1C is a N-kinesin and one can object that as a MT plus end-directed 
motor, it shouldn’t be able to actively move toward the cell centre and hence, 
shouldn’t be able to mediate podosome centripetal relocation. However, KIF1C 
movement toward the centre of VSMCs can be explained by the modification of 
MT organization and orientation at the cell periphery induced by PDBu 
treatment. Indeed, VSMCs treatment with PDBu induces the bundling of MTs in 
the cell body and their bending once they reached the cell periphery (Figure 4.2; 
Zhu et al., 2016). Upon bending, MT plus-ends point and grow toward the cell 
centre, resulting in KIF1C motors to move towards the cell centre. KIF1C 
movement towards the plus-end of these reversed MTs could then mediate the 
centripetal relocation of VSMC podosomes.  
 
 
Figure 4.2: Schematic representation of the bending of microtubules upon PDBu 
treatment in VSMCs. 
In resting VSMCs, MTs grow from the Microtubule Organizing Centre with their plus end 
oriented toward the cell periphery (left and upper right panels). Upon PDBu treatment, 
the growing ends of MTs bend when they reach the cell cortex and MTs keep growing 
with their plus end oriented toward the cell centre. 
Adapted from Zhu et al., 2016 
 
 
 While there is good evidence for the involvement of KIF1C in podosome 
centripetal relocation, nothing is known about the nature of cargoes it transports 
to mediate podosome formation and relocation. KIF1C is known to transport α5-
integrin receptors (Theisen et al., 2012) but so far, the podosomal localization of 
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this precise integrin subunit hasn’t been described. However, integrin β1 
subunit, known to dimerize with α5 to form the major fibronectin receptor (Pytela 
et al., 1985) has been shown to localize at the podosome core (Marchisio et al., 
1988). Other integrin receptors have been shown to localize to the adhesive ring 
of podosomes, such as αvβ3 dimers (Marchisio et al., 1988; Pfaff & Jurdic, 
2001; Chabadel et al., 2007; Myers et al., 2014) or αMβ2 receptors (van den 
Dries et al., 2013b). KIF1C itself localizes to the adhesive ring (Figure 3.7; 
Efimova et al., 2014; Zhu et al., 2016) and it might transport integrins or other 
cargoes from one podosome to the other. 
 
 Indeed, KIF1C accumulates at podosome forming sites before the 
appearance of the core (Zhu et al., 2016) and as described in the introduction 
(Chapter 1-8), the ring is assembled after the polymerization of the core. Two 
hypotheses can be formulated based on current knowledge: KIF1C-mediated 
transport and local accumulation of α5β1 integrins might form micro-domains to 
initiate the podosome polymerization or KIF1C might transport other 
components of the core that control the initial steps of the podosome core 
polymerization, maybe actin nucleation promoting factors (Kaverina et al., 2003; 
Luxenburg et al., 2012). It is noteworthy that these two hypotheses are not 
mutually exclusive.  
 
 
4-2: KIF1C, Myosin IIA and podosome formation in VSMCs 
 
 Using different truncations of KIF1C (Chapter 3-2-1), we identified a 
~150 amino acid long region between the third and fourth coiled-coil domain of 
KIF1C tail that is of major importance for podosome formation. Two proteins that 
were both described for their involvement in the regulation of cellular adhesion 
are known to interact with this region: the non-muscle Myosin IIA (Kopp et al., 
2006) and the Tyrosine phosphatase PTPD1 (Dorner et al., 1998).  
 The non-muscle Myosin IIA is known to localize at podosomes (Kopp et 
al., 2006; Gawden-Bone et al., 2010) where it surrounds the core and sits on top 
of the adhesive ring, associated to actin filaments radiating from the core toward 
the ring (Gawden-Bone et al., 2010; van den Dries et al., 2013). Prior to this 
work, Kopp et al reported that Myosin IIA contractile activity was required for 
podosome formation in macrophages (Kopp et al., 2006). We therefore tested 
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the requirement of Myosin IIA contractile activity for podosome formation in 
VSMCs using two different methods and showed that none of them impaired 
podosome formation in VSMCs (Figures 3.13 and 3.14). Our results are in 
agreements with a study published during the course of this work showing that 
the treatment of VSMCs with 10µM Blebbistatin doesn’t impair their ability to 
form podosomes (Tanaka et al., 2015) and the same kind of results was earlier 
reported in immature dendritic cells (Gawden-Bone et al., 2010; van den Dries 
et al., 2013). 
 
 The difference of results obtained in macrophages and VSMCs or 
dendritic cells could be explained by the type of adhesions these different cell-
types are able to form. Indeed, VSMCs and immature dendritic cells are able to 
form both podosomes and mature focal adhesions (Kaverina et al., 2003; van 
den Dries et al., 2013), while macrophages only form podosomes and immature 
focal complexes (Pixley, 2012). Hence, Myosin IIA contractile activity could be 
more important for podosome formation in macrophages than in VSMCs or 
immature dendritic cells because podosomes are the only type of mature 
adhesion structures macrophages are able to form.  
  
 Another hypothesis one can formulate to explain the difference of 
phenotype observed in macrophages and VSMCs upon Myosin IIA inhibition 
relies on the types of Myosin these cell-types express. Indeed, in contrast to 
macrophages and in addition to the non-muscle Myosin IIA, VSMCs express 
smooth muscle myosin (Gimona et al., 2003). As the non-muscle Myosin IIA, 
the smooth muscle myosin localizes at podosomes (Gimona et al., 2003) and is 
able to bundle actin filaments (Han et al., 2009). However, in contrast to the 
non-muscle Myosin IIA, the smooth muscle myosin is only poorly inhibited by 
Blebbistatin (Kovács et al., 2004), suggesting that it could, at least partially, 
compensate for the loss of Myosin IIA contractile activity upon Blebbistatin 
treatment and ensure podosome formation in VSMCs.  
VSMC treatment with Blebbistatin disrupts the actin stress fiber network (Figure 
3.13). Consequently, one can object that it also seems to impair the smooth 
muscle myosin contractile activity. However, it appears that the smooth muscle 
myosin could be locally activated at podosome sites and not along stress fibers, 
explaining the efficiency of podosome formation while stress fibers are disrupted 
upon Blebbistatin treatment. Indeed, the smooth muscle myosin light chain 
kinase has been shown to be activated by the Ca++/calmodulin complex (Van 
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Lierop et al., 2002) and even though calmodulin localization at podosomes has 
not been addressed yet, its interaction with the actin-associated factor 
caldesmon has been shown to be required for caldesmon translocation from 
stress fibers to podosomes in VSMC treated with PDBu, suggesting that 
calmodulin could also localize to podosomes upon PDBu treatment (Eves et al., 
2006). 
VSMC treatment with PDBu has been shown to induce a sensitization of these 
cells to Ca++ (Woodsome et al., 2001) and an increase of the intracellular Ca++ 
concentration had been shown to correlate with an increase of calmodulin 
activity (Vogel, 1994; Chin & Means, 2000). Taken together, these observations 
suggest that the smooth muscle myosin could be locally activated at podosome 
site, explaining the non-requirement of the non-muscle Myosin IIA contractile 
activity for podosome formation in VSMCs.  
 
 In addition to the decrease of the fraction of macrophages able to form 
podosomes upon Blebbistatin treatment, Kopp et al also reported a modification 
of the cellular distribution of podosomes in cells impaired for Myosin IIA 
contractile activity. Indeed, Blebbistatin-treated macrophages that still form 
podosomes display a loss of peripheral podosomes compared to control cells 
(Kopp et al., 2006). In the same study, they also showed that KIF1C 
accumulates at the plus end of a subset of MTs and that these KIF1C-decorated 
MT plus-ends specifically target peripheral podosomes to induce their fission or 
dissolution and they identified the non-muscle Myosin IIA as a KIF1C interactor 
(Kopp et al., 2006). Based on these results, they hypothesized that KIF1C 
interaction with Myosin IIA may couple actin and tubulin cytoskeletons and 
proposed a molecular model suggesting that the Myosin IIA present at 
podosomes may guide KIF1C to podosome sites. However, direct evidence for 
that model has not been provided in that study (Kopp et al., 2006). 
 
 Based on results obtained during the course of this work and the general 
mechanism of podosome formation in VSMCs that has previously been 
described, it is unlikely that this molecular model applies to the VSMC model. 
First, results presented in this thesis don’t confirm obvious modification of 
podosome distribution upon Myosin IIA inhibition in VSMCs (Figures 3.13 and 
3.14).  
Second, Blebbistatin interacts with Myosin IIA and blocks its binding to actin 
filaments (Kovács et al., 2004). The molecular model established by Kopp and 
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co-workers suggests that the Blebbistatin-induced removal of Myosin IIA from 
podosome actin filaments leads to the loss of peripheral podosomes due to the 
inability of KIF1C to be guided to these peripheral podosomes by the Myosin IIA 
(Kopp et al., 2006). We showed in this study that KIF1C is required for 
podosome formation in VSMCs and that Blebbistatin treatment doesn’t impair 
podosome formation in these cells. If the molecular model presented by Kopp 
and co-workers would apply to VSMCs, one would expect to detect a similar 
phenotype to that observed in A7r5 cells impaired for KIF1C activity in 
Blebbistatin-treated cells, e.g. a decrease of the number of podosome formed 
by Blebbistatin-treated cells or at least a modification of the podosome 
distribution, with podosomes restricted to the cell periphery. However, none of 
these phenotypical modifications have been observed in VSMCs treated with 
Blebbistatin. 
Finally, podosome formation in VSMCs has been correlated with the local 
inhibition of contractility at podosome formation sites (Burgstaller & Gimona, 
2004). Indeed, VSMCs display a very well developed actin stress fiber network 
whose contractility is locally modulated by PDBu treatment to allow its 
remodeling and the concomitant formation of peripheral podosomes (Fultz et al., 
2000; Hai et al., 2002; Burgstaller & Gimona, 2004). PDBu treatment induces 
the contraction of the central region of the cell (Fultz et al., 2000) while at the 
cell periphery, the Myosin IIA contractile activity is inhibited at podosome 
formation sites by the local accumulation of p190RhoGAP (Burgstaller & 
Gimona, 2004).  
As the local inhibition of the Myosin IIA at podosome sites is a prerequisite for 
the formation of these structures and podosomes are primarily formed at the 
periphery of VSMCs, it is not surprising that we could not observed in VSMCs 
the loss of peripheral podosomes that has been reported in macrophages.  
 
 Finally, we addressed the effect of Myosin IIA inhibition on podosome 
formation in A7r5 cells using fixed samples. By doing so, we made sure that the 
timing of podosome induction was consistent between the different conditions 
tested but it also meant missing information relative to podosome dynamics, 
such as the timing of arrival of podosome components, podosome lifespan or 
podosome oscillations. The average number of podosomes formed in A7r5 cells 
whose Myosin IIA contractile activity has been inhibited remains similar to what 
is observed in control cells (Figures 3.13 and 3.14). In fact, we observed a slight 
increase in podosome number formed by cells treated with the Y2732 ROCK 
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inhibitor (Figure 3.14), suggesting that podosome dissolution could actually be 
impaired upon Myosin IIA inhibition. More investigations need to be conducted 
on the involvement of Myosin IIA in podosome formation and turnover because 
apart from its role in podosome oscillations (van den Dries et al., 2013) and its 
localization at radiating actin filaments linking the podosome core to the 
adhesion ring (Gawden-Bone et al., 2010), little is known about its role in these 
processes.  
 
4-3: PTPD1 and podosome formation in VSMCs 
 
 Instead of Myosin IIA, we show here that PTPD1 is required to activate 
KIF1C transport and for its role in podosome formation in VSMCs. 
 
 It is noteworthy that PTPD1 depletion induces a stronger phenotype than 
that observed in KIF1C knockdown cells and this may be due to two main 
reasons: the direct involvement of PTPD1 in the regulation of cellular adhesion 
and its involvement in the regulation of other cellular processes. 
PTPD1 has been shown to be a major regulator of Src and FAK kinases in 
fibroblasts (Cardone et al., 2004; Carlucci et al., 2008). Indeed, in response to 
fibroblast stimulation with EGF (Epithelial Growth Factor), PTPD1 has been 
shown to interact with and dephosphorylate Src Y527, inducing a 
conformational change in Src structure that releases its catalytic domain and 
activates its kinase activity (Cardone et al., 2004). Concomitantly, EGF 
stimulation induces FAK to auto-phosphorylate its Tyrosine 397 residue, 
creating a docking site for the active Src to bind to (Carlucci et al., 2008). 
PTPD1 has been shown to facilitate the interaction of active Src with Y397-
phosphorylated FAK to enhance FAK activity (Carlucci et al., 2008). 
Src and FAK are mainly known for their ability to regulate cellular adhesion 
(Webb et al., 2004). However, these two kinases were also described for their 
involvement in the local enrichment of the plasma membrane in specific 
phosphoinositides (PtdIns(3,4)P2 and PtdIns(3,4,5)P3 to a lesser extend), 
creating micro-domains in close proximity to focal adhesions and whose 
localizations were shown to correlate with the site of emergence of podosomes 
(Oikawa et al., 2008; Yu et al., 2013).  
As it interacts with both kinases to enhance their activity (Carlucci et al., 2008; 
Cardone et al., 2004), PTPD1 could facilitate the formation of these PtdIns-
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enriched micro-domains and the subsequent podosome formation at these 
sites. PTPD1 depletion could impair the formation of these micro-domains and 
the subsequent assembly of podosomes at these sites.  
 
 Podosome formation in VSMCs has been described to initially occur in 
close proximity to focal adhesions (Kaverina et al., 2003; Burgstaller & Gimona, 
2004), a localization that is in agreement with that described in v-Src-
transformed fibroblasts (Oikawa et al., 2008). However, no bias in the 
composition of the plasma membrane at podosome site has yet been reported 
in VSMCs. Given that PTPD1 depletion in VSMCs induces a dramatic decrease 
of the ability of these cells to form podosomes, it would be interesting to address 
this in these cells. Indeed, in addition to test PTPD1 involvement in the 
appearance of PtdIns-enriched micro-domains at the plasma membrane, it 
could help to better understand the mechanism controlling the determination of 
the precise location podosome grow from during the late phase of podosome 
formation.  
 
 In addition to its interaction with Src (Møller et al., 1994; Carlucci et al., 
2008), FAK (Carlucci et al., 2008) and KIF1C (Dorner et al., 1998), PTPD1 has 
been shown to interact with proteins of the Tec kinase family (Jui et al., 2000), 
two mitochondrial A-kinase anchor protein (AKAP), AKAP121/AKAP84 
(Cardone et al., 2004) and the kinesin-3 KIF16B (Carlucci et al., 2010) (Figure 
4.3).  
 
 
Figure 4.3: PTPD1 domain structure and known interactors. 
 
 
 Together with Src, PTPD1 can form a molecular complex with 
AKAP121/AKAP84 that can be targeted at the mitochondria membrane to 
participate in the regulation of the cyclic AMP production (Cardone et al., 2004; 
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Livigni et al., 2006) and PTPD1 interaction with the kinesin-3 KIF16B targets the 
phosphatase at the membrane of endosomes to regulate the recycling of the 
Epithelial Growth Factor Receptor (Carlucci et al., 2010).   
The dramatic phenotype observed in PTPD1-depleted A7r5 cells upon PDBu 
treatment could be explain by the numerous molecular interactions PTPD1 is 
able to establish at different cellular localization. All these interactions could 
dilute the remaining pool of PTPD1 throughout the cell, making it less likely to 
be available for podosome formation.  
 
 Because it enhances Src and FAK activities, PTPD1 catalytic activity has 
been described to modulate the formation and the stability of focal adhesions 
and stress fibers in fibroblasts (Carlucci et al., 2008).  
As podosomes are formed at the interface between focal adhesions and stress 
fibers in VSMCs (Kaverina et al., 2003; Burgstaller & Gimona, 2004), one could 
suspect that PTPD1 knockdown abolishes podosome formation in A7r5 cells 
because it impairs Src and FAK activities, the subsequent formation of focal 
adhesions and stress fibers and consequently the formation of the micro-
domains formed at their interface and that are the sites of emergence of 
podosomes in VSMCs. However, the catalytically inactive PTPD1 mutant 
(PTPD1-C1108S) was able to restore podosome formation in VSMCs depleted 
for the endogenous phosphatase to the same level as the active phosphatase 
does (Figure 3.16), suggesting that PTPD1 phosphatase activity is dispensable 
for podosome formation in VSMCs and pointing at the involvement of its 
scaffolding activity as the important activity of PTPD1 for podosome formation in 
VSMCs.  
 
 However, the involvement of PTPD1 catalytic activity in the regulation of 
the cellular adhesion of VSMCs can’t be ruled out as the over-expression of the 
active form of PTPD1 in control A7r5 cells impaired ability of these cells to form 
podosomes in response to PDBu treatment (Figure 3.18). As mentioned above, 
PTPD1 phosphatase activity stabilizes focal adhesions and stress fibers in 
fibroblasts (Carlucci et al., 2008) and given that the formation of podosomes in 
VSMCs depends on the incorporation in growing podosomes of proteins locally 
released by the depolymerization of focal adhesions and stress fibers, one 
might speculate that the impairment of podosome formation in VSMCs over-
expressing active PTPD1 is due to the stabilization of the pre-existing adhesion 
system. Indeed, if PTPD1 catalytic activity reinforces focal adhesions and stress 
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fibers in VSMCs the same way it does in fibroblasts, these structures may be 
less likely to disassemble upon PDBu treatment. They would then sequester 
their components and make them unavailable for podosome formation. This 
suggests that PTPD1 activity needs to be finely tuned to support the podosome 
formation process.  
 
 In this study, we showed that the PTPD1 phosphatase activity is 
dispensable for podosome formation in VSMCs (Figure 3.16) and that the over-
expression of the catalytically inactive PTPD1 (PTPD1-C1108S) had no 
apparent effect on the ability of control A7r5 cells to form podosomes (Figure 
3.18).  
The catalytic domain of Protein Tyrosine Phosphatases (PTPs) is conserved 
and contains a characteristic PTP signature motif or “P-loop” (Andersen et al., 
2001 Mol Cell Biol). This motif displays a conserved Cysteine residue whose 
mutation in Serine or Alanine abrogates all enzymatic activity without abrogating 
PTP affinity for its substrate (Guan & Dixon, 1991; Andersen et al., 2001).  
The PTPD1 catalytically inactive mutant used in this study was generated 
replacing this conserved Cysteine residue in a Serine amino acid (PTPD1-
C1108S) and was since used as a catalytically inactive form of PTPD1 
(Cardone et al., 2004; Carlucci et al., 2008; Carlucci et al., 2010). No direct 
evidence for the actual abolishment of PTPD1 phosphatase activity has been 
published yet, most likely because all PTPD1 known substrates are enzymes 
that can auto-phosphorylate one of their residues to initiate their own activation 
and their interaction with PTPD1 acts as a support to enhance their activation 
(Jui et al., 2000; Carlucci et al., 2008). However, the level of activation of 
PTPD1 substrates had been shown to decrease in presence of the inactive 
phosphatase and phenotypes observed were consistent with the level of 
activation of these substrates (Jui et al., 2000; Carlucci et al., 2008), suggesting 
that PTPD1-C1108S is indeed catalytically inactive.  
 
4-4: PTPD1 and the activation of KIF1C motor activity 
 
 PTPD1-C1108S over-expression in KIF1C-depleted A7r5 cells restored 
their ability to efficiently form podosomes in response to PDBu treatment (Figure 
3.18), suggesting that catalytically inactive PTPD1 can compensate for KIF1C 
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depletion and that PTPD1 and KIF1C cooperate to mediate podosome 
formation in VSMCs. 
As PTPD1 directly binds the tail of KIF1C (Dorner et al., 1998) and given that 
the interaction of proteins with kinesin tails can modulate their motor activity 
(Coy et al., 1999), we hypothesized that PTPD1 could activate KIF1C motor 
activity. We tested this hypothesis using a α5-integrin transport assay 
established in the lab (Theisen et al., 2012) and showed that PTPD1 over-
expression in cells partially depleted for KIF1C expression restores KIF1C-
mediated α5-integrin transport in the tail of RPE-1 cells (Figure 3.20). While we 
cannot exclude that PTPD1 activates other motors to compensate for the 
reduction of KIF1C levels in these experiments, there are good indications for 
PTPD1 to regulate KIF1C transport non-catalytically.  
 
 PTPD1-mediated activation of KIF1C activity does n0t require PTPD1 
catalytic activity, as both the active and inactive forms of the phosphatase are 
able to restore KIF1C-mediated α5-integrin transport to the tail of RPE-1 cells 
(Figure 3.20). KIF1C has been identified for its ability to interact with the N-
terminal FERM domain of PTPD1 (Dorner et al., 1998). Single molecule assays 
conducted in vitro with purified KIF1C and PTPD1 FERM domain suggest an 
increase of the number of activated KIF1C motors in presence of PTPD1 FERM 
domain (Siddiqui and Straube, unpublished). As the catalytically inactive form of 
PTPD1 seems to activate KIF1C motor activity, it would be interesting to test the 
ability of PTPD1 FERM domain only to compensate for KIF1C depletion in cells. 
If this construct would be able to restore podosome formation and α5-integrin 
transport in KIF1C-depleted A7r5 and RPE-1 cells respectively to the same level 
as PTPD1-C1108S does, this would confirm that this domain is sufficient to 
stimulate KIF1C motor activity and rule out the involvement in KIF1C activation 
of any PTPD1 interactors that does not bind to its FERM domain. 
 
 In addition to KIF1C (Dorner et al., 1998), PTPD1 FERM domain has 
also been shown to interact with the kinesin-3 KIF16B (Carlucci et al., 2010). 
KIF16B is known to regulate the trafficking of early endosomes (Hoepfner et al., 
2005; Blatner et al., 2007) and mediate the recycling of EGFR at the plasma 
membrane (Hoepfner et al., 2005). KIF16B has been shown to anchor PTPD1 
at the membrane of early endosomes and PTPD1 depletion impairs the 
recycling of EGFR receptor to the plasma membrane (Carlucci et al., 2010), 
suggesting PTPD1 and KIF16B work together to regulate EGFR recycling to the 
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membrane. Based on our results and this information, it would be interesting to 
test the ability of PTPD1 to activate KIF16B to determine if PTPD1-mediated 
KIF1C activation is specific of KIF1C motors or if it can be extended to other 
members of the kinesin-3 family.  
 
 PTPD1 FERM domain is also known to interact with the Src kinase 
(Carlucci et al., 2008) and the interaction of KIF1C and Src with the same 
domain of PTPD1 is interesting for two reasons: first, independently of its 
catalytic activity, PTPD1 is known to act as a scaffolding protein bringing 
together two proteins and helping them to functionally work together (Jui et al., 
2000; Carlucci et al., 2008). Then, Src has been shown to phosphorylate KIF1C 
(Dorner et al, 1998). The direct interaction of Src and KIF1C has not been 
addressed yet but because they both interact with the same domain of PTPD1, 
one would suspect that PTPD1 FERM domain brings Src and KIF1C together to 
facilitate the phosphorylation of the kinesin by Src.  
 
 Kinesin phosphorylations of Serine and Threonine residues have been 
shown to participate in the regulation of the motor activity (DeBerg et al., 2013; 
Morfini et al., 2009; Cahu et al., 2008). However, Src is a Tyrosine kinase and 
so far, the effect of kinesin tyrosine phosphorylations has only been addressed 
in the Drosophila kinesin-5 KLP61F (Garcia et al., 2009). Phosphorylation of 
some Tyrosine residues of the KLP61F motor domain had been shown to be 
required for the kinesin-5 to ensure its mitotic spindle maintenance activity, 
suggesting these Tyrosine phosphorylation stimulate the kinesin-5 activity 
(Garcia et al., 2009).  
Src kinase phosphorylates KIF1C but the position(s) it occurs remain unknown, 
but based on results published by Garcia et al, one could speculate that the 
Tyrosine phosphorylation of KIF1C by Src may activate the motor. As no binding 
site for Src has been identified in KIF1C yet, it is suspected that PTPD1 would 
only ensure a scaffolding activity bringing KIF1C and Src together. This 
hypothesis is reinforced by the ability of the inactive phosphatase to stimulate 
KIF1C motor activity in cells.  
Single molecule assay conducted in vitro with purified KIF1C and PTPD1 FERM 
domain showed an increase of the fraction of KIF1C motors moving along MTs 
upon the addition of PTPD1 FERM domain (Siddiqui and Straube, unpublished). 
However, most motors still remained stationary after the addition of PTPD1 
FERM domain, suggesting that PTPD1 could help the activation of the motor but 
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might not be sufficient to allow the full activation of KIF1C motors. It would then 
be interesting to see if the fraction of motors moving along MTs can be 
increased upon the addition of Src to KIF1C and PTPD1 FERM domain in the 
single molecule assay.  
 
 PTPD1 binds KIF1C between its third and fourth coiled-coil domain 
(Dorner et al., 1998). Using cross-linking agents, Dorner et al showed that 
KIF1C could be found as a dimer in cells and computational analysis suggested 
that the region surrounding the fourth coiled-coil domain of KIF1C could mediate 
the dimerization of the motor (Dorner et al., 1999). One could then suspect that 
PTPD1 binding to KIF1C between its third and fourth coiled-coil domain could 
help the dimerization of the motor and facilitate its activation. However, full 
length KIF1C is a dimer at physiological salt concentrations, suggesting an 
interaction should not be required to stabilize the dimerization (Siddiqui and 
Straube, unpublished).  
 
 One last explanation for PTPD1-mediated KIF1C activation would then 
rely on the ability of PTPD1 to bind KIF1C tail and induce a conformational 
change in the structure of the kinesin that would activate it. When inactive, 
conventional kinesins adopt a “close” conformation with their tail interacting with 
their motor domain to abolish their interaction with MTs. Cargo binding to 
Kinesin-1 tail induces a conformational change that releases the motor domain, 
allowing it to interact with and move along MTs (Coy et al., 1999).  
A slightly different model for KIF1A, KIF13A, KIF13B and KIF16B Kinesin-3s 
activation has recently been suggested (Soppina et al., 2014). In this model, 
Kinesin-3s are present as soluble monomers in the cell cytoplasm and display a 
“closed” conformation due to intra-molecular interactions (Al-Bassam et al., 
2003; Lee et al., 2004) Cargo binding induces a disruption of these intra-
molecular interactions, allowing the motor to dimerize, interact with and move 
processively along MTs (Soppina et al., 2014). 
Because full-length KIF1C forms a dimer at physiological salt conditions without 
the requirement of cargo binding (Siddiqui and Straube, unpublished), we 
suspect that the same kind of mechanism could regulate KIF1C activity. In our 
model (Figure 4.4), KIF1C dimers would adopt a “closed” conformation in the 
absence of PTPD1, its tail covering its motor domain or impairing its interaction 
with MTs to inhibit its motor activity. PTPD1 binding to KIF1C tail would 
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destabilize KIF1C auto-inhibitory “closed” conformation, releasing the motor 
domain that would then be able to efficiently interact with and move along MTs.  
 
 
 
Figure 4.4: Model for PTPD1-mediated KIF1C activation.  
In absence of PTPD1, KIF1C adopts a close conformation, its tail covering its motor 
domain and impairing its ability to interact with MTs (upper left) or to move along them 
(lower left). PTPD1 binding to KIF1C destabilizes KIF1C tail interaction with the kinesin 
motor domain, uncovering it (upper right) and making it able to interact with and move 
along MTs (lower right). The arrow indicates the direction of KIF1C movement. 
 
 
 In this study, we proposed a model explaining how PTPD1 binding to 
KIF1C tail could activate KIF1C motor activity. However, a model for the 
regulation of the trafficking of KIF1C-associated vesicles has already been 
proposed in developing neurons (Chapter 1-4, Figure 1.7; Schlager et al., 2010; 
Lee et al., 2015). In this model, BICDR-1 anchors both KIF1C and dynein 
motors at the cargo surface and acts as a molecular switch controlling the 
balance between KIF1C-mediated anterograde and dynein-mediated retrograde 
transport in favour of the latter (Schlager et al., 2010). The Rab6 adaptor protein 
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participates in the regulation of KIF1C-mediated cargo transport as it modulates 
KIF1C folding through its interaction with both its tail and motor domain (Lee et 
al., 2015).  
As PTPD1 seems to activate KIF1C transport activity, it would be interesting to 
test if its presence can disrupt the inhibitory interaction of Rab6 with KIF1C 
motor domain and destabilize the balance between KIF1C- and dynein-
mediated transports in favour of KIF1C in developing neurons. These 
experiments could allow the extension of our proposed model of PTPD1-
mediated activation of KIF1C to a third cell type, show that it is not restricted to 
the regulation of cellular adhesion as KIF1C is known to transport the 
neuropeptide Y in neurons (Schlager et al., 2010) and help to better understand 
how the balance between KIF1C- and dynein-mediated transport is regulated in 
cells. 
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Podosome-regulating kinesin KIF1C translocates to the cell
periphery in a CLASP-dependent manner
Nadia Efimova1,*, Ashley Grimaldi1, Alice Bachmann2, Keyada Frye1, Xiaodong Zhu1, Alexander Feoktistov1,
Anne Straube2 and Irina Kaverina1,`
ABSTRACT
The kinesin KIF1C is known to regulate podosomes, actin-rich
adhesion structures that remodel the extracellular matrix during
physiological processes. Here, we show that KIF1C is a player
in the podosome-inducing signaling cascade. Upon induction
of podosome formation by protein kinase C (PKC), KIF1C
translocation to the cell periphery intensifies and KIF1C
accumulates both in the proximity of peripheral microtubules that
show enrichment for the plus-tip-associated proteins CLASPs
and around podosomes. Importantly, without CLASPs, both
KIF1C trafficking and podosome formation are suppressed.
Moreover, chimeric mitochondrially targeted CLASP2 recruits
KIF1C, suggesting a transient CLASP–KIF1C association. We
propose that CLASPs create preferred microtubule tracks for KIF1C
to promote podosome induction downstream of PKC.
KEY WORDS: CLASP, KIF1C, Podosome, Kinesin, Microtubule,
Trafficking
INTRODUCTION
Microtubules (MTs) serve to deliver and position molecular
complexes and organelles within a cell, thereby defining its
architecture. An important part of this function is locating the
sites of actin cytoskeleton assembly and remodeling (Hoogenraad
and Akhmanova, 2010; Kaverina and Straube, 2011; Etienne-
Manneville, 2013). Amongst other actin-based structures, MTs
regulate invasive protrusions, termed podosomes (Babb et al.,
1997; Linder et al., 2000; Destaing et al., 2003; Evans et al.,
2003; Destaing et al., 2005; Jurdic et al., 2006; Kopp et al., 2006;
Gil-Henn et al., 2007; Purev et al., 2009; McMichael et al., 2010;
Biosse Duplan et al., 2014), and their cancer counterparts,
invadopodia (Schoumacher et al., 2010; Quintavalle et al., 2011).
Podosomes consist of a core of constantly polymerizing actin
filaments and an outer adhesive ring. These structures serve as
exocytosis sites for matrix metalloproteases (MMPs) (Lener
et al., 2006; Gimona et al., 2008; Linder et al., 2011; Murphy
and Courtneidge, 2011). Podosomes are found in multiple
extracellular matrix (ECM)-remodeling cells, such as
osteoclasts, macrophages and synthetic vascular smooth muscle
cells (VSMCs). In these cell types, efficient ECM remodeling
does not occur if podosomes are not present. A growing body of
evidence implicates podosome-dependent ECM remodeling in
cell migration and invasion during morphogenesis (Teti et al.,
1991; Lener et al., 2006; Gil-Henn et al., 2007; Proszynski et al.,
2009; Rottiers et al., 2009; Quintavalle et al., 2010; Linder
et al., 2011; Saltel et al., 2011). For example, the ECM-
remodeling capacity of synthetic VSMCs is important for
angiogenesis and vascular repair (Lener et al., 2006;
Quintavalle et al., 2010; Chen et al., 2013). Also, the migration
and invasion potentials of VSMCs have a direct impact on
atherosclerotic plaque formation and stability (Quintavalle et al.,
2010; Lacolley et al., 2012; Chen et al., 2013).
Podosomes are dynamic structures and are induced or
disassembled in response to physiological signals (Chambers and
Fuller, 2011; Dovas and Cox, 2011; van Helden and Hordijk, 2011;
Hoshino et al., 2013). Podosome dynamics are strongly regulated
by MTs (Babb et al., 1997; Linder et al., 2000; Destaing et al.,
2003; Evans et al., 2003; Destaing et al., 2005; Jurdic et al., 2006;
Kopp et al., 2006; Gil-Henn et al., 2007; Purev et al., 2009;
McMichael et al., 2010; Biosse Duplan et al., 2014). It has become
clear from a number of recent studies that MT–podosome
relationships are multifaceted – both stable (acetylated; Destaing
et al., 2005; Purev et al., 2009; Biosse Duplan et al., 2014) and
dynamic (Kopp et al., 2006; Biosse Duplan et al., 2014) MT
subpopulations are essential for podosome regulation. Moreover,
several independent molecular machineries structurally and/
or functionally link MTs to podosomes, including tubulin
acetylation enzymes (Destaing et al., 2005; Purev et al., 2009;
Biosse Duplan et al., 2014), MT plus-end-associated protein
complexes (EB1; Biosse Duplan et al., 2014), actin-dependent
molecular motors (myosin-X; McMichael et al., 2010) and several
MT-dependent molecular motors (Kopp et al., 2006; Wiesner et al.,
2010; Cornfine et al., 2011). Within the last group, podosome
function in ECM remodeling crucially depends on the kinesins
KIF5B, the KIF3A–KIF3B complex and KIF9, which deliver
MMPs to podosomes (Wiesner et al., 2010; Cornfine et al., 2011).
More intriguingly, the kinesin KIF1C regulates the dynamics of
podosomes themselves (Kopp et al., 2006), possibly owing to
the capacity of this motor to transport essential podosome
components, such as integrins (Theisen et al., 2012). In principle,
such transportation could be either constitutive or triggered
downstream of physiological signals that induce podosome
formation. Activation of KIF1C trafficking would be a suitable
regulatory step in the signaling cascade leading to ECM
remodeling. However, whether KIF1C transport is regulated by
podosome-inducing signals has not been addressed.
In this study, we show that protein kinase C (PKC) activation
strongly facilitates KIF1C transport to the cell periphery to
initiate podosome formation. Moreover, our results reveal that the
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MT-associated proteins CLASPs are necessary for efficient
translocation of KIF1C along MTs and are crucial components
of podosome-induction signaling. Taken together, these findings
reveal a new pathway within the multifaceted MT-dependent
podosome regulation.
RESULTS
Podosome formation in VSMCs requires MTs
In the rat aortic VSMC line A7r5, multiple small podosomes can
be rapidly induced by PKC activation by phorbol ester phorbol
12,13-dibutyrate (PDBu) treatment (Hai et al., 2002). Podosomes
in VSMCs contain specific podosome markers, such as Tks5 (also
known as SH3PXD2A) (Fig. 1A), include accumulations of F-
actin with a characteristic morphology (Fig. 1A,C) and are
enriched in proteins involved in actin polymerization (Hai et al.,
2002; Kaverina et al., 2003; Lener et al., 2006), such as cortactin
(Fig. 1A,F).
We took advantage of the PDBu-inducible podosome model to
address the regulation of de novo podosome formation by MTs.
To test whether MTs are essential for podosome formation, we
completely depolymerized MTs in A7r5 cells by treatment with
nocodazole (supplementary material Fig. S1A–C) and applied
PDBu. We found that the number of podosomes formed was
significantly decreased under these conditions (Fig. 1D,G,H) to
levels comparable to those of non-induced cells (Fig. 1B,E). This
indicates that MTs are required for podosome formation in
VSMCs, as was described previously for macrophages and
osteoclasts (Babb et al., 1997; Linder et al., 2000; Destaing et al.,
2003; Evans et al., 2003; Destaing et al., 2005; Jurdic et al., 2006;
Kopp et al., 2006; Gil-Henn et al., 2007; Purev et al., 2009;
McMichael et al., 2010; Biosse Duplan et al., 2014).
Podosome formation in VSMCs requires KIF1C
It has been proposed that MTs exert their control on podosomes
by delivering regulatory and structural molecules to podosome
sites by MT-dependent transport. Indeed, one of the few
identified molecular players that is essential for podosome
turnover is the kinesin KIF1C (Kopp et al., 2006). Interestingly,
we found that KIF1C was enriched at podosome sites in A7r5
cells (Fig. 1I). By performing small interfering (si)RNA-
mediated depletion of KIF1C in A7r5 cells (Fig. 2I,J), we
found that the number and size of PDBu-induced podosomes
were significantly decreased in the absence of this kinesin
(Fig. 2A–H). This phenotype was rescued by re-expression of
RNA interference (RNAi)-resistant KIF1C–GFP (Fig. 2K–N),
indicating the specificity of the depletion phenotype. In
agreement with this result, the expression of dominant-negative
mutants of KIF1C [either a truncated cargo-binding tail domain
(Fig. 2P) or motor-dead rigor mutant (Fig. 2Q)] mimicked the
effect of KIF1C depletion (Fig. 2O–R). The effects of KIF1C loss
of function were very significant but milder than the effect of
complete MT depolymerization (Fig. 1), suggesting that KIF1C is
an essential, although not the only, factor in MT-dependent
podosome regulation. These data indicate that KIF1C is required
for efficient podosome formation in VSMCs.
The PKC pathway facilitates MT-dependent transport of
KIF1C to the cell periphery
Next, we questioned whether KIF1C-dependent trafficking is
regulated as part of the podosome induction pathway downstream
of PKC. Using A7r5 cells stably expressing low levels of KIF1C–
GFP (supplementary material Fig. S1E), we found that PDBu
treatment strongly stimulated KIF1C–GFP translocation to the
cell periphery (Fig. 3A–C; supplementary material Movies 1, 2).
In contrast to cell-center localization in control cells, KIF1C
accumulated at the cell edge and at the ventral surface of the
lamellae in PDBu-treated cells (Fig. 3D,E). This localization was
abolished by nocodazole treatment (Fig. 3F–H; supplementary
material Fig. S1A,B), indicating that KIF1C targeting to the cell
periphery was MT-dependent. This result indicates that KIF1C
Fig. 1. Podosome formation in A7r5 cells
requires MTs. (A) Visualization of podosomes
in a PDBu-treated A7r5 cell by expression of
Tks5–GFP (red) and immunofluorescence
detection of actin (phalloidin, green) and
cortactin (blue). The boxed region from the
overview (left) is enlarged on the right and
shows Tks5-positive podosomes and their
colocalization with actin and cortactin. Maximal-
intensity projection of a confocal stack. Arrows,
podosomes. (B–G) Wide-field fluorescence
microscopy of actin (phalloidin, B–D) and
cortactin (E–G) in A7r5 cells. Multiple
podosomes are spread throughout a cell after
40 minutes of PDBu treatment (C,F) in contrast
to untreated cells (B,E) or cells pre-treated with
nocodazole for 2 hours before PDBu
application (D,G). Arrows, podosomes.
(H) Podosome numbers based on cortactin
staining (similar to E–G). Data show the
mean+s.e.m. (N540610); *P,161026
(Student’s unpaired two-tailed t-test). (I) KIF1C
(red) accumulates at the cell edge and
podosomes (arrows). Phalloidin, green. The
boxed region from the overview (upper panel) is
enlarged below.
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transport is regulated by podosome-inducing signals and is
therefore an essential step in the signaling cascade leading to
ECM remodeling.
KIF1C moves along CLASP-associated MTs and can be
recruited by CLASPs
In agreement with a prior finding of Kopp and colleagues in
macrophages (Kopp et al., 2006), we found that, in VSMCs, KIF1C
puncta undergo movements predominantly when associated with
the plus ends of polymerizing MTs (supplementary material Fig.
S1F,G; Movies 3, 4). This suggests that KIF1C translocates along
MTs in close association with the MT plus-end tracking protein
(+TIP) complex. Because deposition of KIF1C at the cell periphery
was dramatically increased by PDBu treatment, we tested whether
cellular localization of major +TIPs was influenced by PDBu. We
were looking for a protein that would localize more strongly to
MTs during PDBu treatment than in controls and, therefore, could
be a positive regulator of KIF1C transport. Among the proteins
tested, certain proteins responded to PDBu treatment by decreased
MT-plus-end association, including EB1 (not shown), which was
recently detected as an important podosome regulator (Biosse
Duplan et al., 2014); other proteins did not change significantly
(e.g. CLIP170, not shown). Importantly, we found a striking
change in localization of +TIPs called CLIP-associated proteins
(CLASPs, CLASP1 and CLASP2), which are known to facilitate
MT polymerization and stability (Galjart, 2005; Al-Bassam and
Chang, 2011). Although immunofluorescent staining for
CLASPs normally highlighted short MT plus-end-tracking
comets throughout the whole cell, in PDBu-treated cells,
CLASPs were arranged in extended patterns only at the cell
periphery (Fig. 4A,B); this indicated that CLASP binding to
peripheral MT lattice was specifically enhanced by PDBu. We
hypothesized that the relocation of CLASPs in response to PKC
might be involved in the PDBu-stimulated activation of KIF1C
transport to podosomes and, thus, we concentrated on this
protein in this study.
Interestingly, CLASP-associated MTs were located in the
podosome-rich regions of the cell and were frequently found in
close contact with podosomes (Fig. 4B) and peripheral
accumulations of KIF1C (Fig. 4C). Live-cell imaging indicated
that KIF1C at the cell periphery moved predominantly in
association with CLASP-rich peripheral MTs and accumulated
Fig. 2. Podosome formation in A7r5 cells depends on KIF1C. (A–F) Immunofluorescence visualization of podosomes by actin (phalloidin, green, A,B) and
cortactin (green, E,F). KIF1C (red) is shown in C,D for cells in A,B. NT, non-targeted control siRNA-treated; KIFsi, KIF1C-depleted. (B,D,F) After KIF1C depletion
only few immature podosomes are detected. The remaining KIF1C is detected in the cell center (D). (G) Podosome numbers based on data similar to that shown in
E,F. Data show the mean+s.e.m. (N532); *P,0.01 (Student’s unpaired two-tailed t-test). (H) Average of mean podosome area per cell (mm2) based on data similar
to that shown in E,F. Data show the mean+s.e.m. (N532). *P,161026 (Student’s unpaired two-tailed t-test). (I) Western blotting indicates significant depletion of
KIF1C. Actin is shown as a loading control. Ctr, control; si, KIF1C-depleted. (J) Quantification of KIF1C levels detected by western blotting. Data show the
mean+s.e.m. (N53); *P,0.001 (Student’s unpaired two-tailed t-test). (K,L) Re-expression of KIF1C–GFP (red) in KIF1C-depleted cells (L) rescues podosome
formation as compared with that of GFP-expressing KIF1C-depleted cells (K). GFP is pseudo-colored red. Cortactin, green. (M) Podosome numbers in KIF1C-
depleted and rescued cells. Data show the mean+s.e.m. (N545); *P,0.05 (Student’s unpaired two-tailed t-test). (N) Western blotting indicates KIF1C–GFP
expression in control and KIF1C-depleted cells. Actin is shown as a loading control. (O–Q) Expression of dominant-negative FLAG-tagged KIF1C cargo-binding
domain (P) or rigor motor mutant (Q) suppresses podosome formation as compared with that of controls (O). Cortactin, green. All arrows indicate podosomes.
(R) Podosome numbers in cells expressing dominant-negative constructs. Data show the mean+s.e.m. (N545); *P,0.05 (Student’s unpaired two-tailed t-test).
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in the vicinity of their ends (Fig. 4C,D; supplementary material
Fig. S1D; Movies 5, 6).
Thus, it is possible that CLASPs promote KIF1C transport; for
example, by stimulating KIF1C recruitment to MTs. In agreement
with this hypothesis, when a chimeric protein, in which CLASP2
was combined with the mitochondrial component TOM20
[mito-CLASP, (Efimov et al., 2007)], was expressed in cells, a
significant fraction of KIF1C–GFP accumulated at the
mitochondria, indicating that KIF1C–GFP followed the CLASP
chimera (Fig. 4E–H; supplementary material Fig. S2A,B). This
recruitment is likely mediated by the tail domain of KIF1C,
because the tail domain (Fig. 4E,F,I,J; supplementary material
Fig. S2C,D) but not the KIF1C motor domain (not shown)
was significantly recruited to mitochondria by mito-CLASP.
Interestingly, full-length KIF1C that was recruited to
mitochondria by mito-CLASP was likely functional and
responsive to PKC activation; this was evident from relocation
of mitochondria towards the cell periphery in transfected cells
(Fig. 4K–M; supplementary material Fig. S2E,F). These data
indicate that in cells CLASPs interact with a subset of KIF1C
molecules through the KIF1C tail domain.
CLASPs are necessary for KIF1C trafficking and deposition
at the cell periphery
The evidence that KIF1C transiently associates with CLASPs
suggests that CLASPs might be important for KIF1C transport to
the sites of podosome formation. Thus, we tested whether CLASPs
modulate KIF1C targeting to the cell periphery. Strikingly, CLASP
depletion, by two alternative siRNA combinations (Fig. 5A;
supplementary material Fig. S3), completely abolished KIF1C
accumulation at the cell edge and at podosome formation
sites (Fig. 5B–E; supplementary material Fig. S4A–C). In
CLASP-depleted cells, KIF1C-positive puncta were diffuse
throughout the cell body; however, KIF1C protein levels were
not affected by CLASP depletion (supplementary material Fig.
S3D). Distribution of KIF1C in CLASP-depleted cells was similar
to that observed in nocodazole-treated cells lacking MTs
(Fig. 3G,H; supplementary material Fig. S1B), suggesting that
without CLASP, MTs cannot support KIF1C transport to the cell
periphery. Decreased translocation of KIF1C to the cell periphery
might, in principle, be explained by the low MT number in
CLASP-depleted cells (Mimori-Kiyosue et al., 2005; Efimov et al.,
2007). To test this possibility, we addressed whether KIF1C
accumulations could be found at MT plus ends in CLASP-depleted
cells. We found that, in sharp contrast to the control cells, no
KIF1C accumulation could be detected in association with MTs
under these conditions (Fig. 5C,D; supplementary material Fig.
S4B,C); this indicates that deficient KIF1C distribution at the cell
periphery did not result from the decrease in MT number in
CLASP-depleted cells. Rather, our data suggest that translocation
of this motor along MTs is blocked without CLASPs.
To test this hypothesis directly, we followed KIF1C–GFP
motility in CLASP-depleted and control cells by live-cell
imaging. In control cells, KIF1C–GFP puncta and tubes often
underwent fast directional translocations typical of MT-
dependent membrane trafficking (Fig. 5F,G; supplementary
material Movie 7, left). Interestingly, in the absence of
CLASPs, these movements were largely abolished (Fig. 5H–J;
supplementary material Fig. S4D,E; Movie 7, right), indicating
that CLASPs are required for KIF1C transport along MTs.
CLASPs are necessary for podosome formation
Because the podosome-stimulating kinesin KIF1C cannot
translocate to the cell periphery in CLASP-depleted cells, one
Fig. 3. Podosome induction signaling facilitates MT-dependent KIF1C deposition in lamellae. (A) PDBu facilitates the accumulation of KIF1C–GFP
(green) in the cell periphery. Frames from a single-plane confocal image sequence at 30 seconds (left) and 24 minutes (right) of PDBu treatment. Pseudo-
colored maps of KIF1C intensity [purple (low) to white (high)] at the indicated areas (white brackets) are shown to the upper right. See supplementary material
Movie 1. (B) Deposition of KIF1C–GFP (green) in cell lamellae before (left) and after (right) a 90-minute PDBu treatment. See supplementary material Movie 2.
(C) Fold increase in KIF1C–GFP intensity in cell lamellae in live cells with or without PDBu treatment, based on data as shown in B. Data show the mean+s.e.m.
(N56–12); *P,0.01 (Student’s unpaired two-tailed t-test). (D–G) Immunostained KIF1C (red, arrows) at the cell periphery. KIF1C modestly localizes to the
lamellae of untreated cells (D), and accumulates in cell lamellae after a 40-minute PDBu treatment (E). No KIF1C accumulations are found in nocodazole (noc)-
treated (F) and nocodazole-pretreated plus PDBu-treated (G) cells. The images show maximal intensity projections of confocal stacks. Arrows show KIF1C
accumulations; dashed lines indicate cell outlines. (H) The percentage of the area in cell lamellae taken up by KIF1C accumulation, based on data as shown in
D–G. Data show the mean+s.e.m. (N510); *P,0.001 (Student’s unpaired two-tailed t-test).
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would predict that CLASPs are required for podosome formation.
PDBu treatment of cells depleted of CLASPs by two alternative
siRNA combinations indicated that podosome numbers, detected
by cortactin staining, were dramatically reduced as compared
with those of cells treated with non-targeted control siRNA
(Fig. 6A–F,K). Podosome numbers in CLASP-depleted cells
were efficiently rescued by ectopic expression of CLASP2–RFP,
which cannot be silenced by siRNA combination 2 (Fig. 6G–K).
Depletion of CLASP1 or CLASP2 separately led to partial
podosome suppression (not shown). Thus, it is likely that both
CLASPs act redundantly as essential effectors in the podosome
induction pathway downstream of PKC.
DISCUSSION
Based on our data, we propose a model in which CLASPs act
as essential players in the regulation of podosome formation,
because only CLASP-decorated MTs are capable of supporting
KIF1C translocation to putative podosome sites at the cell
periphery (Fig. 7A). CLASP enrichment at MTs has been
shown previously to result from GSK3b inactivation at the
cell periphery, which leads to enhanced MT binding of
dephosphorylated CLASPs (Wittmann and Waterman-Storer,
2005; Kumar et al., 2009). In our system, this change in MT
binding is likely to be caused by PKC-dependent GSK3b
inactivation triggered by PDBu treatment (Goode et al., 1992).
In organisms, this pathway might be triggered through
extracellular factors that induce podosomes, such as PDGF
signaling (Quintavalle et al., 2010).
Our data implicate CLASPs as important regulatory factors
for the trafficking function of KIF1C. It is also noteworthy that
the effects of KIF1C depletion or inactivation are less striking
than the effects of CLASP depletion, suggesting that additional
factors facilitate podosome formation in a CLASP-dependent
manner. It is plausible to suggest that certain molecular motors
sharing similarities with KIF1C (e.g. other kinesin-3 family
members KIF1B and KIF1A) are involved. However, the nature
Fig. 4. KIF1C associates with CLASP-rich MTs. (A,B) CLASPs (green, white arrows) mark MT plus ends in a non-treated cell (A), but upon PDBu treatment
(B), CLASPs accumulate at the lattice of MTs in close contact with podosomes (cortactin, red). Data show wide-field fluorescence analysis of immunostaining.
(C) KIF1C–mCherry (red, yellow arrows) moves with the end of a GFP–CLASP2-associated MT (green, white arrows) in a PDBu-treated cell. Data show frames
from a video sequence and are enlarged from the box in supplementary material Fig. S1F. See also supplementary material Movies 5, 6. (D) KIF1C (red)
relocation events occurring at the ends of MTs associated with CLASP2 (CL-MT), as compared to the same events superimposed on a spatially shifted RFP–
CLASP2 video sequence, based on data as in supplementary material Movies 5, 6. Data show the mean+s.e.m. (N54 cells, 14–19 events/cell); *P,0.001
(Student’s t-test). (E,F) Colocalization of ectopically expressed KIF1C with mitochondria in cells with (mitoCL) or without (ctr) mito-CLASP expression. Mander’s
coefficients M1 (E) and M2 (F) for thresholded images are shown. Both full-length (left) and (right) and tail domain constructs are recruited to mitochondria by
CLASP. Data show the mean+s.e.m. (N55); *P,0.01 (Student’s t-test). (G,H) KIF1C–GFP (red) colocalizes with CLASP (green, immunostained) and
mitochondria (mCherry–TOM20, blue) in cells with (H) but not without (w/o, G) mito-CLASP. (I,J) FLAG-tagged KIF1C tail (red) colocalizes with CLASP (green,
immunostained) and Mitotracker (blue) in cells with (J) but not without (I) mito-CLASP. See also supplementary material Fig. S2A–D. (K,L) Mitochondria in cells
transfected with mCherry–TOM20 alone (K) or mCherry–TOM20 and mito-CLASP (L). See also supplementary material Fig. S2F,G. Yellow dotted lines indicate
cell borders. (M) The number of mitochondria in lamellae in cells transfected with mCherry–TOM20 or mito-CLASP, based on the data as shown in K,L. Data
show the mean+s.e.m. (N528–36); *P,0.01 (Student’s unpaired two-tailed t-test).
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of additional CLASP-dependent factors is yet unclear; this
study is the first direct evidence that CLASPs regulate
molecular motor function, which has been previously
suggested based on the essential role of CLASPs in specific
cellular processes. For example, CLASP-coated Golgi-derived
MTs have especially strong capacity for transportation and
assembly of Golgi stacks (Miller et al., 2009). Also, CLASP is
essential for the transport or positioning of mitochondria in
Schizosaccharomyces pombe (Chiron et al., 2008), which could
be interpreted as a result of CLASP-dependent kinesin
regulation in that system.
Because CLASP2 can recruit KIF1C to mitochondria, we
propose that MT-bound CLASPs directly stabilize the association
of KIF1C with MTs, similar to the recently discovered function of
doublecortin–KIF1A cooperation in neurons (Liu et al., 2012) or
EB1–KIF17 cooperation in polarizing epithelia (Jaulin and
Kreitzer, 2010). A less likely possibility is that CLASPs
activate KIF1C in an MT-independent manner, similar to
kinesin-1 activation by the MT-associated protein ensconsin
(Barlan et al., 2013). In principle, another possible mechanism
could involve the indirect effect of a CLASP-dependent increase
in MT lifetime and stability (Akhmanova et al., 2001; Mimori-
Kiyosue et al., 2005; Drabek et al., 2006; Lansbergen et al.,
2006), which has been shown to facilitate transport by specific
kinesins (Reed et al., 2006; Cai et al., 2009; Hammond et al.,
2010). Stable MTs are indeed important for podosome regulation
in osteoclasts (Destaing et al., 2005; Purev et al., 2009). However,
KIF1C (similar to another kinesin-3 family member KIF1A; Cai
et al., 2009) moves with growing MT plus ends and thus prefers
dynamic MT tracks rather than stable ones. Moreover, MT
acetylation, typical for stable MTs, suppresses movement of
vesicles associated with KIF1C (Bhuwania et al., 2014).
Accordingly, we suggest that dynamic CLASP-associated MTs
normally serve as preferred tracks for KIF1C transport, and that
relocation of CLASPs to peripheral MTs upon PDBu treatment
facilitates KIF1C translocation to the lamella and, subsequently,
triggers podosome formation (Fig. 7A). This is already the
second reported mechanism whereby dynamic, rather than stable,
MTs regulate podosome formation and dynamics. It has been
shown recently that EB1, a +TIP MT protein that associates only
with polymerizing dynamic MT ends, facilitates podosome
formation in osteoclasts through an interaction with cortactin
(Biosse Duplan et al., 2014). This and our present findings
indicate that targeting of podosomes by dynamic MT ends is
crucial for regulation of these adhesive structures, a mechanism
resembling MT-mediated regulation of focal adhesions (Kaverina
et al., 1999). Overall, our data establish CLASPs and KIF1C as
sequential molecular players in the signaling cascade downstream
Fig. 5. MT-dependent transport of KIF1C to podosomes
requires CLASPs. (A) CLASP1 and CLASP2 depletion levels were
investigated by using western blotting in cells depleted of CLASPs
by siRNA combinations 1 and 2 (CLsi1, CLsi2). Data show the
mean+s.e.m. (N53); *P,0.01 (Student’s unpaired two-tailed t-test).
(B–D) KIF1C (red, arrows) accumulates around podosomes in the
lamellae of PDBu-treated non-targeted control cells (B), but is
missing from the lamellae of CLASP-depleted cells (C,D). Boxed
areas on the left are enlarged on the right. Phalloidin, blue; tubulin,
green (immunostaining). Images show maximal intensity projections
of confocal stacks. (E) The percentage of the area in cell lamellae
taken up by KIF1C accumulation, based on data as shown in B–D.
The control populations are the same as those shown in Fig. 2C,D.
Data show the mean+s.e.m. (N510); *P,0.001 (Student’s unpaired
two-tailed t-test). (F–I) KIF1C–GFP (green) trafficking as visualized
by a single-plane confocal image sequence. Single-frame cell
overviews are shown on the left. Video sequences from the boxed
regions are shown on the right as enlarged maximal intensity
projections over time. Arrows indicate the tracks of KIF1C particle
movement in non-targeted control cells (F,G) and the lack of
directional movement in CLASP-depleted cells (H,I), in PDBu-
treated (G,I) or untreated (F,H) cells. See supplementary material
Movie 7. (J) Directional movement of KIF1C puncta is enhanced by
PDBu in control but not CLASP-depleted cells. The graph is based
on data as shown in F–I and supplementary material Fig. S4D,E.
Data show the mean+s.e.m. (N510–17 cells); *P,0.05 (Student’s
unpaired two-tailed t-test).
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of PKC (Fig. 7B) and as crucial components of the podosome
induction pathway.
MATERIALS AND METHODS
Cells
A7r5 rat smooth muscle cells (ATCC) were grown in low-glucose
(1000 mg/l) Dulbecco’s modified Eagle’s medium (DMEM) without
Phenol Red, supplemented with 10% fetal bovine serum at 37 C˚ and 5%
CO2. Cells were plated on glass coverslips or glass-bottomed dishes
(MatTek) coated with 10 mg/ml fibronectin 24 hours prior to
experiments. In live-cell experiments, cells were maintained on the
microscope stage at 37 C˚ under mineral oil for medium equilibrium
maintenance.
Microscopy
Wide-field fluorescence imaging was performed using a Nikon 80I
microscope with a CFI APO 606oil lens, NA 1.4 and CoolSnap ES CCD
camera (Photometrics). Single-plane confocal live-cell video sequences
(except for Fig. 2A) were taken using a Yokogawa QLC-100/CSU-10
spinning-disk head (Visitec assembled by Vashaw) attached to a Nikon
TE2000E microscope with a Perfect Focus System using a CFI PLAN
APO VC 1006oil lens NA 1.4 and a back-illuminated EM-CCD camera
Cascade 512B (Photometrics) driven by IPLab software (Scanalytics).
The video sequence presented in Fig. 2A was acquired at Nikon
Sweptfield Confocal with an Andor Ultra 897 camera, attached to a
fully motorized Ti-E with Perfect Focus and Tokai Hit incubation
chamber using the 1006 1.45 Lambda objective, and driven by NIS-
Elements AR.
A Leica TCS SP5 confocal laser-scanning microscope with an HCX
PL APO 1006 oil lens NA 1.47 was used for taking confocal stacks of
fixed cells. DeltaVision Elite with Alexa Fluor 488, Alexa Fluor 594 and
Alexa Fluor 647 filter sets (Chroma) and a Coolsnap HQ CCD camera
under control of SoftWorx (Applied Precision LLP) was used for
acquisition and deconvolution of stacks of fixed cells.
Image acquisition and editing
For Fig. 1B–G, Fig. 2A–F, Fig. 4A,B, Fig. 6A–F and supplementary
material Fig. S1A–D, Fig. S3A–C and Fig. S4A–C, wide-field
fluorescence microscopy was used and data were acquired as 12-bit
images. For Fig. 3B, Fig. 4C, Fig. 5F–I and supplementary material Fig.
S1F–J and Fig. S4D,E, single-plane spinning-disk confocal microscopy
was performed and data were acquired as 16-bit images. Two-color
images were taken in near-simultaneous mode. Single timeframes or
maximum intensity projections over time are shown, as indicated in
figure legends. For Fig. 3A, single-plane swept-field confocal
microscopy was used, and data were acquired as 16 bit. Single time
frames are shown. For Fig. 1I, Fig. 3D–G, Fig. 4G–L, Fig. 5B–D,
Fig. 6G–J and supplementary material Fig. S2, laser-scanning confocal
microscopy was used and data were acquired as 8-bit images. All
channels were acquired in sequential mode to avoid cross-talk. Single
slices or maximum intensity projections are shown, as indicated in figure
Fig. 6. Podosome formation in A7r5 cells
requires CLASPs. (A–F) Cortactin
immunostaining of vehicle-treated (A–C) and
PDBu-treated (D–F) cells. Arrows, podosomes.
Cells were transfected with non-targeted control
siRNA (A,D), CLASP-specific siRNA combination
1 (CLsi1; B,E) or CLASP-specific siRNA
combination 2 (CLsi2; C,F). Podosomes are
formed in controls (D, arrows), but not in CLASP-
depleted cells (E,F). Images were acquired by
using wide-field fluorescence microscopy. (G–J) In
cells treated with CLASP-specific siRNA
combination 2, podosome formation in PDBu (I) is
rescued by expression of siRNA2-insensitive
RFP–CLASP2 (H,J). Cortactin immunostaining is
shown in G,I. Arrows show podosomes.
(K) Podosome numbers were quantified, based on
data similar to that shown in A–J. Data show the
mean+s.e.m. (N545615); *P,161025 (Student’s
unpaired two-tailed t-test).
Fig. 7. Models of the roles of CLASPs and KIF1C in podosome
formation. (A) A model of podosome regulation by CLASP-dependent
KIF1C transportation. Upon PDBu treatment, CLASP is recruited to MTs and
stimulates KIF1C binding to MTs. This leads to KIF1C-dependent transport of
essential factors to podosome formation sites. (B) A schematic
representation of the proposed signaling cascade triggered by
PDBu treatment.
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legends. For Fig. 1A and Fig. 2K,L,O–Q, wide-field deconvolution
microscopy was performed, with images acquired as 16 bit. Maximum
intensity projections of deconvolved image stacks are shown. For all
multi-color images, single channels were contrasted independently;
gamma-adjustment was used to visualize minor details. The kymograph
(supplementary material Fig. S1I) was built along a freehand line using
the ImageJ ‘reslice’ function.
Treatments
For MT depolymerization, nocodazole (2.5 mg/ml) was added to the
culture medium for 2 hours. For stimulation of podosome formation,
phorbol 12,13-dibutyrate (PDBu) (Sigma) was used at a final
concentration of 5 mM for 40 minutes in fixed-cell experiments or was
added to the medium during live-cell imaging.
siRNA and expression constructs
Two different combinations of mixed siRNA oligonucleotides against
CLASP1 and CLASP2 were used. Combination 1 (Mimori-Kiyosue
et al., 2005) included the CLASP1-targeted siRNA sequence 59-
CCUACUAAAUGUUCUGACC-39 and the CLASP2-targeted siRNA
sequence 59-CUGUAUGUACCCAGAAUCU-39. Combination 2
(custom design, Sigma) included the CLASP1-targeted siRNA sequence
59-CGGGAUUGCAUCUUUGAAA-39 and the CLASP2-targeted siRNA
sequence 59- CUGAUAGUGUCUGUUGGUU-39. The KIF1C-targeted
siRNA sequence was 59- GUGAGCUAUAUGGAGAUCU-39. Non-
targeting siRNA (Dharmacon) was used for controls.
The following plasmid constructs were used: RFP–cortactin (a gift
from Marko Kaksonen, EMBL, Heidelberg, Germany), KIF1C–GFP and
KIF1C–mCherry (Theisen et al., 2012), EB3–mCherry lentiviral
construct (a gift from Al Reynolds, Vanderbilt University, TN),
mCherry–dTOM20 (Drosophila outer mitochondrial protein; a gift from
Ethan Lee, Vanderbilt University, TN), Tks5–GFP (Oikawa et al., 2008;
a gift from Tsukasa Oikawa, Kobe University, Japan), GFP–CLASP2 and
RFP–CLASP2 (gifts from Anna Akhmanova, Utrecht University, the
Netherlands). Mito-CLASP (dTOM20 fused with the N-terminal end of
CLASP2a in a pCS2 vector) was used for CLASP mislocalization to
mitochondria (Efimov et al., 2007).
Cloning of the dominant-negative mutations was based on the FLAG-
tagged rescue construct of human KIF1C p46FLAG-KIF1CRIP1, which
has been described previously (Theisen et al., 2012). The motor and neck
domain (amino acids 1–359) was deleted by amplifying the KIF1C tail
using PCR with the primers 59-ATGAATTCTATGGCCCGGCTGATTA-
GAGAGC-39 and 59-GTGGATCCACAGCTGCCCCACTCTC-39 and
digestion with EcoRI and BamHI. The G102E rigor mutation was
introduced into the KIF1C motor domain using a three-step mutagenesis
PCR with upstream primer 59-GGAATTCTGGAGCTATGGCTGGTG-39,
downstream primer 59-ACTGACCTTCTCCGAGTCC-39 and mutagenesis
primer 59-TGGTATAGGATTTCTCAGCCC-39. A fragment comprising
the N-terminal half of the motor domain containing the mutation was
replaced in p46FLAG-KIF1CRIP1 using EcoRI and BsiWI.
The KIF1C rescue plasmid that was used in this study to produce
KIF1C that was protected against the KIF1C siRNA was generated on the
basis of pKIF1C-eGFP described previously (Theisen et al., 2012). Five
silent point mutations were introduced in the RNAi target site using a
three-step PCR with upstream and downstream primers as for G102E
rigor and the mutagenesis primer 59-CTGTGGAGGTGTCTTACAT-
GGAAATCTACTGTGAGCG-39. The fragment containing the mutation
was exchanged with EcoRI and BsiWI to generate pKIF1CRIP2-eGFP.
Deletion of the KIF1C tail beyond the first two coiled-coil domains was
performed by introducing a BamHI restriction site after amino acid
position V490 in KIF1C using the primers 59-GGAATTCTGGAGCT-
ATGGCTGGTG-39 and 59-GAAGGGATCCACAGTTCCCCCATC-
CTC-39, and replacing the BsiWI–BamHI fragment in pKIF1CRIP2-
eGFP with the truncated fragment to create pKIF1CRIP2(1–490)-eGFP.
Transfection, infection and stable lines
For transient transfection of plasmid DNA, Fugene6 (Roche) or Amaxa
nucleofection (Lonza) (X-001 program) were used according to the
manufacturer’s protocols. Experiments were conducted 18–24 hours after
transfection. For siRNA oligonucleotide transfection, HiPerFect (Qiagen)
was used according to the manufacturer’s protocol. Experiments were
conducted 72 hours after transfection, as at this time minimal protein
levels were detected. For viral infection, supernatant containing lentiviral
particles was collected from HEK293T cells transfected with the
lentiviral expression vectors and second-generation packaging
constructs (Invitrogen). A7r5 cells were infected with supernatant
containing lentiviral particles in the presence of 8 mg/ml polybrene
overnight.
The EB3–mCherry A7r5 stable line was generated using lentiviral
constructs and maintained under the same conditions as A7r5. The
KIF1C–GFP stable A7r5 cell line was produced by G418 antibiotic
selection (500 mg/ml). HEK293T cells were cultured in high-glucose
DMEM supplemented with 10% fetal bovine serum.
Antibodies and immunofluorescence
The following antibodies were used: rabbit polyclonal anti-CLASP2 VU-
83 (Efimov et al., 2007), rabbit polyclonal anti-CLASP1 (Epitomics), rat
monoclonal anti-CLASP2 KT69 (Fitzgerald), mouse monoclonal anti-a-
tubulin DM1a (Sigma), rabbit polyclonal anti-tubulin (Abcam), rabbit
polyclonal anti-KIF1C (Cytoskeleton), mouse monoclonal (Upstate),
rabbit polyclonal (Cell Signaling Technology) anti-cortactin and mouse
monoclonal anti-FLAGH M2 (Sigma) antibodies. Highly cross-absorbed
goat anti-mouse-IgG and anti-rabbit-IgG antibodies conjugated to Alexa
Fluor 350, Alexa Fluor 488 and Alexa Fluor 568 (Invitrogen, Molecular
Probes) were used as secondary antibodies. The actin cytoskeleton was
visualized by using phalloidin conjugated to Alexa Fluor 350, 488, 568
or 647 (Invitrogen, Molecular Probes). For immunofluorescence
microscopy, cells on coverslips were fixed in 4% paraformaldehyde
plus 0.3% Triton X-100 in cytoskeleton buffer (10 mM MES, 150 mM
NaCl, 5 mM EGTA, 5 mM glucose and 5 mM MgCl2, pH 6.1) for
10 minutes at room temperature, or in 4% paraformaldehyde plus 0.1%
glutaraldehyde and 0.3% Triton X-100 in cytoskeleton buffer for
10 minutes at room temperature, or for 5 minutes in methanol (for
anti-CLASP2 staining) at 220 C˚. Fixed cells were soaked in PBS for
§1 hour. Then, non-specificity was blocked with blocking solution (1%
horse serum, 0.1% BSA in PBS) for 30 minutes. Incubation with the
primary antibodies was performed for 1 hour, and samples were then
incubated for 40 minutes with the secondary antibodies. All antibodies
were diluted in blocking solution prior to use. Immunostaining was
performed at room temperature. After washing, samples were mounted
into ProLongH Gold Antifade Reagent (Invitrogen, Molecular Probes) on
glass slides and stored at 220 C˚.
Western blot analysis
Western blotting was performed with the Protein Electrophoresis and
Western Blotting System (Bio-Rad). Briefly, cells collected from a 10-
cm dish were pelleted and resuspended in Laemmli Sample Buffer (Bio-
Rad). We applied 30 mg of total protein samples to a 10%
polyacrylamide gel and processed for electrophoresis. Nitrocellulose
membrane (0.45 mM) was used for protein blotting. The membrane was
incubated with primary and then secondary (LI-COR, IRDyeTM 800 or
700) antibodies diluted in Odyssey Blocking Buffer. To reduce the
background, 0.2% Tween-20 was added. Odyssey Infrared Imaging
System (LI-COR) was used for membrane scanning.
Quantitative analyses
Podosome number per cell (Fig. 1H; Fig. 2G,M,R; Fig. 6K) and average
podosome size (Fig. 2H) were quantified using ImageJ particle analysis
or ImagePro Analyzer (Media Cybernetics) on thresholded images of
cortactin staining visualized by wide-field or deconvolved (DeltaVision)
fluorescence microscopy. Objects were verified by comparing with actin
staining, and wrongly merged objects were split manually.
To measure the fold increase of KIF1C–GFP intensity at the cell edge
(Fig. 3C), 6 mm (20 pixels) around the cell edge was quantified using
single-plane spinning-disk confocal movies of KIF1C–GFP-expressing
cells. For the first and last frames of a movie, a cell outline was drawn
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and a band of 6-mm (20 pixels) width was taken for quantification. After
background subtraction, the summarized fluorescence intensity within
these bands was measured and the ratio between the last and the first
frames was taken as the fold increase.
The accumulation of KIF1C in lamellae (Fig. 3H) was quantified
using maximal intensity projections of confocal stacks of immunostained
KIF1C. A cell outline was drawn and a band of ,20-mm (150 pixels)
width was taken as the cell lamella. The area of lamella and area of
KIF1C accumulations were quantified using the ImageJ particle
analysis tool, and the percentage of area that contained KIF1C was
quantified.
The number of KIF1C movement events that colocalized with MT plus
ends was determined using spinning-disk confocal sequences (5 seconds/
frame) of KIF1C–GFP and EB3–mCherry-expressing cells. First, all
events of directional KIF1C displacement for 4 pixels or more were
marked in the GFP channel. Then, moving KIF1C particles were
superimposed on the mCherry channel in the ‘real’ or ‘flipped’ (control)
orientation. The number of KIF1C particles moving together with EB3
comets was detected, and the percentage of colocalized movements out of
the overall movement events was quantified. The number of KIF1C
movement events that colocalized with CLASP-coated MTs was
quantified similarly, with RFP2CLASP2 in the red channel. A flipped
red channel was used as a control. The number of KIF1C particles moving
along CLASP-rich MTs was detected, and the percentage of colocalized
movements out of the overall movement events was quantified.
KIF1C trafficking (Fig. 3J) was determined using spinning-disk
confocal sequences (5 seconds/frame) of KIF1C–GFP-expressing cells.
KIF1C puncta were manually tracked using the MTrackJ plugin of
ImageJ. Particle displacements .0.2 mm (microscope resolution) were
isolated. Trajectories were summed and divided by the total number of
particles analyzed per cell; this calculation gives the distance travelled
per particle. This analysis is modified from an approach used previously
(Barlan et al., 2013).
The colocalization of KIF1C and mitochondria (Fig. 4E,F) was
quantified as Manders coefficients using the JACoP plugin of ImageJ.
Mitochondria images were thresholded automatically and KIF1C images
were thresholded for the equal number of pixels above background.
The mitochondria in lamella (Fig. 4M) were quantified using ImageJ
particle analysis on thresholded images of mCherry–TOM20 visualized
by wide-field fluorescence microscopy, after exclusion of a 20-mm-wide
area of compacted mitochondria around the nucleus.
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Abstract
Human cells express 45 kinesins, microtubule motors that transport a variety of molecules and organelles
within the cell. Many kinesins also modulate the tracks they move on by either bundling or sliding
or regulating the dynamic assembly and disassembly of the microtubule polymer. In migrating cells,
microtubules control the asymmetry between the front and rear of the cell by differentially regulating
force generation processes and substrate adhesion. Many of these functions are mediated by kinesins,
transporters as well as track modulators. In this review, we summarize the current knowledge on kinesin
functions in cell migration.
The kinesin superfamily
The first kinesin to be discovered, kinesin-1, was isolated as
the translocator molecule in the squid giant axon [1]. Since
then, a superfamily comprising more than 40 kinesins in 14
families has been identified, many of the members of which
are microtubule-dependent translocators such as kinesin-1.
All kinesins contain amotor domainwithATPase activity and
a microtubule-binding interface. The ATP hydrolysis cycle is
coupled to changes in the affinity formicrotubules and allows
the motor to perform work. The tails of kinesins are highly
diverse and bind cargo proteins, adapters and regulatory
proteins. Themotor domain can either be positioned at theN-
terminus of the molecule for plus-end-directed motors such
as kinesin-1, at the C-terminus inminus-end-directedmotors
of the kinesin-14 family or in the middle of the molecule such
as in kinesin-13s. Many kinesins have adopted additional
functions beyond transporting cargo along microtubules
(Figure 1). For example, the homotetrameric kinesin-5 walks
on two microtubules at the same time to separate the spindle
poles at the beginning of mitosis [2], whereas kinesin-13s
are specialized microtubule depolymerases that use ATP
hydrolysis to induce microtubule disassembly, but can no
longer walk along microtubules [3]. This multitude of
functions in the transport of cellular cargo alongmicrotubules
and the organization and dynamics of the microtubule
cytoskeletonmakes kinesins central players in many essential
biological processes such as cell division, morphogenesis and
locomotion.
Cell migration
Cell migration underlies embryonic development, immune
responses and wound healing. Cell migration is stimulated
by physical signals, such as the loss of cell–cell contacts
Key words: cell adhesion, cell migration, force generation, intracellular transport, kinesin,
microtubules.
Abbreviations: APC, adenomatosis polyposis coli; Arp, actin-related protein; MMP, matrix
metallopeptidase; VEGF, vascular endothelial growth factor.
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and by chemical extracellular signalling through chemokine
gradients. Directional migration requires the establishment
and maintenance of a distinct front and rear of the cell and
can be thought of as a cycle of four processes: protrusion
at the leading edge, the formation of new adhesions at the
leading edge, the release of adhesions at the rear of the cell
and retraction of the cell rear (Figure 2). Cell migration
is largely driven by the polymerization of actin filaments
at the cell cortex and the myosin-mediated contraction of
actin bundles [4,5]. Adhesion is mediated by integrin-rich
adhesion structures that link extracellular fibres to the actin
cytoskeleton [6]. Microtubules are emerging as important
regulators of the cell migration machinery, controlling force
generation, substrate adhesion and signalling pathways [7,8].
Many of these functions are mediated or modulated by
kinesins (Figure 3) and will be discussed in detail in the
following sections.
Organization of the microtubule network
in migrating cells
Many cells depend on the microtubule cytoskeleton to
maintain the polarity of the migrating cell and for the
asymmetric regulation of force generation and adhesion at
the front and rear of the cell. The microtubule cytoskeleton
itself needs to be asymmetric to control polarity. Most
notable are the position of the centrosome in front of the
nucleus and the majority of microtubules pointing with their
plus-ends towards the leading edge of the cell. The minus-
end-directed microtubule motor dynein is implicated in the
positioning of the centrosome by exerting pulling forces on
microtubules reaching the cell edge. The front-bias is achieved
partly by the nucleation of front-directed microtubules from
the trans-Golgi network [9] and partly by the differential
regulation of microtubule dynamics in the front and
rear of the cell. This not only regulates the microtubule
number, but also the accumulation of post-translational
modifications in front-directed microtubules. A number of
kinesins preferentially transport cargo along microtubules
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Figure 1 Kinesin functions
Kinesins function as walking machines to transport cargo along microtubules (green), as dynamases to change the balance
of microtubule assembly and disassembly to either stabilize or destabilize microtubules and as cross-linkers to bundle
microtubules in speciﬁc orientations or to slide microtubules relative to one another.
Figure 2 Simpliﬁed model of cell migration
Cell migration requires the polarization of the cell with a morphologically
and biochemically different front and rear. The migration process involves
the cyclic protrusion and adhesion at the front and retraction of the cell
rear to allow forwards movement.
carrying certain modifications [10–12]. This mechanism adds
further front-directed bias to the microtubule network in
migrating cells, thereby facilitating the efficient delivery of
vesicles and molecular cargoes to the leading edge. Kinesins
not only transport these cargoes, but also contribute to
the organization of the microtubule network itself. For
example, the kinesin-13KIF2C/MCAK(mitotic centromere-
associated kinesin) reduces the lifetimes of microtubules
in the rear of the cell [13], whereas the kinesin-4 KIF4
stabilizes microtubules at the leading edge [14]. Both these
kinesins, thus, contribute to the differences in dynamics
between front- and rear-facing microtubules. The kinesin-2
KIF3A regulates the orientation and dynamicity of front-
directed microtubules [15]. The inhibition of either of these
kinesins results in decreased cell migration, which has been
attributed to mis-regulation of microtubule organization and
dynamics. Indeed, the suppression of dynamic growth and
shrinkage excursions of microtubule ends using low doses of
microtubule targeting agents impairs cell migration [16,17].
Thus kinesins are important regulators of microtubule
dynamics whose activities serve to maintain a front-biased
microtubule network.
Contribution to force-generation processes
As mentioned above, the actin cytoskeleton is usually
credited with providing the driving forces for cell protrusion
and contractility. However, microtubules are approximately
200 times stiffer than actin filaments [18] and, when laterally
reinforced, can bear very high compressive loads [19].
Application of microtubule depolymerizers to polarized
epithelial cells or fibroblasts leads to the contraction of
cells [20], suggesting that microtubules are important as
a load-bearing element in cells. Furthermore, the sliding
of microtubules in bundles by kinesin-1 motors generates
pushing forces that drive the protrusion of neurites early in
neuronal differentiation [21]. Likewise, kinesin-5 KIF11/Eg5
has been implicated in cross-linking microtubules to prevent
their penetration into parts of the neuronal growth cone. This
process is important to relay the signal of path-finding cues
to changing the direction of growth cone advance [22].
More indirectly, kinesins transportmRNAs encoding actin
and components of the actin assembly-promotingmachinery,
as well as actin regulators themselves, to the leading edge.
The accumulation of mRNA for actin, profilin and actin-
related protein (Arp)2/3, the main nucleator of branched
actin-filaments in lamellipodia at the leading edge, requires
microtubule-based transport [23–25]. Localized translation
of these mRNAs is required for efficient directionally-
persistent cell migration as it determines the sites of actin
nucleation [23]. The kinesin-2 family members KIF3A and
KIF17 bind to adenomatosis polyposis coli (APC) [26,27].
APC accumulates at the leading edge of the cell and stabilizes
microtubules, but is also a potent actin nucleator itself and
acts in synergy with formins to form long, unbranched
actin filaments [28]. The inhibition of kinesin-1 results in
reduced lamellipodial protrusion [29]. One potential cargo
of kinesin-1 mediating this function is WAVE2, which
depends on KIF5B for its localization to the leading edge of
migrating MDA-MB-231 cells [30]. WAVE2 promotes actin
nucleation and branching by Arp2/3, with both processes
being required for lamellipodia formation and protrusion
[31]. The identification of a kinesin-1 interaction motif has
led to the discovery of more than 400 potential cargoes of
kinesin-1 [32]. It is, therefore, likely that kinesin-1 mediated
transport stimulates cell protrusion through the delivery of a
number of factors to the leading edge.
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Figure 3 Kinesins transport cargo to the leading and trailing edge of the cell
This transport is required for force generation, cell adhesion and matrix remodelling. Kinesins modulate microtubule dynamics
spatially distinct at front and rear of the cell, setting up the polarity of the microtubule cytoskeleton, required for microtubules’
function in signalling, force generation and adhesion control.
Regulation of cell adhesion
The importance of microtubules and kinesins in the regu-
lation of cellular adhesion to the extracellular substrate has
been known for over a decade. Microtubule ends repeatedly
target focal adhesion sites and cause their dissolution [33].
The depolymerization of microtubules or the inhibition of
kinesin-1 leads to an increase in focal adhesion size [34,35].
Although clathrin-mediated endocytosis has been implicated
in mediating the microtubule-dependent destabilization of
focal adhesions, it is still unclear which cargoes are delivered
by which kinesin to mediate these functions [36,37]. One
possible mechanism is the release of adhesions from the
extracellular matrix using secreted proteases. KIF5B and
KIF3B transport the matrix metallopeptidase 9 (MMP-
9) to the cell periphery where it is released to the
extracellular environment and subsequently activated to
allow the degradation of collagen and elastins, an activity
essential for macrophage migration during the inflammatory
response [38]. KIF5B and KIF3A/KIF3B are involved in the
surface exposure of the transmembranous MT1 (membrane
type 1)-MMP [39], a collagenase responsible for the activation
of other MMPs [40] as well as the degradation of the matrix
components in close contact with the cell. Using in situ
zymography, the kinesin-9 KIF9 has also been shown to be
involved inmatrix degradation [41], but which protease KIF9
transports remains to be identified.
Other kinesins promote cellular adhesion by contributing
to the recycling of integrins, the major receptors of
extracellular matrix proteins. The kinesin-3 KIF1C is
involved in both focal adhesion maturation and formation
of protruding adhesion structures called podosomes [42–
44]. KIF1C participates in the maturation of trailing focal
adhesions through its α5β1-integrin transport activity [44].
α5β1-integrin is the main fibronectin receptor [45]. When
KIF1C transport is impaired, migrating retinal pigment
epithelium cells fail to form mature focal adhesions at the
rear, reducing their ability to maintain the directionality of
migration [44]. Recently, the kinesins KIF4A andKIF15 have
also been implicated in integrin recycling: KIF15, a kinesin-
12, is required for the internalization of α2β1-integrin, one of
the most important collagen receptors [46], whereas kinesin-
4 KIF4A transports α5β1-integrin into developing axons
[47]. Integrin recycling involves routes through different
compartments and complex sorting mechanisms to fine-
tune the set of displayed cell-surface receptors [48]. It is
very likely that kinesins play an important part in cargo
sorting and directional transport for spatial exocytosis with
the potential to differentially regulate substrate adhesion in
different regions of the cell.
Besides integrins, other adhesionmolecules are transported
alongmicrotubules. The kinesin-3KIF14 transports adhesion
proteins such as cadherin 11 (CDH11) and melanoma cell
adhesion molecule (MCAM) to the cell surface, thereby
decreasing the ability of cells to migrate and invade tissues
[49]. Consistent with this, KIF14 is a prognostic marker
for the metastatic potential of cancer: lung adenocarcinoma
expressing high levels of KIF14 develop fewer metastases
than those expressing low levels of KIF14 [49]. KIF14 over-
expression also impairs integrin activation, leading to mis-
regulated cell adhesion and cell migration [50].
Furthermore, kinesins have been implicated in the control
of specialized matrix-remodelling adhesion structures called
podosomes or invadosomes. Podosomes are protruding
adhesion structures formed at the ventral side of some
C©The Authors Journal compilation C©2015 Biochemical Society
82 Biochemical Society Transactions (2015) Volume 43, part 1
migratory and invasive cells that allows their trans-migration
of the basement membrane. KIF1C and KIF9 are required
for the formation as well as the turn-over of podosomes [41–
43]. Depletion of either of these kinesins leads to a dramatic
reduction in the number of podosomes formed by cells.
KIF1C and KIF9 have been observed to decorate the plus-
ends of a subset of microtubules targeting podosomes. When
podosomes are contacted by microtubule ends, they adopt a
dynamic behaviour, which results in the fusion or the fission
of targeted podosomes [43].
Signalling pathways regulating cell
migration
Recent studies highlighted the involvement of kinesins in
the control of signalling pathways regulating cell migration.
KIF3A over-expression in prostate cancer cells induces
activation of the Wnt/β-catenin pathway [51] leading to an
increase in cell proliferation as well as cell migration ability of
these cells. This function could be mediated by APC, which
controls the activity of β-catenin and binds to KIF3A [27].
Signalling is also promoted by kinesin-mediated receptor
trafficking. In vascular smooth muscle cells, in response
to vascular endothelial growth factor (VEGF) stimulation,
the kinesin-3 KIF13B transports vesicles containing newly
synthesized VEGF receptor 2 (VEGFR2) from the Golgi
to the plasma membrane. The exposure of the receptor at
the endothelial cell surface is required for VEGF-induced
endothelial cell migration [52].
The kinesin-3 KIF14 negatively regulates integrin inside-
out signalling [50]. KIF14 interacts with Radil, an effector of
Rap1.Rap1 is a smallGTPase thatmediates integrin activation
and clustering in its activated GTP-bound form [53]. KIF14
recruits Radil to microtubules and, thereby, controls the
amount of Radil available for binding to Rap1-GTP at the
plasma membrane [50]. Thus KIF14 fine-tunes the balance
between cell adhesion and cell migration.
Kinesins also bind to a number of signalling modules,
scaffold proteins with important roles in signalling processes,
which also mediate activation and cargo-loading of kinesins
[54]. It will be interesting to see to which extent these
signalling proteins affect the activity of kinesin cargoes and
modulate the signalling state atmicrotubule endswhere cargo
and motors tend to accumulate.
Conclusion
Kinesins are involved in most steps of cell migration,
from force-generating processes that allow protrusion, to
regulating adhesion and matrix degrading capabilities and
the modulation of signalling pathways controlling migration.
Until now, studies have tended to focus on one kinesin’s
involvement in one aspect of cell migration. How several
kinesins work together and how the different cargoes of each
kinesin contribute to its function in regulating cell migration
is a key challenge for the future. Important requirements to
successfully address this challenge will be the identification
of the cargoes being transported by each kinesin and the
microtubule sub-populations that serve as preferential tracks
for their transport. Recent developments, including assays
that facilitate kinesin-cargo identification [55] and attempts
to crack the tubulin code [12,56], promise significant progress
in this area in the coming years.
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